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RNA interference (RNAi) refers to a conserved sequence-specific gene 
regulation mechanism mediated by small RNA molecules. RNAi plays a 
fundamental role in many important biological processes in eukaryotes. In 
addition, it becomes a valuable research tool for genomic scale analysis of 
gene function as well as a potential therapeutic strategy for many diseases. 
RNAi process is mainly divided into three steps: dicing, RNA-induced 
silencing complex (RISC) assembly and silencing. Dicing and silencing are 
carried out by two super RNA-protein complexes: the small RNA-processing 
machinery and the RISC. Ribonuclease III (RNase III) enzymes in the small 
RNA-processing machinery dice the precursor double-stranded RNAs 
(dsRNAs) into small dsRNAs of 21~27 nucleotides (nts), whereas Argonaute 
in the RISC is the key effector for slicing mRNA or repressing the translation 
of the mRNA targets in a sequence-specific manner.  
Structural and functional studies on RNase III enzymes and Argonautes 
have revealed the molecular mechanisms regarding small RNA biogenesis and 
RISC-mediated gene silencing in great details. However, the structural 
mechanism regarding RISC assembly, the primary step linking dicing and 
silencing, is largely unknown. Human RNA helicase A (RHA or DHX9) was 
reported to function as an RISC-loading factor and such function is mediated 
mainly by its dsRNA-binding domains (dsRBDs). Here, we report the crystal 
structures of human RHA dsRBD1 and dsRBD2 in complex with dsRNAs, 
respectively. Structural analysis not only revealed the structural features of 
higher small interfering RNA (siRNA)-binding affinity displayed by dsRBD1, 
but also identified a crystallographic dsRBD pair of physiological significance 
in cooperatively recognizing dsRNAs. Structural observations were further 
validated by isothermal titration calorimetric assay (ITC). Moreover, 
co-immunoprecipitation (co-IP) assays coupled with RNase treatment as well 
as mutagenesis assay demonstrated that integrated tandem dsRBD1+2 with 
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high dsRNA-binding affinity are required for RHA to associate with RISC and 
such association is mediated by dsRNA.  
RNase III enzymes are a collection of Mg2+-dependent endoribonucleases 
that show specificity for dsRNA cleavage. Recently, an RNase III protein 
(named as DCR1) containing an N-terminal domain (NTD), an RNase III 
domain and two C-terminal dsRBDs has been shown to serve as the Dicer of 
several budding yeast species. This finding led us to investigate the structure 
and function of a budding yeast Dicer-like protein from a budding yeast 
species lacking Argonaute, the P. stipitis. Here we report the crystal structure 
of the NTD from P. stipitis DCR1 (PsDCR1). Sequence alignment analysis 
and structural comparison between the PsDCR1 NTD and the NTD from K. 
polysporus DCR1 (KpDCR1) suggest that they may share common functions 
and evolutionary origin. Analytical ultracentrifuge (AUC) and Glutaraldehyde 
(GA)-crosslinking assays showed that  NTD from PsDCR1contributes an 
additional dimerization interface to PsDCR1 homodimer. However, this 
interface is not essential for the dimerization of PsDCR1. The electronic 
mobility shift assay (EMSA), ITC and RNA cleavage assays together 
validated the essential roles of RNase III domains in dsRNA cleavage and 
dsRBD1 in dsRNA binding. Meanwhile, they demonstrated the importance of 
its NTD and C-terminal dsRBD-like domain (dsRBD-L) in the assembly of 
optimum PsDCR1-dsRNA ribonucleoprotein complex for efficient dsRNA 
cleavage. By a co-IP experiment, we further showed that the NTD and 
dsRBD-L domain associate with each other.  
Taken together, our structural and functional efforts reveal a potential 
working model for siRNA recognition by RHA tandem dsRBDs, and together 
they provide direct structural insights into RISC assembly facilitated by RHA. 
In addition, our structural and functional studies of PsDCR1 validate the 
specific roles and the relationships of those domains within PsDCR1, and 
together they shed some light on the functions of PsDCR1. These features of 
PsDCR1 may also be extrapolated to budding yeast Dicer. 
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CHAPTER 1: Introduction 
Central dogma is a fundamental rule that governs the transfer of genetic 
information in organisms. The main theme in central dogma is that DNA is 
transcripted into RNA, and then RNA is translated into protein (Crick, 1970). 
This production line of proteins should be tightly regulated to ensure that the 
expression level of each protein exactly meets the requirements of an 
organism’s development, both spatially and temporally. Therefore, diverse 
regulatory processes can be found in each step of this line in eukaryotes, such 
as the transcriptional control through the actions of control factors on gene 
regulatory sequences, the post-transcriptional control through RNA export, 
RNA splicing and message RNA (mRNA) stability regulation, the translational 
control as well as the post-translational control through various protein 
modifications, etc. (Dahan et al, 2011). In addition, RNA silencing or RNA 
interference (RNAi) has been discovered to be one of the most powerful 
regulatory processes, as it regulates at least 30% of gene expression at both 
post-transcriptional and translational levels in eukaryotic cells (Carthew & 
Sontheimer, 2009; He & Hannon, 2004).  
RNAi is a biological process where gene expression is inhibited by small 
RNA molecules. This process not only plays an important role in directing 
development through regulating gene expression, but also functions as a cell 
immunity system against foreign nucleic acid invaders, such as the genetic 
materials of virus during infection and the transposons (He & Hannon, 2004; 
Plasterk, 2002). Recently, RNAi has become a valuable research tool for 
studying gene function in vivo, especially for genomic-scale and high 
throughput analysis (Mohr et al, 2010). Meanwhile, it is also a potential gene 
therapeutic strategy for many diseases (Martinez et al, 2013). Hence, 
investigating the detailed mechanism of RNAi is of great importance. 
Generally, RNAi process can be divided into three sequential steps: 
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dicing, RNA-induced silencing complex (RISC) assembly and silencing. 
Dicing is the processing of long precursor double-stranded RNAs (dsRNAs) 
into small dsRNAs of characteristic size and structure. RISC assembly is the 
incorporation of the small dsRNAs into Argonaute proteins to form the 
functional RISC, while silencing is the inhibition of specific gene expression 
by RISC through distinct mechanisms. The dicing and silencing steps are 
carried out by two super protein-RNA machineries, the RNA-processing 
machinery and the RISC, respectively. During the last 15 years, significant 
research efforts have been invested into the dicing and silencing steps. Owing 
to the rapid progress on X-ray crystallography, a technique that allows the 
elucidation of the three-dimensional structures of macromolecules at 
atomic-level resolution, the structural mechanisms of dicing and silencing 
have been uncovered to a large extent. However, current knowledge on the 
RISC assembly step is still limited. Particularly, the structure mechanism and 
functional components of this step are largely unknown. By utilizing 
immunoprecipitation combined with proteomics, a variety of proteins 
associated with Argonaute have been identified (Hock et al, 2007; Landthaler 
et al, 2008; Meister et al, 2005). A subset of these proteins is proposed to be 
involved in the RISC assembly step. However, the structure and detailed 
functions of these proteins need further investigation. 
Exciting findings have been emerging from the field of RNAi from time 
to time. In 2009, David P. Bartel’s group reported that RNAi is indeed present 
in several budding yeast species (Drinnenberg et al, 2009). This is against a 
previous notion that RNAi is absent in all budding yeast species. They also 
showed that these species use a noncanonical Dicer protein to generate 
siRNAs (Drinnenberg et al, 2009). Although structural and functional studies 
on a noncanonical Dicer protein and an Argonaute protein from a budding 
yeast species have provided important insights into the budding yeast RNAi 
pathway, yet the detailed RNAi pathway in budding yeast, the existence of 
RNAi in other budding yeast species and the function of budding yeast 
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Dicer-like proteins in several budding yeast species lacking Argonaute 
proteins remain largely unknown. 
In the subsequent sections of this chapter, we will review (1) the general 
RNAi pathway in mammals; and (2) the structural insights into dicing and 
silencing provided by structural studies of key components involved in these 
steps; as well as (3) the current view of RISC assembly in both D. 
melanogaster and mammals; and finally (4) the fundamentals of X-ray 
crystallography. 
1.1 A biological overview of RNAi 
1.1.1 General RNAi pathway in mammals 
In 1998, Craig C. Mello and Andrew Fire reported that dsRNA 
successfully silences the targeted gene when they were investigating the 
regulation of muscle protein production (Fire et al, 1998). This gene silencing 
phenomenon, together with previous reported phenomena including quelling 
(Romano & Macino, 1992), co-suppression (Van Blokland et al, 1994) and 
virus-induced gene silencing (VIGS) (Dougherty & Parks, 1995), are 
collectively termed as RNAi or RNA silencing. Subsequent studies on RNAi 
have elaborated this pathway in great detail. 
One of the hallmarks of RNAi is the small dsRNAs with distinct features. 
These small dsRNAs are 21-30 nucleotides (nts) in length, and each of them 
contains a 5’ phosphate and a 3’ 2-nt overhang. Based on their cellular origins 
and structures, the small dsRNAs found in mammals are roughly classified 
into three types: small interfering RNAs (siRNAs), microRNAs (miRNAs) 
and PIWI-interacting RNAs (piRNAs) (Yang & Yuan, 2009). The piRNAs are 
known to be germ line-specific. However, a large portion of the piRNA 
pathway remains uninvestigated. In contrast, the siRNA and miRNA pathways 
are well established. The differences between miRNAs and siRNAs mainly lie 
on two aspects (Carthew & Sontheimer, 2009; Wilson & Doudna, 2013). 
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Firstly, the miRNAs are endogenous, as they are the transcriptional products 
of the organisms’ own genome. Whereas the siRNAs are mainly exogenous 
(exo-siRNAs), as they are derived from viruses and transgenes. Nevertheless, 
there is a small subset of endogenous siRNAs (endo-siRNAs) derived from 
self-complementary hairpin transcripts, convergent mRNAs and mobile 
elements (Fukunaga et al, 2012). Secondly, the miRNAs contain mismatches 
and bulges in their duplexes, as they are generated from the 
primary-microRNAs (pri-miRNAs) with a partially complementary 
double-stranded stem. In contrast, the siRNAs are perfectly matched in their 
duplexes, since they are excised from the fully complementary long dsRNAs. 
These differences indicate that the biogenesis of miRNAs and siRNAs adopt 
different mechanisms. 
As shown in Figure 1-1, the biogenesis of miRNAs in mammals starts 
from the cleavage of pri-miRNAs by microprocessors (Gregory et al, 2004). 
The pri-miRNA contains a double-stranded stem region of ~33 base pairs (bps) 
flanked by a 5’ and a 3’ long single-stranded (ss) ends and a distal terminal 
loop. The microprocessor is a protein complex consisting of a ribonuclease III 
(RNase III) family member Drosha and a dsRNA-binding domain 
(dsRBD)-containing protein (dsRBP) DGCR8 (Denli et al, 2004; Han et al, 
2004). Drosha cleaves pri-miRNAs via the assistance of DGCR8 where 
DGCR8 recognizes the stem-ssRNA junction of the pri-miRNAs and helps to 
position the cleavage sites of Drosha ~11 bps away from the junction (Han et 
al, 2006; Sohn et al, 2007). This cleavage step happens in the nucleus. After 
cleavage, the products named precursor-microRNAs (pre-miRNAs) are 
exported to cytoplasm with the help of exportin-5 and Ran-GTP (Lund & 
Dahlberg, 2006; Yi et al, 2003). The pre-miRNAs are then recognized and 
cleaved by another RNase III family member Dicer to the miRNAs with the 
distinct features as mentioned above (Bernstein et al, 2001; Zamore et al, 





Figure 1-1 The siRNA (left) and miRNA (right) pathways of RNA interference 
(Wilson and Doudna 2013). 

duplexes (Hammond et al, 2001). One strand of the duplex is selected as guide 
strand, while the other one is named as passenger strand and removed 
immediately. The guide-strand RNAs then direct bound Argonautes to target 
mRNAs and pair with mRNAs by complementary base-pairing (Hammond et 
al, 2000). Finally, specific gene expression is inhibited through either mRNA 
cleavage or translational repression (Pillai et al, 2007). 
 Unlike the miRNA pathway, the siRNA pathway in mammals starts 
from the processing of long dsRNAs into siRNAs by Dicer in cytoplasm. After 
cleavage, the siRNA pathway and the miRNA pathway converge at 
downstream steps.  
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1.1.2 Drosha and Dicer, two key components in si/miRNA biogenesis 
Another hallmark of RNAi is Dicer. Both Drosha and Dicer, two key 
components in siRNAs and miRNAs biogenesis, belong to the RNase III 
family. The structural studies of the RNase III proteins have provided direct 
structural basis for the biogenesis of the small dsRNAs in RNAi pathways. 
Here, we review the structure and functions of the RNase III family proteins. 
1.1.2.1 Domain composition of the RNase III family proteins 
The RNase III family is a collection of Mg2+-dependent 
endoribonucleases that show specificity for dsRNA cleavage (Robertson et al, 
1968). Based on domain composition, the RNase III family proteins are 
divided into three classes, exemplified by bacterial RNase III, human Drosha 
and Dicer, respectively (Blaszczyk et al, 2004). As shown in Figure 1-2A, 
class 1 is the simplest and smallest one among these three classes. Each 
member of class 1 contains a single RNase III domain followed by a dsRBD. 
Class 2 is a little bit more complicated, where each member harbors a long 
N-terminal region, two RNase III domains (denoted as RNase IIIa and IIIb) 
and a C-terminal dsRBD. Class 3 is the most complicated class. Typically, 
each member in class 3 contains an N-terminal DExD/H-box helicase core 
followed by a DUF283 domain, a PAZ domain, two RNase III domains and a 
C-terminal dsRBD (MacRae & Doudna, 2007). The sequence of the RNase III 
domain is characterized by a stretch of conserved residues (37-ETLEFLGD-44 
in A. aeolicus RNase III). This stretch of residues is known as the RNase III 
signature motif. It is this signature motif that led to the discovery of RNase III 
family members.  
1.1.2.2 Functions of the RNase III family proteins 
Functionally, the RNase III family enzymes play a major role in a wide 
variety of dsRNA precursors processing. Bacterial RNase III enzymes are 
involved in precursor ribosomal RNA (pre-rRNAs), tRNAs and phage mRNAs 
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processing (Apirion & Miczak, 1993). Drosha recognizes and processes the 
pri-miRNAs into the pre-miRNAs via the assistance of DCGR8, thereby 
playing a role in the miRNAs biogenesis (Han et al, 2006). Alternatively, 
human Drosha is also involved in the processing of pre-rRNAs (Wu et al, 
2000). Dicer is a specialized RNase III that process long dsRNAs or 
pre-miRNAs into siRNAs or miRNAs with a precise length ranging 21-23 nts. 
Thus, Dicer is critical for the biogenesis of both siRNAs and mi RNAs 
(Bernstein et al, 2001).  
On the other hand, the accessory domains or interaction partners of 
different RNase III enzymes render them specificity in either substrates or 
product length. As mentioned above, the Drosha-binding partner DGCR8 
functions as a molecular anchor which positions the cleavage sites ~11 bps 
from the dsRNA-ssRNA junction (Han et al, 2006). The dsRBD of Rnt1 
specifically binds to the tetraloop AGNN of substrate RNAs (Leulliot et al, 
2004; MacRae & Doudna, 2007). The helicase core of Dicer specifically 
recognizes the hairpin RNA loop, while the PAZ domain of Dicer accurately 
determines the product length by recognizing the 3’ 2-nt overhangs of 
substrate RNAs (Lingel et al, 2004; Ma et al, 2012; Ma et al, 2004).  
1.1.2.3 Structural insight into dsRNA processing by the RNase III family 
proteins  
Rich structural information of the RNase III proteins has extensively 
elucidated the structural mechanisms of their substrate recognition and target 
cleavage. To date, a series of bacterial RNase III structures have been reported 
in different forms, including free form, divalent metal ions-binding form and  
dsRNAs-binding form (Blaszczyk et al, 2004; Blaszczyk et al, 2001; Gan et al, 
2005; Ji, 2006). In these structures, the RNase III proteins are homodimerized 
via the RNase III domains. The dimerization of the RNase III domains creates 
a valley which accommodates the substrate dsRNA (Figure 1-2B&C). An 
initial study reveals that the three-dimensional fold of the RNase III 
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polypeptide chains brings together two clusters of catalytically active residues 
at both ends of the valley. The two clusters of residues were proposed to be 
two compound catalytic centers with each center consisting of two RNA 
cleavage sites. This study led to the double-processing-center model 
(Blaszczyk et al, 2001). However, a subsequent study on both human Dicer 
and E. coli RNase III has amended this model to the single-processing-center 
model (Zhang et al, 2004). Within the single processing center, there are two 
RNA cleavage sites. Each RNA cleavage site cleaves one strand of the duplex 
RNA, and thereby generates products with 3’ 2-nt overhangs. The structure of 
an A. aeolicus RNase III catalytic mutant bound to its dsRNA product (Figure 
1-2C) has provided the structural basis for the single-processing-center model 
as well as the induced-fit model (Ji, 2006). In the induced-fit model, a linker 
region between the RNAse III domain and the dsRBD facilitates reorientation 
of the dsRBD during protein-RNA recognition (Figure 1-2B&C).  
Initial structural and biochemical studies on the RNase III proteins imply 
that the Dicer protein may function through intramolecular dimerization via its 
two RNase III domains. This implication has later been verified by the crystal 
structure of a “minimal Dicer” from a human parasite G. intestinalis (Figure 
1-2A&D) (Macrae et al, 2006b). In the structure of G. intestinalis Dicer, the 
arrangement of the two RNase III domains (denoted as RNase IIIa and RNase 
IIIb) closely resembles that of the RNase III domains from the A. aeolicus 
RNase III homodimer (Figure 1-2F). This finding further suggests that 
dimerization within the two RNase III domains and the 
single-processing-center model may be applicable to all RNase III enzymes. In 
addition, the structure of PAZ-dsRNA complex (Figure 1-2E) reveals that the 
PAZ domain specializes in the 3’ 2-nt overhang recognition (Ma et al, 2004). 
Moreover, the distance from the processing center to the 3’ 2-nt 
overhang-binding site is ~65 ϳ, which is equal to the length of a 25-bp dsRNA. 
Based on these observations, structural modeling of a 25-bp dsRNA into the G. 




Figure 1-2 Crystal structures of RNase III family enzymes. 
(A) A schematic representation of the domain structure of the three classes of RNase 
III family enzymes. The color code of the protein domains in (B, C, D, E, F) are 
the same as shown in (A) while all RNA molecules are colored in gold. 
(B) Cartoon view of the crystal structure of T. maritima RNase III in ligand-free 
form (PDB: 1O0W). B&C together show the induced-fit process of prokaryotic 
RNase III during dsRNA binding. 
(C) Cartoon view of a catalytic mutant A. aeolicus RNase III bound to its cleaved 
dsRNA product (PDB: 2EZ6). 
(D) Cartoon view of the crystal structure of G. intestinalis Dicer (PDB: 2FFL). 
(E) Cartoon view of the crystal structure of PAZ-dsRNA complex, with each PAZ 
domain bound to one end of the 9-bp dsRNA (PDB: 1SI3). 
(F) Superimposition of the RNase III domains of A. aeolicus RNase III homodimer 
(in pink) with the G. intestinalis Dicer (RNase III domains in yellow). 
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Under this mechanism, Dicer first recognizes the 3’ 2-nt overhangs with its 
PAZ domain. Then, Dicer measures the distance from the dsRNA 3’ to the 
cleavage sites with the connector  helix. Finally, Dicer cuts the duplex 
dsRNAs at the cleavage sites (Macrae et al, 2006a). The function of the PAZ 
domain has been further validated by the observation that the deletion of PAZ 
domain from Dicer generates dsRNA products with variable lengths in vitro 
(MacRae et al, 2007). 
1.1.2.4 Structure of the canonical Dicer 
Although the studies on G. intestinalis Dicer has far-reaching implications 
for the understanding of the structural mechanism of dsRNA processing by the 
canonical Dicer, the G. intestinalis Dicer is only a simplified version of the 
canonical Dicer. The canonical Dicer contains additional DEXD/H-box 
helicase core and dsRBD (Figure 1-2A). Moreover, the canonical Dicer in 
humans generates products of 21-23 nts in length, which is relatively shorter 
than the products of G. intestinalis Dicer. In order to obtain the 
three-dimensional structure of ~200 KD canonical Dicer, other techniques, 
such as cryo-electron microscope (Cryo-EM) and single particle analysis, have 
been utilized. Those initial EM structures of Dicer-TRBP2 and 
Dicer-Ago2-TRBP2 from human show that human Dicer adopts an L-shape 
conformation (Lau et al, 2009; Wang et al, 2009a). Based on a 
newly-developed domain localization strategy for EM, a more recent structure 
allows us to observe the three-dimensional molecular architecture of the 
human Dicer more clearly (Lau et al, 2012). Comparison between the human 
Dicer and the G. intestinalis Dicer reveals a notable difference in the 
arrangement of their two RNase III domains. The RNase III domains of 
human Dicer are reoriented with respect to the PAZ domain, leading to a more 
compact structure (Figure 1-3A). This reorientation may explain why the 
human Dicer generates shorter products. Moreover, in this structure, the 
additional helicase core forms a clamp-like structure embracing the RNase III 
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domains (Figure 1-3B&C). This arrangement is in good agreement with two 
proposed functions of the helicase core. During the processing of the long 
dsRNAs, this helicase core drives the whole dicing machinery to translocate 
along the long dsRNAs by virtue of consuming ATP; while during the 
processing of the pre-miRNAs, the helicase core specifically recognizes the 
loop region of pre-miRNAs (Ma et al, 2012). These two functions of helicase 
core are well established for D. melanogaster Dicer-1 and Dicer-2 (Cenik et al, 
2011). 
 
Figure 1-3 EM structure of human Dicer (Lau et al, 2012) 
(A) The EM structure of the human Dicer. The crystal structure of G. intestinalis 
Dicer (PDB: 2FFL) docked onto the positions of the PAZ and DUF283 domains 
identified in this EM map. The double-headed arrow indicates the rearrangement 
required to align the RNase III domains in the two models. 
(B) Segmented map of the human Dicer with crystal structures of homologous 
domains docked. The homologous domain derived from the following structures: 
PDB 4A36, 2KOU, 2FFL4 and 3C4T.  
(C) Model for the pre-miRNA recognition by the human Dicer. A pre-miRNA hairpin 
is modeled into the proposed binding channel of the human Dicer, with the 
stem-loop fit in the RNA-binding cleft of the helicase core. 
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1.1.3 Dicer binding partners, TPBP2 and PACT 
Most Dicer proteins have been shown to interact with dsRBPs. In D. 
melanogaster, Dicer-2 is associated with R2D2 or Loquacious-PD (Loqs-PD), 
and Dicer-1 is associated with Loqs-PA or Loqs-PB (Saito et al, 2005). The 
four isoforms (Loqs-PA, Loqs-PB, Loqs-PC, Loqs-PD) of Loqs and R2D2 are 
all dsRBD-containing proteins (dsRBPs) (Liu et al, 2006; Marques et al, 2009). 
Although these dsRBPs share similar domain composition, they have distinct 
roles in the RNAi pathway of D. melanogaster, which will be discussed in 
detail later. In humans, trans-activation response RNA-binding protein 2 
(TRBP2) and protein activator of PKR (PACT), are associated with Dicer by 
forming a triple complex (Haase et al, 2005; Kok et al, 2007; Lee et al, 2006). 
Both TRBP2 and PACT contain three copies of dsRBDs. The first two 
N-terminal dsRBDs of each protein are responsible for dsRNA binding, while 
the third noncanonical dsRBD is in charge of interacting with Dicer (Daniels 
et al, 2009; Lee et al, 2006). Remarkably, TRBP2 and PACT play different 
roles in the RNAi pathway of humans. Specifically, TRBP2 contributes to 
accelerating dicing kinetics by enhancing the stability of Dicer-substrate 
binding (Chakravarthy et al, 2010), generating small RNA isoforms (Lee & 
Doudna, 2012), assisting duplex loading from Dicer to Argonaute and sensing 
the asymmetry of RNA duplex (Chendrimada et al, 2005; MacRae et al, 2008; 
Wang et al, 2009a). PACT functions in product length determination and 
generates isoforms of small RNAs. However, due to substrate specificity, their 
functions do not overlap (Lee et al, 2013). 
1.1.4 Argonaute, the key effector of RISC-mediated gene silencing  
Argonaute protein is the third hallmark of RNAi. In mammals, although 
the biogenesis of siRNAs and miRNAs are different in some aspects, these 
two categories of small RNAs are all loaded onto Argonautes to form the 
mature RISC for downstream gene silencing. Small RNA and Argonaute are 
two essential components of RISC, while RISC is the key effector of small 
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RNA-mediated gene silencing. Therefore, the key to analyzing the detailed 
mechanism of RNA-mediated gene silencing runs in parallel with the study of 
the structure and functions of Argonautes. 
1.1.4.1 Structures of prokaryotic Argonautes 
Argonautes are found in archaea, bacteria and eukaryotes. Generally, they 
are divided into two clades: Argonaute clade and PIWI clade. In mammals, 
there are 4 Argonaute clade members (Ago1, Ago2, Ago3 and Ago4) and 3 
PIWI clade members (MIWI, MILI and MIWI2). The Argonaute clade is 
involved in the siRNAs and miRNAs-mediated gene silencing while the PIWI 
clade is involved in the germline-specific events (Girard et al, 2006). All four 
Argonaute clade members share similar domain composition, including 
N-terminal, PAZ, MID and PIWI domains (Figure 1-4A). However, Ago2 is 
the only member in Argonaute clade that is indispensable for mammal 
development. Moreover, only Ago2-containing RISC is reported to be capable 
of substrate RNA cleavage (Liu et al, 2004). At the same time, the first crystal 
structure of a full-length Argonaute protein from the archaeal P. furiosis 
(PfAgo) was reported. Within this structure, the N-terminal, PIWI and MID 
domains form a crescent-shaped base, where the PIWI domain is positioned at 
the center of the base. While the PAZ domain is held above this base by a 
“stalk” which is formed by the linker region between the N-terminal and PAZ 
domain. The “slicer” role of Argonaute in RISC was raised based on the 
observation that the PIWI domain adopts a RNaseH-like fold (Song et al, 
2004). Collectively, these and many other biochemical and structural data 
established Ago2 as the catalytic engine of RNAi in mammals (Liu et al, 2004; 
Meister et al, 2004; Song et al, 2004). Subsequent structural studies on A. 
aeolicus Argonaute (AaAgo) in its free form and bound with an externally 
siRNA, established this eubacterial AaAgo as a bona fide guide-strand 
DNA-mediated site-specific RNA endonuclease (Yuan et al, 2006; Yuan et al, 
2005). Follow-on structural studies on eubacterial T. thermophiles Argonaute 
14 

(TtAgo) have provided substantial details for understanding the guide-strand 
recognition as well as the RNA target recognition and cleavage (Wang et al, 
2008a; Wang et al, 2009b; Wang et al, 2008b). In the structure of TtAgo-guide 
DNA (Figure1-4B), the guide-strand DNA locates in the “guide-strand-binding  
 
Figure 1-4 Structural mechanism of guide-strand and target recognition by 
prokaryotic Argonautes. 
(A) A schematic representation of the domain structures of Argonautes. The color 
code of the protein domains in (B, C, D) are the same as shown in (A). 
(B) Cartoon representation of the crystal structure of TtAgo bound to a 
5'-phosphorylated 21-nt guide-strand DNA (PDB: 3DLH).  
(C) Cartoon representation of the crystal structure of TtAgo bound to a 
5'-phosphorylated 21-nt guide-strand DNA and a 20-nt target RNA (PDB: 3F73).  




channel” between the PAZ-containing lobe (N-terminal and PAZ domains) and 
the PIWI-containing lobe (MID and PIWI domains). The 5’ phosphate of 
guide-strand DNA is anchored by the junction of MID and PIWI domains, 
while the 3’ 2-nt overhang is anchored by the PAZ domain. The exposed base 
2-6 of the Watson-Crick edges on the guide strand is identified as part of the 
“seed region” (Wang et al, 2008b). The arginine residue which locks base 
10-11 at the cleavage site is reoriented in the TtAgo-guide DNA-target RNA 
ternary complex (Figure 1-4C). Moreover, the guide-strand-binding channel is 
widened in the ternary complex to accommodate the additional target RNA. 
Mutagenesis experiments have revealed that the cleavage activity of TtAgo is 
severely reduced or abolished if a single mismatch is introduced into the seed 
region (2-8 nt) or the regions near the cleavage site (9-10 nt and 11-12 nt) 
(Wang et al, 2008a). Significant domain rearrangements are associated with 
small RNA binding, RNA target nucleation, propagation and cleavage, which 
were observed in a series of ternary complex structures of TtAgo catalytic 
mutants bound to a guide DNA and target RNAs of various lengths (Wang et 
al, 2009b). It was also observed for the first time that 3’-end of guide strand is 
released from the PAZ binding pocket during the propagation and cleavage 
steps of the siRNA-mediated cleavage cycle. These observations have led to 
the four-step Argonaute-mediated catalytic cleavage cycle model (Figure 
1-4D).  
1.1.4.2 Structure of eukaryotic Argonautes 
Although the function of prokaryotic Argonautes has not been 
investigated, their structural studies have presented the first view of the 
three-dimensional structures of their eukaryotic counterparts. They have 
further implied us possible mechanism of RNA-mediated mRNA cleavage in 
eukaryotes. However, eukaryotic Argonautes differ from prokaryotic 
Argonautes in several aspects. Firstly, eukaryotic Argonautes are relatively 
larger than prokaryotic Argonautes due to the insertion segments. Secondly, 
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eukaryotic Argonautes use RNA guide strands rather than DNA guide strands. 
Thirdly, eukaryotic Argonautes recruit a variety of binding partners for gene 
silencing (Meister et al, 2005). Therefore, to further investigate the functions 
of RISC in mammals, continuous structural and functional efforts on the 
eukaryotic Argonautes are required.  
 
Figure 1-5 Crystal structures of eukaryotic Argonautes. 
(A) Cartoon presentation of the human Ago2 in complex with miR-20a (PDB: 4F3T). 
The 5' uridine of miR-20a is shown as red stick and the unique nucleotide 
specificity loop is also highlighted in red.  
(B) Cartoon presentation of the crystal structure of K. polysporus KpAgo in complex 
with guide RNA (PDB: 4F1N). The 5' uridine of guide RNA and corresponding 
specificity loop are also highlighted in red. Two constant insertion segments 
within PAZ domain was highlighted in blue. 
(C) Cartoon diagram of our current view of eukaryotic Argonautes recognizing 
guide-strand RNA. The magenta spheres are Mg2+ ions. The 5’-phosphate 
binding pocket is located at the junction of MID and PIWI domains, while the 3’ 




Initial view of eukaryotic Argonaute proteins comes from the structural 
information of their isolated domains. The structural studies of MID and PAZ 
domains have provided important structural insights into 5’ nucleotide 
recognition, the sequence bias at the 5' position of the guide strand and 
specific 3’ 2-nt overhang recognition (Boland et al, 2011; Boland et al, 2010; 
Frank et al, 2010; Lingel et al, 2004; Ma et al, 2004; Ma et al, 2005). Recently, 
several groups have achieved dramatic breakthrough in structure 
determination of the full-length eukaryotic Argonautes. Almost concurrently, 
the structures of three eukaryotic Argonautes have been determined: the 
human Ago2 (Schirle & MacRae, 2012), human Ago2-miR-20a complex 
(Elkayam et al, 2012) and the K. polysporus Argonaute bound to a 
guide-strand RNA (Nakanishi et al, 2012). The human Ago2 (hAgo2) has a 
similar overall structure and guide-strand binding mode to those of prokaryotic 
Argonautes. Moreover, the folds of individual domains are well conserved 
among all Argonautes, while their relative positions are not well aligned. The 
“seed region” (2-8 nt) is also observed in hAgo2 (Figure 1-5C). However, 
several new features are present in the hAgo2 structure. Firstly, the 
guide-strand-binding channel in hAgo2 is more hydrophilic than that of the 
prokaryotic Argonaute, which may explain why eukaryotic Argonautes prefer 
RNA rather than DNA. Secondly, a kink (the helix-7) is introduced into 6-7-nt 
of the guide-strand RNA (Figure 1-5C), which may function in specific 
miRNA target recognition and product release. Thirdly, there are 
tryptophan-binding sites on the surface of PIWI domain, suggesting that this is 
the interaction area for the GW182 family proteins (Schirle & MacRae, 2012). 
Remarkably, the human Ago2-miR-20a complex represents the hAgo2 bound 
to a physiologically significant substrate. Striking similarities between the 
hAgo2 and prokaryotic Argonautes are observed again (Figure 1-4B&C, 1-5A). 
Moreover, both biochemical and structural data reveal that the miR-20a 
stabilizes the hAgo2 by interacting with every domain of hAgo2. The hAgo2 
stabilizes the miR-20a by several kinks and turns which protrude to the 
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RNA-binding channel (Elkayam et al, 2012). The overall structure of the 
budding yeast Argonaute from K. polyporus (KpAgo) resembles the bilobal 
architecture of other eukaryotic Argonautes, except for some insertion 
segments (Figure 1-5B). Notably, apart from the previously confirmed 
catalytic triad in other Argonautes, the fourth catalytically active residue has 
been identified (Figure 1-5C). The authors have also proposed that the 
catalytic tetrad (H, D, D, E) is universally conserved among the majority of 
RNase H family members (Nakanishi et al, 2012). Together with biochemical 
studies, the structural study established KpAgo as a budding yeast “slicer” 
dependent on Mg2+ ions, similar to hAgo2.  
1.1.5 Argonaute binding partner, GW182 
Small RNA-mediated gene silencing regulates gene expression through 
three mechanisms: mRNA cleavage, translational inhibition followed by 
mRNA degradation, and heterochromatin modification (Lippman & 
Martienssen, 2004; Jackson & Standart, 2007). Although Ago2 is the only one 
that processes robust “slicer” activity among the four Argonaute members in 
mammals, the other three Argonautes are shown to be capable of small 
RNA-mediated gene silencing through translational inhibition (Pillai et al, 
2007). After the small RNAs are loaded onto Argonautes and the mature 
RISCs are formed, it is the time to choose a mechanism for gene silencing. 
The mechanism is determined by two factors: the complementary degree of 
guide strand-mRNA target and the Argonaute that the small RNA is loaded 
onto (Carthew & Sontheimer, 2009). The small RNAs silence gene expression 
through mRNA cleavage only when they are loaded onto Ago2 and their guide 
strands are fully complementary to their target mRNAs. On the other hand, the 
small RNAs silence gene expression through translational repression when 
they are loaded onto other Argonautes or their guide strands are partially 
mismatched with their target mRNAs at or near their center. In mammals, the 
vast majority of miRNAs silence gene expression through translational 
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repression. Under this mechanism, Argonautes recruit a family of glycine- and 
tryptophan-rich proteins, the GW182 family. 
GW182 proteins consist of two parts of known functions: N-terminal GW 
repeats for Argonaute-binding, and the Mid and C-terminal regions for gene 
silencing (Eulalio et al, 2009). The depletion of GW182 in D. melanogaster 
suppresses the silencing of miRNA targets, suggesting a crucial role of 
GW182 in the miRNA pathway (Rehwinkel et al, 2005). Furthermore, 
translation repression and mRNA degradation are observed after tethering 
GW182 to a reporter mRNA, demonstrating that GW182 proteins function 
downstream of Argonautes (Behm-Ansmant et al, 2006). Recently, it has been 
shown that GW182 proteins directly recruit the PAN2-PAN3 and 
CCR4-CAF1-NOT1 deadenylase complexes to mRNA through direct 
interactions with PAN3 and NOT1 (Braun et al, 2011). More recently, the 
crystal structure of hAgo2 in the presence of two tryptophan amino acids has 
been determined (Schirle & MacRae, 2012). The spacing between the two 
tryptophans in the hAgo2 structure matches well with the distance of 
tryptophan residues in GW182 proteins, suggesting that the Ago2 PIWI 
domain is the interaction site for the GW motif of GW182. 
1.1.6 RISC assembly linking small RNA biogenesis and gene silencing 
In the last 15 years, the efforts on studying the RNAi pathway have been 
mainly invested into the small RNAs biogenesis and the RISC-mediated gene 
silencing step. However, the RISC assembly, the key step linking these two 
steps, remains largely unknown. The RISC assembly is an ordered assembly 
line to form the mature functional RISC. Generally, during this process, a 
series of actions occur. Firstly, a small RNA duplex is loaded onto an 
Argonaute. Then, one strand of the duplex is selected as the guide strand, 
while the other strand is selected as the passenger strand. Finally, the duplex is 
unwound followed by the passenger strand removal, while the guide strand is 
retained in the Argonaute. The RISC assembly of the siRNA pathway in D. 
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melanogaster has been throughout studied. In the following section, we first 
review the RISC assembly in D. melanogaster.  
1.1.6.1 The siRISC assembly in D. melanogaster 
Different from mammals’ genomes which encode one Dicer protein and 
four Argonautes, the D. melanogaster genome encodes two Dicer proteins 
(Dicer-1 and Dicer-2) and two Argonautes (Ago1 and Ago2). The deletion of 
Dicer-1 blocks the miRNA biogenesis, while the deletion of Dicer-2 blocks the 
siRNA biogenesis (Lee et al, 2004). After the biogenesis of siRNAs and 
miRNAs, these small RNAs are sorted into either Ago1 or Ago2 (Tomari et al, 
2007). Due to their structural differences, the miRNA duplexes are generally 
loaded onto the Ago1-containing RISC, while the siRNA duplexes are loaded 
onto the Ago2-contiaing RISC (Okamura et al, 2004). 
In the siRNA pathway of D. melanogaster (Figure 1-6A), two 
components are essential for the siRNAs biogenesis, Dicer-2 and a dsRBP, 
where the dsRBP is either R2D2 or Loqs-PD. The vast majority of siRNAs are 
processed by the Dicer-2/R2D2 complex (Liu et al, 2003; Tomari & Zamore, 
2005). Only a small subset of siRNAs (the self-complementary hairpin 
transcripts) is processed by the Dicer-2/Loqs-PD complex (Hartig & 
Forstemann, 2011). After the long dsRNAs are processed by the Dicer-2/R2D2, 
the siRNA products are released into the cytoplasm and rebound by the 
RISC-loading complex (RLC) (Preall et al, 2006). This finding suggests that 
the dicing and siRISC assembly in D. melanogaster are uncoupled. This 
“uncoupling model” matches well with the strict small RNA sorting system in 
D. melanogaster (Tomari et al, 2007). Apart from being the key components 
of the dicing machine, Dicer-2/R2D2 complex also constitutes the minimal 
RLC and plays important roles in siRNA sorting (Tomari et al, 2007), duplex 
loading and guide strand selection in D. melanogaster. An initial biochemical 
study reveals that R2D2 facilitates siRNA loading through binding to the 
siRNA duplex via its double dsRBDs (Liu et al, 2003). A subsequent genetic 
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study has not only confirmed this finding, but also pointed out that the 
Dicer-2/R2D2 complex, rather than the Dicer-2 or the R2D2 alone, has 
detectable binding with the siRNA duplex (Liu et al, 2006). Moreover, the 
R2D2/Dicer-2 acts as a pair of protein sensor for the siRNA thermodynamic 
asymmetry through the following mechanism. R2D2 first binds to one siRNA 
end which has higher thermodynamic stability, while Dicer-2 binds to the 
other end. This binding orientates the Dicer-2/R2D2 heterodimer on the 
siRNA duplex. Then, this siRNA duplex with a prefixed orientation is loaded 
onto Ago2. Finally, stable R2D2 binding requires the 5’-phosphate of the 
strand that is excluded from Ago2 as the passenger strand, while the other 
strand retained in Ago2 is selected as the guide strand (Pham et al, 2004; 
Tomari et al, 2004). 
 Hsc70/Hsp90 chaperone machinery is required to assist the siRNA 
duplex loading, while it is not necessary for subsequent strand separation and 
target recognition (Iwasaki et al, 2010). The authors also proposed that the 
chaperone machinery functions through facilitating siRNA duplex loading in a 
“rubber band model”. In this model, the siRNA duplex is first loaded via 
stretching the rubber band (opening the conformation of the Argonaute protein 
by Hsc70/Hsp90), which is driven by consuming ATP. Then, the release of the 
tension (Argonaute returns from the opened to the closed conformation) assists 
the duplex unwinding (Kawamata & Tomari, 2010). 
For the duplex unwinding, two models have been proposed: the helicase 
model and the duplex-loading model. In the helicase model, the duplexes are 
unwound before being loaded onto Argonautes, and the unwinding is executed 
by the associated RNA helicases (Meister et al, 2005). However, no RNA 
helicase has been characterized to be essential for duplex unwinding. 
Therefore, this model remains to be validated. On the other hand, RNA duplex, 
instead of guide strand only, is loaded onto Argonaute in the duplex-loading 
model. Moreover, for highly complementary siRNA duplexes which are 
loaded onto Ago2, the unwinding is facilitated by the slicer activity of Ago2, 
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which is denoted as slicer-dependent unwinding. While for RNA duplexes 
which are loaded onto non-catalytic active Argonautes, the unwinding is 
facilitated by the intrinsic instability of mismatches-containing miRNA  

Figure 1-6 RISC assembly in different organisms (Kim & Kim, 2012). 
(A) Assembly of the siRISC in D. melanogaster. Dicer-2 and R2D2 have dual 
functions in the long dsRNAs processing and the siRISC assembly.  
(B) Assembly of the miRISC in D. melanogaster. Dicer-1 and Loqs function in the 
pre-miRNAs processing while the miRLC is not established. 
(C) Assembly of the miRISC in the Dicer-dependent mode in mammals. The 
pre-miRNAs processing and miRNA duplexes loading are either coupled or 
uncoupled.  
(D) Certain Dicer-dependent miRNAs can also form miPDC prior to the assembly of 
miRLC. 
(E) Assembly of miRISC in the Dicer-independent mode in mammals. The 
Dicer-independent pre-miRNAs such as pre-miR-451 are processed directly by 
Ago2 in miPDC. 
23 

duplexes, which is denoted as slicer-independent unwinding. Compared to the 
helicase model, the duplex-loading model is universally accepted. 
In the slicer-dependent unwinding, the catalytic active Ago2 first nicks 
the passenger strand at 9-10-nt, where the passenger strand serves as a target 
mRNA. This slicer activity of Ago2 is required for Ago2-containg RISC 
assembly in both D. melanogaster and mammals (Leuschner et al, 2006; Liu et 
al, 2009; Matranga et al, 2005; Miyoshi et al, 2005; Rand et al, 2005). 
Specifically, biochemical studies suggest that either chemical modifications 
that block passenger strand cleavage by Ago2 or catalytic mutants of Ago2 
inhibit RISC activation in D. melanogaster (Matranga et al, 2005; Rand et al, 
2005). Then, the nicked passenger-strand fragments are then cleaved by C3PO 
(Component 3 Promoter of RISC), a newly-identified Mg2+-dependent 
endonuclease complex which consists of two evolutionarily conserved 
proteins: Translin and TRAX (Liu et al, 2009; Ye et al, 2011). Without C3PO, 
the recombinant Dicer-2/R2D2/Ago2 displays lower RISC activity than S2 
extracts in the long dsRNA-initiated or the siRNA-initiated pathways (Liu et 
al, 2009). The final functional RISC is a 80s complex which contains Ago2, 
guide-strand siRNA, components of RLC and other factors (Pham et al, 2004). 
1.1.6.2 The miRISC assembly in D. melanogaster 
In the miRNA pathway of D. melanogaster (Figure 1-6B), Dicer-1 and 
Loqs-PA/PB are involved in miRNA biogenesis. Loqs-PA and Loqs-PB 
stimulate and direct the specific pre-miRNA processing activity (Saito et al, 
2005). Interestingly, Loqs-PA/PB and R2D2 represent two distinct functional 
modes for dsRBPs in the RNAi pathways of D. melanogaster. R2D2 is not 
absolutely required for the siRNA production, but is indispensable for the 
siRISC assembly. In contrast, Loqs-PA and Loqs-PB enhances the miRNA 
production, but is largely dispensable for the miRISC assembly (Liu et al, 
2007). After the miRNA duplexes are generated, they are sorted into the 
Ago1-containing RISC. However, it is still not clear whether miRLC exists in 
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D. melanogaster or not. Some studies claim that Dicer-1 is critical for the 
miRISC assembly (Liu et al, 2007), while other studies have shown that 
neither Dicer-1 nor Dicer-2 is required for the miRNA loading (Kawamata et 
al, 2009). Similar to the siRISC assembly, Hsc70/Hsp90 chaperone machinery 
and ATP are both required for the miRNA loading rather than the duplex 
unwinding (Iwasaki et al, 2010). Since the slicer activity of Ago1 is limited, 
miRNA duplexes are unwound in the slicer-independent-unwinding mode. 
Their unwinding is facilitated by both the release of tension in the “rubber 
band model” and the mismatches present in the seed region (guide position 
2-8-nt from 5’-end) or 3’-mid (guide position 12-16-nt) of miRNA duplex 
(Kawamata et al, 2009). 
1.1.6.3 The RISC assembly in mammals 
In general, the RISC assembly in mammals shares major features of the 
RISC assembly in D. melanogaster. First, TRBP2, a homologue of R2D2 and 
Loqs, is associated with Dicer and functions in both small RNA biogenesis 
and RISC assembly, as mentioned earlier. Second, the small RNAs are loaded 
onto Argonautes as duplexes, and the guide strands are selected based on the 
thermodynamic asymmetry of duplexes (Khvorova et al, 2003; Schwarz et al, 
2003). Third, the unwinding and passenger strand removal mechanisms of 
siRNAs and miRNAs in mammals are similar to that of siRNAs and miRNAs 
in D. melanogaster, respectively (Leuschner et al, 2006; Ye et al, 2011; Yoda 
et al, 2010).  
However, since the RISC assembly of mammals is more difficult to study 
than that of D. melanogaster, there exist several subjects of debate for 
mammalian RISC assembly. The first subject of debate is about the existence 
of a small-RNA sorting system. Some studies suggest that small RNAs enter 
all 4 Argonaute members (Ago1-4 in mammals) independent of their 
sequences (Dueck et al, 2012; Liu et al, 2004), while other studies show that a 
small-RNA sorting system and a specific small RNA-Argonaute protein 
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interaction may also exist for mammalian Argonaute proteins (Burroughs et al, 
2010; Siomi & Siomi, 2008). The second one is about the requirement of 
Dicer/TRBP2 in RISC assembly. Some studies suggest that 
Dicer/TRBP2/Ago2 are the essential components of RLC (Doi et al, 2003) and 
the reconstituted RISC using this trimmer and a guide-strand RNA has dicing, 
RISC assembly and slicing activities (MacRae et al, 2008; Wang et al, 2009a). 
Conversely, other studies show that Dicer and TRBP2 appear to be 
dispensable for the siRISC loading both in vitro and in vivo (Betancur & 
Tomari, 2012; Kanellopoulou et al, 2005; Murchison et al, 2005; Ye et al, 
2011). The third one is about the requirement of ATP for siRNA duplexes 
loading. Earlier studies claim that the RISC assembly in mammals is 
ATP-independent (Gregory et al, 2005; MacRae et al, 2008; Maniataki & 
Mourelatos, 2005), while a subsequent study suggests that the human RISC 
assembly is ATP-dependent (Yoda et al, 2010). The coupling of dicing and 
RISC assembly is the fourth subject of debate. It has been established in D. 
melanogaster that dicing and RISC assembly are uncoupled. In humans, some 
groups suggest that dicing and miRISC assembly are coupled (Gregory et al, 
2005; Maniataki & Mourelatos, 2005). A recent study also supports this 
“coupling model” (Liu et al, 2012). They further reported that, in mammalian 
miRNA pathway, there are Dicer-dependent miRNA precursors and 
Dicer-independent miRNA precursors (Figure 1-6C-E). The miRLC 
containing Dicer/TRBP2/Ago2 is the primary machinery that carries out both 
pre-miRNA processing and miRNA loading for the Dicer-dependent miRNA 
precursors. This suggests that miRLC couples the processing of the 
pre-miRNAs with the loading of the miRNAs (Gregory et al, 2005; Liu et al, 
2012). This “coupling model” is further supported by the observation that 
Ago2 in mammals is already physically associated with Dicer prior to 
encountering with the pre-miRNAs or the long dsRNAs (Chendrimada et al, 
2005; Maniataki & Mourelatos, 2005; Meister et al, 2005). However, the 
“uncoupling model” was also observed in another study (Yoda et al, 2010). 
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Remarkably, a miPDC (miRNA precursor deposit complex) is identified in the 
mammalian miRISC assembly (Figure 1-6D&E). Both the miPDC and the 
catalytic activity of Ago2 are required for the generation of miRNAs from the 
Dicer-independent miRNA precursors (Liu et al, 2012).  
Virtually, once the guide strand is incorporated into Ago2, the guide 
strand-Ago2 complex dissociates from the other components of RLC and is 
ready for target mRNA recognition (Maniataki & Mourelatos, 2005). 
1.1.7 RHA function in RISC assembly in human cells 
Although previous structural studies on Argonautes and functional studies 
on the RISC assembly of D. melanogaster shed some light on the RISC 
assembly in mammals, a major question still remains unanswered: what 
factors are necessary for the RISC assembly in mammals in addition to 
Ago2/Dicer/TRBP2? In human cells, many proteins have been shown to 
associate with Argonautes by immunoprecipitation combined with the 
proteomics analyses (Hock et al, 2007; Landthaler et al, 2008; Meister et al, 
2005), where RNA helicase A (RHA) is one of them. 
Recently, RHA was shown to interact with Ago2, TRBP2 and Dicer in 
human cells. Notably, RHA functions as a duplex RNA-loading factor in the 
RISC assembly, which is indicated by the fact that the RHA depletion in 
human cells reduced RISC formation. Specifically, northern blot showed that 
the amounts of both guide-strand RNA and passenger-strand RNA associated 
with Ago2 are reduced in the RHA-depletion cells (Robb & Rana, 2007). 
These evidences suggest that RHA functions in the RNAi pathway by 
promoting the formation of active RISC through facilitating the loading of the 
small duplex RNA onto Ago2. 
RHA is a DEIH-motif-containing helicase (also known as DHX9). In as 
early as 1992, RHA was isolated from the Hela cells to dissect its RNA 
winding activity (Lee & Hurwitz, 1992). Subsequent molecular cloning 
identified the sequence apparently homologous to Nuclear DNA helicase II 
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(NDHII) and D. melanogaster maleless protein (MLE). The MLE is a protein 
regulating dosage compensation in D. melanogaster (Kuroda et al, 1991). 
RHA contains a helicase core (DEIH and Helicase domains) flanked by two 
tandem dsRBDs at its N-terminus and one RGG motif at its C-terminus 
(Figure 3-1A) (Zhang & Grosse, 1997). Remarkably, the two dsRBDs of RHA 
are essential for interaction with RISC, while the helicase core is not 
absolutely required to facilitate the formation of active RISC in humans (Robb 
& Rana, 2007). However, the detailed functions of these two dsRBDs of RHA 
in RISC assembly have not yet been studied, and the underlying structural 
mechanism of RHA in RISC loading is still unknown.  
1.1.8 RNAi in budding yeast 
RNAi is an evolutionarily conserved process discovered in a wide range 
of eukaryotic organisms, including fission yeast, insects, plants and mammals. 
For a long time, it had been presumed that RNAi is lost in budding yeast. 
Despite the fact that the two key effectors within this process, Argonaute and 
Dicer, have not yet been found in the model budding yeast S. cerevisiae, 
Argonaute genes have been identified in other four budding yeasts species: S. 
castellii, K. polysporus, C. albicans and C. tropicalis (Scannell et al, 2007). 
Recently, Drinnenberg et al. pushed the boundary of RNAi to budding yeast 
by showing that RNAi is indeed present in several budding yeast species, 
including S. castellii, K. polysporus and C. albicans (Drinnenberg et al, 2009). 
By high-throughput sequencing of small RNAs which harbor 
5’-monophosphates and 3’-hydroxyls, the small RNAs of ~23 nts in length are 
found to be abundant in these species. Moreover, sequence analysis has 
showed that the small RNAs of different species have different 5’-nucoletide 
bias. These small RNAs are mapped to the repetitive elements of budding 
yeast’s genome sequence, including the long terminal repeat retrotransposons 
(Ty elements), the long interspersed nuclear element-like retrotansposons 
(LINE) and the subtelomeric repeats (Y’ elements). By bioinformatics and 
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biochemical analyses as well as in vivo knockout experiments, a set of proteins 
named DCR1 is proven to be the budding yeast Dicer. The DCR1 is a protein 
containing a well-structured N-terminal domain (NTD), an RNase III domain 
and two C-terminal dsRBDs (Figure 4-1B). This domain composition of 
budding yeast Dicer is dissimilar to their counterparts from fission yeast and 
other higher eukaryotes (Figure 1-2A).  

Figure 1-7 Structural insights into dsRNA processing by K. polysporus DCR1. 
(A) Cartoon view of the crystal structure of KpDCR1 (PDB: 3RV0). 
(B) Cartoon view of the crystal structure of A. aeolicus RNase III bound to its dsRNA 
(PDB: 2EZ6). 
(C) Structural alignment of A. aeolicus RNase III with KpDCR1 based on their 
RNase III domain. The RNase III domains of A. aeolicus are colored in cyan, 
while the RNase III domains of KpDCR1 are colored in yellow and wheat. 
(D) Rotate (C) 90ealong y-axis.  
 
As discussed in section 1.1.2.3, canonical Dicer proteins processing 
dsRNAs into small RNAs with precise length mainly rely on its PAZ domain 
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(Macrae et al, 2006a). Therefore, due to the lack of PAZ domain, it is an 
enigma how the DCR1 generates small dsRNAs of specific length. This puzzle 
was later resolved by the structural and functional studies on the DCR1 from 
K. polysporus (KpDCR1) (Weinberg et al, 2011). The authors showed that 
budding yeast Dicer DCR1 uses a distinct mechanism for precise dsRNA 
processing, named “the inside-out mechanism”. Unlike the canonical Dicer 
which binds to dsRNA at its terminus as a monomer, the DCR1 binds to 
dsRNA at an arbitrary position as a homodimer. Structural alignment showed 
that the three-dimensional arrangements of the RNase III domains of these two 
proteins are well conserved, which suggests that the binding mode of the 
DCR1 and dsRNA may be similar to that of A. aeolicus RNase III and dsRNA 
(Figure 1-7). The binding of one DCR1 dimer facilitates the cooperative 
binding of the other DCR1 dimers along the long dsRNA, while the slow 
product release enables additional dimers to bind before the previously bound 
dimers release from the dsRNA. In the end, many DCR1 dimers align along 
the long dsRNA. The distance between consecutive dimers serves as the 
molecular ruler and determines the length of cleaved products. The crystal 
structure of KpAgo has also been determined (Nakanishi et al, 2012). The 
structural similarities and differences of KpAgo with other Argonautes were 
discussed earlier. 
Similar to the four abovementioned Argonaute-containing species, the 
DCR1-like protein are found also in other budding yeast species, such as 
Debaryomyces hansenii (D. hansenii) and Pichia stipitis (P. Stipitis) 
(Drinnenberg et al, 2009). However, these species lack the Argonaute protein. 
Thus, it is puzzling whether RNAi exists in P. stipitis and D. hansenii or not. P. 
stipitis is a species of well-studied and native xylose-fermenting yeast. Xylose 
is a major constituent of plant lignocellulose, and its fermentation is important 
for the bioconversion of plant biomass to fuels and chemicals (Jeffries et al, 
2007). As RNAi is a promising tool for engineering the genetic information, 




Collectively, it is of great interest to study the three-dimensional structure 
of DCR1 in P. stipitis, with the hope that the structural observations may shed 
some light on the functions of this budding yeast Dicer-like protein.  
1.2 Overview of X-ray crystallography 
1.2.1 A brief historic introduction of X-ray crystallography 
The establishment of X-ray crystallography is initialized by the progress 
in three areas: diffraction, crystal symmetry and X-rays. In 1665, the 
“diffraction” phenomenon was first observed by Francesco Maria Grimaldi, 
where the wave impinging on a scatterer was broken up into different 
directions. Subsequent studies showed that the spacing between the scatterers 
and the wavelength of the impinging wave should be similar in size to produce 
significant diffraction. Crystal symmetry was first investigated by Nicolas 
Steno in 1669 and later by René Just Haüy in 1784. Their studies, together 
with followed-on studies, led to the idea that crystals are a regular 
three-dimensional array of atoms. The X-rays were discovered by Wilhelm 
Conrad Rontgen in 1895. However, it has taken decades to confirm the nature 
of X-rays. Subsequent studies proposed that X-rays are waves of 
electromagnetic radiation with wavelength ranging 1-100 Å. 
The idea of combining X-rays and diffraction to investigate the crystals 
was prompted by Paul Peter Ewald and Max von Laue.. That is, crystals may 
serve as scatterers and diffract X-rays. In 1912, Von Laue and his two 
technicians, Walter Friedrich and Paul Knipping, passed a beam of X-rays 
through a copper sulfate crystal and recorded a large number of well-defined 
spots on a photographic plate (von Laue, 1915). This experiment not only 
confirmed the previous proposal that X-rays are waves of electromagnetic 
radiation which exhibits both wave-like and particle-like properties, but also 
led to the conclusion that crystals are composed of periodic arrays of atoms. It 
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is these periodic arrays of atoms that cause this distinct diffraction pattern. In 
1912-1913, physicists William Lawrence Bragg and his father William Henry 
Bragg connected the observed spots on the diffraction pattern with the 
reflections from evenly spaced planes within a crystal (Bragg, 1912; Bragg, 
1913b; Thomas, 2012). Meanwhile, they showed that the diffraction pattern 
can be used to determine the relative positions of atoms in a crystal. One year 
later, they were awarded the Nobel Prize in Physics due to this significant 
contribution. 
 After this pioneering work, the field of molecular structure 
determination based on X-ray diffraction developed rapidly. Although those 
earlier determined structures were simple inorganic crystals and minerals, they 
still revealed several fundamental laws of physics and chemistry. For example, 
the solved structure of table salt in 1914 proved the existence of ionic 
compounds, and the solved diamond structure showed that length of C–C 
single bond is 1.52 Å (Bragg, 1913a; Bragg & Bragg, 1913). Due to the 
progress on computational and experimental methods, the application of X-ray 
crystallography to protein structure determination became feasible. In 1958, 
John Cowdery Kendrew and Max Perutz solved the structure of sperm whale 
myoglobin, the first protein structure. Since then, the time of macromolecular 
structure determination has come. The structures of an abundance of important 
biological molecules and drug targets have become available, and these 
structural data have provided structural basis for both functional studies and 
rational drug design.  
Other structure determination methods are also available, such as Nuclear 
Magnetic Resonance (NMR) and Cryo-EM. Different from NMR, X-ray 
crystallography has no size limitation for the molecules to be studied. 
However, one major disadvantage of X-ray crystallography is the requirement 
for high quality crystals. In contrast, Cryo-EM that does not require crystals 
has attracted more and more attention recently. Cryo-EM is a structure 
determination technique for very large protein complexes, such as virus coat 
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proteins and amyloid fibers. However, the determined structures from this 
technique are generally in lower resolution than those from X-ray 
crystallography. Nevertheless, this weakness could be overcome by the 
combination of Cryo-EM with either X-ray crystallography or NMR.  
1.2.2 Introduction to the theory of X-ray crystallography 
To understand the theory of X-ray crystallography, it is essential to 
understand three major parts: (1) What constitutes a crystal; (2) How crystal 
diffracts X-rays; and (3) How to transform the diffraction data to the real 
molecular structure. We present the details in the following sections.  
1.2.2.1 Crystals  
Crystals can be seen as the precisely ordered three-dimensional arrays of 
molecules. The fundamental unit of a crystal is an asymmetric unit, where 
there is no symmetry-related component. The manner that a crystal ordered 
from the fundamental unit can be described as follows. Firstly, a set of 
symmetry operations is applied to the asymmetric unit, which creates a 
collection of asymmetric units. The combination of these operations is called 
the point group of a crystal. These symmetry operations include rotation, 
inversion, reflection, screw axis and glide plane. Secondly, a parallelepiped of 
minimum volume which encloses a full complement of the asymmetric units is 
selected as a unit cell. Thirdly, the unit cells are packed periodically along the 
unit cell axes, and then a crystal is generated. Therefore, a crystal can be 
considered as a combination of the unit cell contents and the periodicity of 
packing of these unit cells. Each unit cell consists of a complement of 
asymmetric units, and these asymmetric units are related to each other by the 
point group. When each unit cell in a crystal is represented by a point and each 
point is located at an identical position within each unit cell, the crystal lattice 
is generated. There are 14 possible lattices (called Bravias lattice) for all seven 
crystal systems (Triclinic, monoclinic, orthorhombic, Tetragonal, Trigonal, 
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Hexagonal and Cubic). The complete symmetry information of a crystal, 
including the lattice type and point group, is termed as the space group of the 
crystal. Theoretically, there are a total of 230 types of space group. However, 
for biological molecules where homochirality is present, symmetries that 
contain inversion and reflection operations are eliminated, leading to only 65 
types of space groups for biological macromolecules. 
1.2.2.2 X-ray Diffraction theory 
X-rays are electromagnetic waves with wavelengths in angstroms size 
ranging 1-100 Å, and it contains the proper wavelengths for the diffraction 
experiments of molecules with an average bond length of ~ 1.5 Å. X-rays are 
scattered by electrons of atoms within the molecules during a diffraction 
experiment, whereas light and electrons are scattered by specimens under a 
light microscopy and an electron microscopy, respectively. Unlike the 
scattered light and the scattered electrons which can be focused by a glass lens 
and an electromagnetic field, respectively, no properties of X-rays can be used 
to focus the scattered X-rays. Both the focused scattered light and the focused 
scattered electrons give rise to the images of specimens, while no lens is 
available for X-ray diffraction experiments to gather the scattered X-rays by 
crystals and focus them into images of electrons of atoms in a crystal. 
Fortunately, the crystal lattice serves as half a lens and makes it possible to 
collect the information on the Fourier transform space. That is, the diffraction 
pattern of the crystal can be collected at proper positions. 
As remarked above, a crystal is a combination of the unit cell contents 
and the crystal lattice. Mathematically, a crystal is the product (convolution) of 
a unit cell and a lattice. Similarly, the diffraction pattern of a crystal is the 
product (convolution) of the diffraction pattern of the unit cell and the 
diffraction pattern of the crystal lattice. Mathematically, it is formulated as 
follows. 
   	 
    
   
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where    is the diffraction pattern of the unit cell, 
   is the 
diffraction pattern of the crystal lattice and 
   is the diffraction 
pattern of a crystal. 
The dark spots on the diffraction pattern are termed as reflections. Based 
on the equation above, each reflection is the product (convolution) of the 
Fourier transform of the unit cell contents and the Fourier transform of the 
crystal lattice at the spot. As the diffraction pattern (Fourier transform) of a 
cluster of random atoms is non-periodic and continuous, while the diffraction 
pattern of a point lattice is periodic and discrete, this product (convolution) 
thereby generates a periodic and discrete diffraction pattern. This kind of 
diffraction pattern is normally observed in a diffraction experiment. 
A unit cell can be imagined to be intersected by families of planes. Each 
family of planes is denoted as hkl. The h, k and l are all integral numbers and 
characterized by the number of times they intersect each cell edge (a, b, c). A 
collection of all hkls are named as Miller indices. A specific Miller index 
samples all unit cells of a crystal in a similar manner. The interplanar spacing 
of some families of planes satisfies the Bragg’s law, which is shown as 
follows. 
     
where d represents the interplanar spacing, is the incident angle, n is any 
integer and is the wavelength of the X-rays. X-rays that are diffracted in the 
directions of these families of planes constructively interfere with each other 
and give rise to a single reflection on the diffraction pattern. In contrast, 
X-rays diffracted in the directions of families of planes with interplanar 
spacing not satisfying the Bragg’s law are destructively interfered and cancel 
each other. To this end, crystal diffraction experiments can be considered as 
that X-rays are diffracted in the direction of infinite sets of planes with 
different Miller indices. Moreover, each spot on the diffraction pattern 




1.2.2.3 Back from diffraction pattern to molecular structure 
The diffraction pattern is also called the diffraction space, Fourier 
transform space or reciprocal space, while the molecular structure is called the 
real space. The lattice of diffraction pattern is termed as the reciprocal lattice. 
A reciprocal lattice point corresponds to the end point of a vector which is 
drawn from a common origin for the hkl family of planes with the direction of 
plane normal and the length of 1/d (d is the interplanar spacing). 
As demonstrated by Fourier, any periodic wave can be decomposed into 
an infinite series of sine waves, and each wave has a specific amplitude, phase 
and frequency. This decomposition is known as the Fourier analysis. 
Reversibly, the original wave can be reconstructed from these component 
waves, and this reconstruction is known as the Fourier synthesis. Moreover, 
the more component waves are used for the reconstruction, the more the 
reconstructed wave resembles the original wave (McPherson, 2011). 
Alternatively, a crystal can be conceived of as a three-dimensional, periodic 
electron density wave, while each family of planes can be considered as a 
component wave with a frequency of hkl. Therefore, if we add together all 
component waves of a crystal, we can reconstitute the three-dimensional 
electron density wave of the crystal.  
To this end, the crystal diffraction experiment functions as the Fourier 
analysis to decompose the electron density wave of a crystal to its component 
waves, while the crystal structure determination functions as the Fourier 
synthesis to reconstitute the electron density wave from these component 
waves. The equation of the electron density reconstruction is shown as follow. 
   




where   is the electron density at the point (x, y, z) in the unit cell, V is 
the unit cell volume,  !"#######$ is the amplitude of the reflection hkl and ' !" is 
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the phase of the reflection hkl. Within this equation,  !"#######$%&'()* represents 
the structure factor of the reflection hkl. In other words,  !"#######$%&'()* is the 
combined diffraction result for X-rays diffracted in the direction of plane hkl. 
As the diffraction pattern is the Fourier transform of the real space, each 
reflection is the Fourier transform of a component wave. Therefore, each 
reflection is also a wave with specific amplitude, phase and frequency. The 
frequency of each reflection is hkl, while the amplitude can be obtained 
directly, as it correlates to the intensity of the spot on the diffraction patterns. 
This correlation is described as follows.  
2 !" 3  !"#######$
,
 
where 2 !" represents the intensity of the reflection hkl. However, the phase 
 !" needs to be figured out by other approaches which will be discussed later.  
Collectively, we can reconstitute the electron density map based on 
intensities, phases and frequencies of the reflections through Fourier synthesis. 
When we have more high resolution data, there are more reflections 
corresponding to higher Miller indexes families of planes. In this case, we can 
reconstitute a higher resolution electron density map. As the electron density 
will have a positive value at the vicinity of an atom, corresponding to that 
atom, the structural model of the molecule can thus be built based on the 
electron density map. 
1.2.3 Experimental procedures in X-ray crystallography 
In an X-ray diffraction experiment, a beam of X-rays passes through a 
crystal which is mounted on a pin on the rotating goniostat, and then the 
diffracted X-rays generate a diffraction pattern on a detector.  
1.2.3.1 Growing a protein crystal 
To determine the three-dimensional structure of macromolecules, it 
requires diffraction-quality crystals. To grow a protein crystal, the prerequisite 
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is to obtain a large amount of pure, homogenous and well-folded proteins. 
Proteins are either obtained from native sources (cellular extracts) or 
purposely expressed in organisms (bacteria, yeast and fungi) by utilizing 
recombinant DNA technology. After expression, protein purification is 
performed based on different characteristics of proteins, such as solubility, 
charge, size, fused affinity tags and binding specificity to their partners. The 
quality of protein is then assessed by SDS-PAGE, dynamic light scatting 
(DLS), circular dichroism (CD) and mass spectrometry (MS), etc. Prior to 
crystallization trials, proteins are dialyzed against proper buffers and 
concentrated to optimal concentrations. 
Crystallization procedures are divided into initial screening and 
followed-on optimization. The major goal of initial screening is to search 
conditions containing proper buffers, pH values, salts, precipitants and 
temperatures, wherein the protein can form “stable nuclei” and crystals can 
grow continuously based on the nuclei. The fundamental principle of 
crystallization is presented in the phase diagram of crystallization, as shown in 
Figure 1-8. There are three commonly used crystallization methods: hanging 
drop vapor diffusion method, sitting drop vapor diffusion method and 
microbatch. Among them, the hanging drop vapor diffusion method is the 
most popular one for the crystallization of macromolecules. The principle of 
vapor diffusion methods is described as follows. First, 1 l of protein and 1 l 
of reservoir solution are mixed and equilibrated against ~600 ml reservoir 
solution. Since the droplet has a lower reagent concentration than the reservoir 
solution, the water in the droplet evaporates and ends up into the reservoir. 
During this equilibration process, protein concentration in the droplet 
increases slowly and may reach a point where supersaturation and nucleation 
occur. After nucleation, the remaining protein molecules stack on the nuclei 
and crystals grow. Finally, the new equilibrium is reached. In order to obtain 
diffraction-quality crystals, crystallization optimization is usually performed. 
The methods include fine-tuning the initial conditions by either Grid screen or 
38 

additive screen, intervening the crystallization process by seeding, optimizing 
protein itself by systematical N-terminal or C-terminal truncation (Graslund et 
al, 2008), proteolysis (Dong et al, 2007), mutagenesis (Derewenda, 2004), etc.  

Figure 1-8 Phase diagram of crystallization (Snell et al, 2008) 
It consists of three regions, the undersaturation, the supersaturation, and the solubility 
curve that separates them. Ideal crystal growth would start from nucleation zone, just 
beyond the metastable zone. After nucleation, the solution would return to the 
metastable zone and crystals continue to grow based on the few nuclei. 
1.2.3.2 Data collection 
For data collection, there are four major steps: (1) Taking the crystal out 
form its mother liquid and mounting it to the goniostat; (2) Generating a finely 
collimated beam of monochromatic X-rays; (3) Systematically rotating the 
crystal with respective to the X-ray beam; (4) Recording the diffraction 
patterns and the intensities of the reflections.  
Usually, the crystals are soaked in their mother liquid supplemented with 
cryo-protective reagents after being taken out from the droplets (Pflugrath, 
2004). Then, the crystals are either directly mounted to the goniostat or kept at 
the cryogenic temperature (~ -173 ć. Goniostat is the device which rotates 
the crystal with a small angular increment at a fix speed. For X-ray sources, 
sealed X-ray tubes, rotating anodes and synchrotrons are available. Currently, 
the sealed X-ray tubes are rarely used. The rotating anodes are commonly used 
in the in-house diffraction machines, while the synchrotrons are only available 
39 

at the specialized facilities. Synchrotron dominates the field with its unique 
and highly desirable features. Unlike the other X-ray sources which produce 
characteristic spectral lines, synchrotron source produces a broad spectrum of 
wavelengths. Users can therefore select a particular wavelength purposely, as 
that in the anomalous dispersion methods. In addition, the synchrotron source 
is an advanced generator of X-ray beams with intensity two or three orders of 
magnitude stronger than that of other X-ray sources. This is of great 
significance in improving the resolution of the data, especially for small 
crystals and crystals with large unit cell dimensions. However, this high 
intensity also has its disadvantage, since it will destroy the crystals quickly 
once the beam line passes through them. This is also the major reason to adopt 
the cryo-protection strategy. For data recording, the devices include film, 
diffractometer, area detector, image plate and charge coupled device (CCD). 
Among these detectors, image plate and CCD are widely adopted nowadays. 
The data recording system of most in-house diffraction machines is image 
plate. On the other hand, CCD is exclusively used in synchrotrons, as it 
provides instantaneous readout of data. This is necessary for X-rays sources 
with strong intensity and a short exposure time. In addition to the impressive 
advancements in X-ray sources and detectors, there are progress on other 
techniques, such as computer program and dewar for crystals shipping. These 
techniques greatly help researchers in this research field. 
1.2.3.3 Solving the phase problem  
As mentioned earlier, the reconstitution of the electron density map of a 
molecule requires two data sets: the intensity and the phase of each reflection. 
Investigators can measure the intensity of each reflection on the diffraction 
pattern directly, but the phase information is lost. Then, several methods have 
been developed to retrieve the phase information. These methods include (1) 
Deconvolution of the Patterson map; (2) Direct method; (3) The heavy atom 
method; (4) Isomorphous replacement (IR) method; (5) Anomalous scattering 
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method; and (6) Molecular replacement (MR) method.  
Deconvolution of the Patterson map method can solve the structure only 
if it contains very few (3 or 4) atoms. Therefore, it cannot be used for protein 
structure determination. However, this method can be used in combination 
with other methods to deduce the positions of heavy atoms or anomalous 
scatterers. 
Direct method is a strictly mathematical method independent of 
additional data to determine the structure. There exist two requirements, in 
order to apply this method. First, the structure should contain less than 100 
atoms. Second, the resolution of the data should be as high as about 1.0 Å. 
These two requirements limit the application of this method in 
macromolecular structure determination. 
The heavy atom method is another method only applicable to small 
molecules (Sim, 1960). Meanwhile, the crystals should contain at least one 
heavy atom. As heavy atoms have much more electrons than other light atoms 
in small molecules, the phases of these light atoms contribute little to the 
phase of the whole structure ('), while the phase of the heavy atom ('45) is 
approximated to '. Once the coordinate of the heavy atom is calculated by the 
Patterson method, '45  can be calculated. Then, '45  and the measured 
intensities can be used to calculate the electron density of the molecule. Based 
on the electron density map, the positions (x, y, z) of light atoms are roughly 
identified. These positions, in turn, are used in the next round of electron 
density calculation. After several iterative cycles, all positions of light atoms 
can be accurately identified. 
The IR method provides a prominent solution to the phase problem of 
large molecules, such as proteins. There are two major requirements for this 
method. The first one is to obtain a native crystal and a derived crystal (heavy 
atom-containing). Second, structurally identical feature called “isomorphous” 
is required for these two crystals (Blow & Rossmann, 1961; Crick & Magdoff, 
1956). The underlying principle of this method is that the unknown phase of a 
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wave with measurable amplitude can be determined by measuring the 
amplitude of the resultant wave after “beating” it against a wave with known 
amplitude and phase. In a simplified version, this method is based on the 
equation678/45################$  678########$ 9 45#######$. As the coordinates (x, y, z) of the heavy 
atoms in the unit cell can be obtained by the Patterson method, both amplitude 
and phase of 45#######$  can be calculated from the structure factor equation. 
Moreover, the amplitudes of 678/45################$ and 678########$ can be directly obtained 
from the measured intensities of the derived and native crystals, respectively. 
Based on these available data, the '678 can thus be calculated. However, the 
calculated phase from single derivative (SIR) can be either ' or –', leading 
to a phase ambiguity.Fortunately,this problem can be resolved by either using 
two or multiple heavy-atom derivatives (so called the MIR method) or by 
combining the IR method with the anomalous scattering method. 
The anomalous scattering method is a variant of IR method, including 
single-wavelength anomalous diffraction method (SAD) and 
multiple-wavelength anomalous diffraction method (MAD) (Hendrickson, 
1991; Rice et al, 2000). Both SAD and MAD rely on the anomalous scattering 
effects of the anomalous scatterers within crystals. The anomalous scattering is 
a negligible effect for light atoms, such as C, H, O and N in proteins. However, 
it can be significant for heavy atoms, such as selenium in selenomethonines, 
irons in heme groups, Zn, Cu, etc. Therefore, these heavy atoms can serve as 
anomalous scatterers after being introduced into crystals by either soaking 
crystals in heavy atom solutions or other chemical methods. Unlike the IR 
method which requires both native and “isomorphous” derived crystals, both 
SAD and MAD need only a single heavy atom-containing crystal. Therefore, 
anomalous scattering methods have a major advantage, as they avoid the data 
scaling between native and derived crystals. Although both SAD and MAD 
rely on the anomalous scattering effect, they are different in several aspects. 
Usually, SAD is combined with other phasing information to solve the phase 
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ambiguity, such as the IR method, solvent flattering and non-crystallographic 
symmetry. SAD requires that the data resolution is 2.5 Å or better. It is 
noteworthy that the wavelength for data collection is close to the absorption 
edge of the heavy atom in the derivative for SAD. In contrast, MAD uses at 
least two wavelengths which can give large phase contrast for data collection. 
One is the absorption edge of the heavy atom in the derivative while the other 
one is some distance away. Similar to the reason of using multiple heavy-atom 
derivatives in the MIR method, two or even more data sets from different 
wavelengths can be introduced to reduce the phase ambiguity. The tenability 
of the synchrotron source makes this method feasible. Similar to the IR 
method, the coordinates (x, y, z) of anomalous scatterers in SAD and MAD 
may first be deduced either by the anomalous difference Patterson map or by 
the direct method. 
Molecular replacement (MR) is another solution to the phase problem 
(Rossmann, 1990). The idea behind this method is that the phase problem of 
an unknown molecule can be approximately deduced from a known 
homologous structure. The process of MR is presented as follows. First, we 
have a determined structure which is homologous to the unknown structure, 
and the coordinates of the known structure are used to compute its diffraction 
pattern. Second, the spatial relationship between this calculated pattern and the 
diffraction pattern of unknown structure is figured out by rotation and 
translational search. Third, the known molecule is placed into the unit cell of 
the unknown molecule. In this case, the initial positions of atoms in the 
unknown molecule are obtained. Based on the positions of atoms, phases of 
the unknown molecule are then calculated, and they provide adequate 
estimation of its real phases. Finally, these approximated phased and measured 
intensities are used to calculate the electron density map of the unknown 
molecules. Further improvement is required to refine the unknown structure in 
both real space and reciprocal space. As more and more structures are 
available in the protein data bank (PDB), this method will have ever greater 
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application in protein structure determination.  
1.2.3.4 Refinement and structure validation 
Once the phase and amplitude of each structure factor are known, the 
electron density map of a crystal is calculated. The coordinates (x, y, z) of 
atoms in the unit cell can be approximately determined, and the initial model 
is built. The initial model is subject to further refinement. Refinement can be 
performed in real space, reciprocal space and the combination of these two. In 
real space, the coordinates of atoms are used to calculate the structure factor 
:7"#######$ and':7". ':7", together with ;$ (;$  <=>?########$ @ :7"#######$<), are used 
to calculate the difference Fourier map. The coordinates are then adjusted 
based on the difference Fourier map, and those adjusted coordinates are used 
in next round of refinement. Reciprocal space refinement relies on the R factor 
with the objective of the R factor minimization (Brunger et al, 1987). The R 
factor measures the agreement of the built model with the real structure of the 
molecule. R is defined as follows. 
A  B CC !"C=>? @ C !"C:7"C !" B C !"C=>? !"  
For macromolecular structural determination, the acceptable R ranges 
from 15% to 25%. To avoid over fitting, Rfree is introduced. The idea of Rfree is 
to set aside a subset of data (5%-10%) during refinement (Brunger, 1992). In 
general, Rfree is usually 5%-8% higher than R. A good model should have both 
R and Rfree within the acceptable ranges. The geometry of the molecule is 
finally checked by a program like Procheck, which calculates the 








1.3 Research aims and Significance 
1.3.1 Research aims 
Although it has been proposed that the dsRBDs of RHA are essential for 
RHA to promote RISC assembly (Robb & Rana, 2007), the structural and 
functional features of the RHA dsRBDs in RISC assembly are largely 
unknown. Therefore, the aim of this thesis is to gain the structural insights into 
RISC assembly facilitated by RHA dsRBDs. More specifically, the objectives 
of this project are: 
 To examine the binding capability between RHA dsRBDs and siRNA 
duplex. 
 To determine the crystal structures of RHA dsRBDs in complex with 
dsRNA duplexes. 
 To pinpoint the residues on dsRBDs crucial for dsRNA duplex binding. 
 To investigate the biological significance of tandem dsRBDs in RHA. 
 To explore the functional roles of RHA dsRBDs in RISC assembly. 
From the studies of the dsRNA processing by the noncanonical Dicer 
from budding yeast, we speculate that a subset of RNase III proteins which 
contains an NTD, an RNase III domain, a dsRBD and a C-terminal dsRBD or 
dsRBD-like domain may represent a unique class of noncanonical Dicer. This 
class of noncanonical Dicer may be exemplified by the DCR1 from K. 
polysporus (Weinberg et al, 2011). Although the structure and function of 
KpDCR1 have been extensively studied, the specific roles of its NTD and its 
C-terminal dsRBD2 remain unknown. Moreover, the structure and function of 
a DCR1-like protein from P. stipitis (PsDCR1), another budding yeast species 
lacking Argonaute, were not investigated. Therefore, the aim of the second 
project is to explore the structure and function of PsDCR1. More specifically, 
the objectives of this project are: 
 To determine the crystal structure of PsDCR1. 
 To compare the determined structure of PsDCR1 with that of KpDCR1. 
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 To explore the function of the PsDCR1 as well as the specific roles of its 
NTD and dsRBD-L domains. 
1.3.2 Significance of this study 
Although dsRBD is one of the most extensively studied domains in terms 
of structure and biochemistry, the abundance of its interaction partners renders 
dsRBD functional diversity and makes the mechanistic roles of dsRBDs not 
easy to elucidate. Particularly, the N-terminal dsRBDs of RHA play important 
roles in enabling RHA to interact with the essential components of different 
cellular processes. Hence, the structural and functional studies of dsRBDs with 
their binding partners may provide meaningful information to analyze the 
specific roles of RHA dsRBDs in the context of RISC assembly in human cells. 
Moreover, a protein harboring multiple dsRBDs is a common feature of many 
RNA binding proteins in RNAi. Hence, the investigation of the biological 
significance of the tandem dsRBDs of RHA may provide the basis for this 
feature. 
The structural study on PsDCR1 and structural comparison of PSDCR1 
with KpDCR1 may shed some light on the functions of PsDCR1. In turn, the 
structural and detailed functional studies on PsDCR1 could provide perceptive 
information to dissect the specific roles of unique domains of budding yeast 
Dicer. 
Both studies could expand our current knowledge of the RNAi pathway 
in both mammals and budding yeast.  
In order to achieve the objectives described above, X-ray crystallography 
was used for this study. In addition to X-ray crystallography, other methods, 
such as the recombinant techniques, and molecular and cellular techniques, 
were also introduced into this thesis for functional studies. The following 






1.4 Organization of this thesis 
This dissertation presents the structural and functional studies of two 
proteins, RNA Helicase A (RHA) from Homo sapiens and a budding yeast 
Dicer-like protein (PsDCR1) from P. stipitis. The organization of this thesis is 
as follows: 
In Chapter 1, we have introduced the RNAi pathways mainly from the 
perspective of structural studies of the key components, the fundamental of 
X-ray crystallography, the aims and significance of this thesis. Chapter 2 
provides a detailed description of the materials and methods used in this thesis. 
Chapter 3 presents the crystal structures of RHA dsRBD1/RNA duplexes and 
dsRBD2/RNA duplexes, as well as functional studies of how RHA dsRBDs 
function in RISC assembly in human cells. Chapter 4 reports the crystal 
structure of the NTD of PsDCR1 and illustrates the role of individual domain 
and relationship of domains of PsDCR1. Chapter 5 gives a conclusion and 

















CHAPTER 2: Materials and Methods 
2.1 Cloning 
2.1.1 E. coli bacteria culture 
E. coli strains DH5 and BL21/DE3/RILP were used for cloning and 
protein expression, respectively. Both strains were cultured in autoclaved LB 
media (1% Bacto®-tryptone, 0.5% Bacto®-yeast extract, 1% NaCl) under 
vigorous shaking (250 rpm) or on LB plates at 37 ć. LB plates were prepared 
by supplemented LB media with 1.5% Bacto®-agars before autoclave.  
2.1.2 Plasmid construction 
All target DNA fragments were amplified from specific templates by 
PCR. The RHA dsRBD fragments were amplified from the full-length 
RHA-encoding gene of Homo sapiens (Accession No.: NM_001357.4). The 
PsDCR1 fragments were amplified from the full-length PsDCR1-encoding 
gene of Scheffersomyces stipitis (also named Pichia stipitis) CBS 6054 
(Accession No.: XM_001383513.1). The fragments of Ago2 and TRBP2 were 
amplified from two sequenced plasmids containing the full-length 
Ago2-encoding gene and the TRBP2-encoding gene of Homo sapiens 
(Accession No.: NM_012154.3 and NM_134323.1), respectively. Both the 
RHA-encoding gene and the PsDCR1-encoding gene were purchased from 
Open Biosystems (http://www.thermoscientificbio.com/openbiosystems/). The 
pre-mixed, ready to-use Taq PCR Master Mix Kit (QIAGEN, Cat #201445) 
that contains Taq DNA Polymerase, PCR Buffer, MgCl2, and dNTP at 
optimized concentrations were used. The composition of the 50 l PCR 
reaction mixture are as follows: 25 l PCR mix solution, 1 l forward primer 
(10 M), 1 l reverse primer (10 M), 1l DNA templates (~50 ng/l), 22 l 
distilled water. PCR reactions were performed on an iCycler Thermal Cycler 
(Bio-Rad). All primers are listed in Table 2-1. 
48 

PCR products were analyzed by agarose-gel electrophoresis. The target 
bands with correct size were illuminated and cut under the Safe ImagerTM2.0 
Blue-Light Transilluminator (Invitrogen, Cat #G6600). The PCR products 
were purified using the QIAquick PCR Purification Kit (QIAGEN, Cat 
#28704) according to the manufacturer’s instruction. Purified PCR products 
and vectors were digested by double restriction enzymes (NEB). The 
restriction enzymes were selected according to the pair of designed primers. 
After purification of digested products, the Rapid DNA Ligation Kit (Roche, 
Cat #11635379001) was used for ligation. Then, the ligation products were 
transformed into DH5 competent cells for colony screening. Several single 
colonies were picked, and each colony was inoculated into a separate test tube 
containing 3 ml LB media. Cells were cultured overnight, and plasmids were 
extracted using the QIApre Spin Miniprep Kit (Qiagen, Cat #27106) according 
to the manufacturer’s instruction. The extracted plasmids were subjected to 
double restriction enzyme digestion for identification. The plasmids harboring 
correct size inserts were subjected to DNA sequencing. All constructs 
generated in this thesis are listed in Table S-1 and Table S-2. 
  
Table 2-1 Primers used in this thesis for plasmid construction 
 
RHA dsRBDs constructed into pGEX-6p-1 and pXJ40-c-Myc  
BamHI- dsRBD-1 (F)  5’-CGCGGATCCATGGGTGACGTTAAAAATTTT 
BamHI- dsRBD-131 (F)  5’-CGCGGATCCGGCTATGGTGTTCCTGGGC 
BamHI- dsRBD-165 (F)     5'-CGCGGATCCGAAGTGGATTTAAATGCTG   
XhoI- dsRBD-72 (R) 5'-CCGCTCGAGTTATCATATTCGAACCAAATAGTTA 
XhoI- dsRBD-80 (R1)  5'-CCGCTCGAGTTATCAAACTTCTTCACTCTTTATTTC 
XhoI- dsRBD-91 (R) 5'-CCGCTCGAGTTATCAAAGTGGGGGCGGAGATGCTAC 
XhoI- dsRBD-130 (R)  5'-CCGCTCGAGTTATCAAGAGGCCCCTACCTCAGAA 
XhoI- dsRBD-264 (R)      5'-CCGCTCGAGTTATCACTTTGTAAGTCCGGAGTAA 
XhoI- dsRBD-318 (R)  5'-CCGCTCGAGTTATCAGAACTGAGCCAATTTGCC 
Ago2 domains constructed into pcDNA5-FRT-6hFlag 
BamHI- Ago2-1 (F)   5’-CGCGGATCCATGTACTCGGGAGCCGGCCCCG 
XhoI- Ago2-232 (R) 5’-CCGCTCGAGTTACTCGATTACTGGCTGTGCCTTG 
BamHI- Ago2-227 (F) 5’-CGCGGATCCGCACAGCCAGTAATCGAGTTTG 
XhoI- Ago2-438 (R) 5’-CCGCTCGAGTTACCGCATGTCCCAGACGCCC 
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BamHI- Ago2-439 (F) 5’-CGCGGATCCAACAAGCAGTTCCACACGG 
SalI-- Ago2-578 (R) 5’-TACGCGTCGACTTACAGGATGTTGTTCACGCC 
BamHI- Ago2-516 (F) 5’-CGCGGATCCCAGCTGGTGGTGGTCATCC 
XhoI- Ago2-859 (R) 5’-CCGCTCGAGTTATCAAGCAAAGTACATGGTGCGC 
TRBP2 domains constructed into pcDNA5-FRT-6×Flag  
BamHI- TRBP2-1 (F) 5’-CGCGGATCCATGAGTGAAGAGGAGCAAGG 
XhoI-TRBP2-120 (R) 5’-CCGCTCGAGTTATCACTCAGGCAGTGAAGAGTCTAG 
BamHI- TRBP2-121 (F) 5’-CGCGGATCCGACATTCCGGTTTTTACTGC 
XhoI-TRBP2-227 (R) 5’-CCGCTCGAGTTATCACGTGTGCACTCGAAGCAGC 
BamHI- TRBP2-228 (F) 5’-CGCGGATCCGTGCCTCTGGATGCCCGGG 
XhoI-TRBP2-366 (R) 5’-CCGCTCGAGTTATCATCACTTGCTGCCTGCCATG 
PsDCR1 constructed into pET29a  
BamHI-Pcha-Dcr-1 (F) 5’-CGCGGATCCATGAGCCAGTTTGGCAGCC 
XhoI-Pcha-Dcr-566 (R2)   5'-CCGCTCGAGAATGGTGCCTTTGCAAATT 
PsDCR1 truncated fragments constructed into pET28b  
NdeI-Pcha-Dcr-75 (F) 5’-GGAATTCCATATGGGCTTTGTGGATCTGCAGA 
XhoI-Pcha-Dcr-566 (R1)  5'-CCGCTCGAGTTATCA AATGGTGCCTTTGCAAATT 
PsDCR1 truncated fragments constructed into pET-SUMO-28a 
BamHI-Pcha-Dcr-190 (F)  5’-CGCGGATCCGAAAAACGTGTGTTTACCA 
XhoI-Pcha-Dcr-459 (R1)  5'-CCGCTCGAGTTATCATTCATCTTCTTCACGGCTA 
BamHI-Pich-Dcr-183 (F)  5’-CGCGGATCCGTGGATAGCAGCAGCACCCAG 
XhoI-Pich-Dcr-447 (R1)  5'-CCGCTCGAGTTATCATTTCACGCTATCTTTACGATC 
BamHI-Pcha-Dcr-206 (F)   5’-CGCGGATCCCCGTTTATTAAAGATCAGACCC 
XhoI-Pcha-Dcr-445 (R1)  5'-CCGCTCGAGTTATCAGCTATCTTTACGATCAATTTCC 
BamHI-Pcha-Dcr-212 (F)  5’-CGCGGATCCACCCTGTATGAACGTGTGTTTG 
XhoI-Pcha-Dcr-454 (R1) 5'-CCGCTCGAGTTATCAGCTACGTTTGCTTTTGCTGC 
XhoI-Pcha-Dcr-426 (R1)  5'-CCGCTCGAGTTATCAGTTTTTCAGCGCATCCATC 
BamHI-Pcha-Dcr-200 (F) 5’-CGCGGATCCAACAAACATCCGCCGCTG 
XhoI-Pcha-Dcr-431 (R1) 5'-CCGCTCGAGTTATCATTCCAGCAGCTGACGGTTTTTC 
BamHI-Pcha-Dcr-187 (F)  5’-CGCGGATCCAGCACCCAGGAAAAACGTGTG 
BamHI-Pcha-Dcr-192 (F) 5’-CGCGGATCCCGTGTGTTTACCACCGGCATTG 
BamHI-Pcha-Dcr-196 (F)  5’-CGCGGATCCACCGGCATTGATAACAAACATC 
PsDCR1 NTD constructed into pGEX-6p-1 and pXJ40-c-Myc  
BamHI-Pcha-Dcr-70 (F)  5’-CGCGGATCCAGCGTGCCGCCGATTGG 
XhoI-Pcha-Dcr-170 (R1) 5'-CCGCTCGAGTTATCAATCGTTCAGCTGCGCAAT 
XhoI-Pcha-Dcr-175 (R1) 5'-CCGCTCGAGTTATCATTCGCTATCGCTGCAATC 





XhoI-Pcha-Dcr-566 (R1) 5'-CCGCTCGAGTTATCA AATGGTGCCTTTGCAAATT 
2.1.3 Site-directed mutagenesis 
All mutant alleles were prepared using the QuickChange Site-Directed 
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Mutagenesis Kit (http://www.genomics.agilent.com/) according to the 
manufacturer’s instruction and verified by DNA sequencing.  
2.1.4 Preparation of E. coli competent cells 
A single freshly grown E. coli colony from LB agar plates was inoculated 
into 100 ml of LB media without antibiotics and then grown at 37°C with 
shaking at 250 rpm to an OD600 value of 0.4~0.5. The cells were chilled on ice 
for 15 mins and spun down by centrifugation at 4,000 rpm for 10 mins at 4 °C. 
The pellet was resuspended by swirling or gently vortexing in 50 ml of 
ice-cold and sterile CaCl2-Glycerol solution (0.1 mM CaCl2 and 15% 
glycerol). The cells were then incubated on ice for another 15 mins. After a 
second round of centrifugation at 4,000 rpm for 10 mins at 4 °C, the cell 
pellets are resuspended by 4 ml ice-cold CaCl2-Glycerol solution. Aliquotes 
(100l) of resuspended cells were flash frozen in liquid nitrogen and then 
stored at -80 ć. 
2.2 Protein expression 
2.2.1 Small scale protein expression 
Protein expression constructs were transformed into the BL21/DE3/RILP 
competent cells. Before large scale protein expression, small scale tests were 
performed. For the small scale test, a single colony was inoculated into 4 ml 
LB media with proper antibiotics. The cells were cultured at 37 ć with 
shaking to an OD600 value of 0.6-0.8. Then, protein expression was introduced 
by the addition of 0.4 mM isopropyl--D-thiogalactopyranoside (IPTG), and 
the cells were shaken at 20 ć for additional 16 hrs. For control cells, no 
IPTG was added. Both control and induced cells were spun down. Pellets were 
resuspended in 500 l buffer Z [25 mM Tris (pH7.4), 25 mM KH2PO4 (pH 
6.8), 500 mM NaCl, 10% Glycerol, 1 mM DTT] and broken down by 
sonication. After centrifugation at 12000 rpm for 10 mins, the supernatants 
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were mixed with SDS-PAGE loading buffer. All mixtures were boiled on a 
100 ć heat block for 5-10 mins and then subjected to SDS-PAGE. 
2.2.2 Large scale protein expression 
If proteins were expressed and soluble in the small scale test, the large 
scale expression (8 L) was then performed to obtain a larger amount of 
proteins for crystallization experiments. Similar to the small scale expression, 
large scale protein expression started from inoculating a single colony into 100 
ml LB media with proper antibiotics. The cells were cultured at 37 ć with 
shaking (250 rpm) overnight. Aliquots of the 100 ml cell culture were then 
inoculated into 8 flasks, each containing 1 L of LB media with proper 
antibiotics. The cells were cultured at 37 ć with shaking to an OD600 value 
of ~0.4. Then the temperature and speed of shaker were reduced to 20 ć 2ˈ00 
rpm, respectively. After ~15 mins, the protein expression was induced in the 
same way as described for small scale expression. 
2.2.3 Expression of selenomethionine (SeMet)-substituted protein  
For expression of SeMet-substituted proteins, the 1hM9 media was used. 
Before preparing 1hM9 media, 5hM9 stock solution was prepared by 
dissolving 56.5 g of M9 minimal salts (including 33.9 g/L Na2HPO4, 15 g/L 
KH2PO4, 2.5 g/L NaCl, and 5 g/L NH4Cl, Sigma, Cat #6030) into 1 L water. 
Then the composition of 1 L of 1hM9 media is as follows: 200 ml 5hM9 
salt solution, 2 ml 1 M MgSO4, 20 ml 20% glucose, 2 ml 0.05 M CaCl2 and 
distilled H2O. The prepared media was autoclaved immediately and cooled 
down to ~50 ć when proper antibiotics was added. 
A single colony was cultured overnight in 3 ml LB media with proper 
antibiotics at 37 °C with shaking (250 rpm). The overnight culture was spun 
down and the pellet was resuspend in 30 ml 1hM9 media with proper 
antibiotics. The cells were cultured at 37 °C for additional 6-7 hrs and then 
transferred into 300 ml fresh 1×M9 media with proper antibiotics. The cells 
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were cultured at 37 ć with shaking (250 rpm) overnight. Aliquots of the 300 
ml cell culture were then inoculated into 8 flasks, each containing 1 L freshly 
prepared 1hM9 media with proper antibiotics. The cells were cultured at 
37 °C to an OD600 value of 0.6-0.8. Amino acids mixture [L-lysine (100 mg), 
L-phenylalanine (100 mg), L-threonine (100 mg), L-isoleucine (50 mg), 
L-leucine (50 mg), L-valine (50 mg) and Seleno-DL-methionine (25mg)] was 
added to each flask. The cells were shaken for additional 15 mins. Finally, the 
protein expression was introduced in the same way as described above. 
2.3 Protein purification 
After expression for ~16hrs, the cells were harvested by centrifugation. 
The pellets were resuspended and passed through a cell disruptor 
(www.avestin.com) five times. After ultracentrifuge at 40,000 rpm for 1h, the 
supernatants were then loaded to appropriate affinity columns for the first step 
of protein purification. 





All proteins in this thesis were purified at 4°C by using ÄKTA explorer 
or ÄKTA prime plus purification system (GE Healthcare). The flowcharts of 
all protein purification are illustrated in Figure 2-1, while the general 
procedures of each technique are described below. 
2.3.1 Affinity chromatography 
2.3.1.1 HIS or HIS-Sumo affinity chromatography 
HIS or HIS-Sumo affinity chromatography was applied to proteins that 
are fused with polyhistidine (HIS) or HIS-Sumo tag. The protein sample was 
loaded onto a clean and pre-equilibrated His column (GE Healthcare) at the 
flow rate of 1 ml/min. After loading, the non-specifically bound proteins were 
washed out by EQ buffer [25 mM Tris (pH 7.4), 250 mM NaCl, 10% Glycerol, 
1 mM DTT]. While the specifically bound proteins were eluted out by 
stepwise increments of imidazole concentration (from 25 mM, 150 mM. 250 
mM, 500 mM, 750 mM to 1 M). After elution, the column was re-equilibrated 
by EQ buffer. The fractions corresponding to A280 absorption peaks were 
analyzed by SDS-PAGE. The fractions containing the target protein were 
pooled together and dialyzed against proper dialysis buffer. During dialysis, 
Ulp1 (or P19) was added into the pooled fractions for HIS-Sumo tag cleavage, 
whereas thrombin was used for the N-terminal HIS tag cleavage. After dialysis, 
the mixture was supplemented with 25 mM imidazole and reloaded onto His 
column for tag removal. The flowthrough containing target protein was 
collected.   
2.3.1.2 GST affinity chromatography 
GST affinity chromatography was applied to proteins fused with a GST 
tag. The protein sample was loaded onto a clean and pre-equilibrated GST 
column (GE Healthcare) at the flow rate of 0.8 ml/min. After loading, the 
non-specifically bound proteins were washed out by STE buffer [25 mM (Tris 
pH 7.4), 500 mM NaCl, 10% Glycerol, 1 mM DTT and 1 mM EDTA]. The 
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bound proteins were eluted by freshly prepared reduced glutathione (GSH) [10 
mM GSH, 10 mM Tris (pH 8.0)]. After elution, the column was re-equilibrated 
by STE buffer. The fractions corresponding to A280 absorption peaks were 
analyzed by SDS-PAGE. The fractions containing the target protein were 
pooled together and dialyzed against proper dialysis buffer. During dialysis, 
PreScission Protease was added for GST tag cleavage. Finally, the GST was 
removed by either reloaded onto GST column or gel filtration when the size 
difference between the target protein and GST is large. 
2.3.1.3 Heparin affinity chromatography 
Heparin affinity chromatography was specifically applied to purify 
nucleic acid-binding proteins, such as RHA dsRBD fragments in this thesis. 
The sample containing DNA/RNA-binding proteins was dialyzed against a 
buffer with low ionic strength before being loaded onto a clean and 
pre-equilibrated Heparin column (GE Healthcare) at the flow rate of 1 ml/min. 
After loading, the non-specifically bound proteins were washed out by Mono 
QA [25 mM Tris (pH 7.4), 0.4 mM DTT and 0.1 mM EDTA]. The specifically 
bound proteins were eluted by NaCl gradient from 0 to 1 M. The fractions 
corresponding to A280 absorption peaks were analyzed by SDS-PAGE. 
2.3.2 Ion-exchange chromatography 
Ion-exchange chromatography was used to separate proteins based on 
their difference in net charge. Two columns are available: HiTrap Q column 
and HiTrap SP column. Q column was applied to proteins with isoelectric 
point (PI) below 7.0, while SP column was used for proteins with PI above 7.0. 
The procedures of protein purification using both columns were the same as 
that of Heparin column.  
2.3.3 Size exclusion chromatography (Gel filtration) 
Gel filtration was used to separate proteins based on their difference in 
molecular size. Two types of gel filtration column were used: HiLoad 26/60 
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Superdex 75 (GE Healthcare, Cat #17-1070-01) and HiLoad 26/60 Superdex 
200 (GE Healthcare, Cat #17-1071-01). Superdex 75 was selected for proteins 
with lower molecular weights ranging 3-70 KD, while Superdex 200 was used 
for proteins with higher molecular weights ranging 10-600 KD. The gel 
filtration buffer was prepared as follows: 25 mM Tris (pH 7.4), 500 mM NaCl, 
0.5 mM EDTA and 4 mM DTT. In order to improve the resolution of 
separation, the protein sample was concentrated to ~10-15 ml before being 
injected to the super loop. 
2.4 Protein analysis 
2.4.1 SDS-PAGE 
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) 
was performed throughout the protein purification process. Bio-Rad 
SDS-PAGE apparatus was used for SDS-PAGE gel running. The gel was 
prepared according to standard protocol and run in the 1×SDS-PAGE running 
buffer (25 mM Tris, 192 mM glycine, 0.1% SDS). After electrophoresis, the 
gel was stained by Coomassie Brilliant Blue staining. 
2.4.2 Protein concentration measurement 
The concentrations of proteins used for crystallization experiments were 
roughly measured by the Bradford method. 500 l of Bradford reagent (Sigma, 
Cat #B6916) was mixed homogenously with 500 l of sterile H2O in a 
disposable cuvette (Sigma, Cat #C5416). 1 l of protein sample was then 
added into the mixture. After blanking, the absorbance of the sample was 
measured in a spectrophotometer at 595 nm, and the protein concentration was 
determined according to the standard curve.  
The concentrations of proteins used for isothermal titration calorimetric 
(ITC) experiments were accurately measured by NanoDrop 2000 UV-Vis 
Spectrophotometer (Thermo Scientific). The concentration of each sample was 
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measured three times and averaged for analysis. 
2.4.3 Dynamic light scattering (DLS) 
DLS was used to monitor the homogeneity of the protein sample at 
different stages of concentration. The DLS measurements were performed at 
room temperature on a DynaPro (Protein Solution) DLS instrument. 
Before measuring, all protein samples and control buffers were first 
filtered through a 0.1m filter to avoid any dust and unwanted aggregates, and 
then degased on a thermal vacuum followed by ultracentrifuge for at least 15 
mins to remove bubbles. The cuvette was rinsed with filtered water for several 
times, 100% ethanol and then filtered water again for several times to cleanse 
and remove dust. Before measuring the sample, sample buffer was loaded into 
the cuvette by the long gel loading tips and measured, which serves as a blank. 
For each sample, at least 20 acquisitions were collected.  
2.5 Crystallization and crystal optimization 
After dialysis, the proteins were then concentrated to optimal 
concentrations in a Centriprep-30 (Amicon). During the various stages of 
concentration, the homogeneity of the protein was checked by DLS following 
the procedures described above. The optimal concentration of a protein for 
crystallization was also determined by the results of pre-screening tests using 
Grid Screen Kits from Hampton Research (Table S-3). At the optimal 
concentration, around 1/3-1/2 of the drops should show precipitation in the 
pre-screening tests. After concentration, the proteins were subsequently 
subjected to crystallization trials. 
All crystallization trials were set up using the hanging drop vapor 
diffusion method at 20 ºC. The screen kits from Hampton Research, Qiagen 
and Crystalgen, as listed in Table S-3, were prepared according to their 
formulation sheets. Typically, 1.0 l of sample (protein or protein/RNA 
mixture) and 1.0 l of reservoir solution were mixed and equilibrated against 
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600 l of reservoir solution. Once initial hits were observed, crystallization 
optimizations were performed to get diffraction-quality crystals. 
2.5.1 Crystallization of RHA dsRBD/GC10 duplex and limit proteolysis 
The purified RHA dsRBD fragments were dialyzed against dialysis 
buffer containing 100 mM NaCl and 25 mM Tris (pH 7.4). The RNA oligos 
were slowly added into the RHA dsRBD proteins with a molar ratio of 1.1:1. 
The mixture was then incubated overnight before setting up the crystallization 
trays. The final protein concentrations in the mixed solution were 
approximately 10 mg/ml.  
Initial attempts to screen the crystallization conditions of various RHA 
dsRBD fragments  in complex with different RNAs (Table 2-2) by combining 
the multiple-construct approach (Graslund et al, 2008) and the incomplete 
sparse matrix approach failed. Then, limited proteolysis analyses of purified 
RHA dsRBD1 (residues: 1-130) and dsRBD2 (residues: 131-318) were 
conducted. Serial dilutions (0.0625, 0.125, 0.25, 0.5, 1.0, 2.0 M) of five 
different proteases (Trypsin, Chymotrypsin, Elastase, Subtilisin, Pepain) were 
added to 4 mg/ml purified dsRBD1 (1-130) and dsRBD2 (131-318). After 
incubation at 37 ć for 10 mins or 30 mins, all samples were loaded to 15% 
SDS-PAGE for analysis. The proteinase-resistant bands were cut and 
submitted for mass spectrometric (MS) analysis. The identified bands were 
cloned, expressed and crystallized in the same way as other fragments 
described above. 






5’-Biotinlayted-RNA23-strand 1 Biotin-5’ -AGACUGAAGUGGGGAAAGGUUCC-3’ 
RNA23-strand 2 5’-AACCUUUCCCCACUUCAGUCUUU-3’ 




2.5.2 Crystallization of the NTD of PsDCR1  
The purified PsDCR1 NTD fragments were dialyzed against dialysis 
buffer [100 mM NaCl, 25 mM Tris (pH 7.4)] and concentrated to ~8 mg/ml 
for subsequent crystallization. The NTD of PsDCR1 containing residues 
70-170 was successfully crystallized in various conditions of Screen Kits from 
Hampton Research. For structure determination purpose, the SeMet-labeled 
protein was then prepared after introducing double mutations (L95M/I96M) 
into the protein sequence by the site-directed mutagenesis. The preparation of 
SeMet-NTD strictly followed the protocol in section 2.2.3. The SeMet-protein 
was dialyzed and concentrated in a similar way with the native NTD. 
2.5.3 Crystallization and optimization of PsDCR1 RNase III-dsRBD 
domains 
  The purified PsDCR1 RNase III-dsRBD fragments were dialyzed 
against dialysis buffer [500 mM NaCl, 4mM DTT, 25 mM Tris pH 7.4)] and 
concentrated to ~15 mg/ml for subsequent crystallization. As listed in Table 
S-2, many fragments containing the RNase III and dsRBD domains of 
PsDCR1 were subjected to crystallization trials. The first observed crystals 
were from a fragment containing 200-431aa. 
A series of approaches were then adopted to optimize this successful hit. 
The approaches were: fine-tuning the crystallization conditions, additive 
screening, dehydration (Heras et al, 2003), systematic N/C-terminal 
truncations based on secondary structure prediction (Graslund et al, 2008), 
proteolysis (Dong et al, 2007) and mutational protein surface engineering by 
the introduction of K300A/E303A/E304A/K307A mutations (Derewenda, 




2.6 Data collection and structure determination 
2.6.1 For RHA dsRBDs/GC10 duplxes crystals 
Crystals of dsRBDs/GC10 duplexes were flash frozen in liquid nitrogen 
with cryo-protectant (the reservoir solution supplemented with 30% glycerol). 
The data of dsBD1/GC10 duplexes were collected on beamline X29A at the 
National Synchrotron Light Source at Brookhaven National Laboratory (X29A, 
NSLS). While the data of dsBD2/GC10 duplexes were collected on beamline 
U17 at Shanghai Synchrotron Radiation Facility (BL17U, SSRF). A total of 
360 frames with 1 oscillation at wavelength 1.007 Å were collected on each 
RHA dsRBD1/GC10 duplexes crystal, whereas a total of 180 frames with 1 
oscillation at wavelength 0.9792 Å were collected on each RHA 
dsRBD2/GC10 duplexes crystal. Both data sets were processed by HKL2000 
(www.hkl-xray.com), and both structures were determined by the MR method 
(MOLREP/CCP4). Structure models were built using the program O 
(http://xray.bmc.uu.se/alwyn) and refined using the REFMAC/CCP4 
(www.ccp4.ac.uk). The coordinates were deposited in the PDB with the 
following accession codes: 3VYY for RHA dsRBD1/GC10 duplexes and 
3VYX for RHA dsRBD2/GC10 duplexes. 
2.6.2 For PsDCR1 NTD crystals 
Crystals of the native PsDCR1 NTD were flash frozen in liquid nitrogen 
with reservoir solution directly, whereas crystals of SeMet-labeled PsDCR1 
NTD were flash frozen in liquid nitrogen with cryo-protectant (reservoir 
solution supplemented with 30% glycerol). Both data sets were collected on 
beamline U17 at Shanghai Synchrotron Radiation Facility (BL17U, SSRF). A 
total of 360 frames with 1 oscillation at wavelength 0.9793 Å were collected 
on a native PsDCR1 NTD crystal, whereas a total of 360 frames with 1 
oscillation at wavelength 0.9794 Å were collected on a SeMet-labeled 
PsDCR1 NTD crystal. Bothe data sets were processed by HKL2000 
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(www.hkl-xray.com). The structure of the SeMet labeled NTD was determined 
by the SAD method, while the structure of the native NTD was determined by 
the MR method using the determined SeMet-labeled NTD structure as the 
search model. The initial model was built using the program O 
(http://xray.bmc.uu.se/alwyn), and further refined using REFMAC/CCP4 
(www.ccp4.ac.uk). 
2.7 Isothermal titration calorimetric (ITC) assay 
All ITC experiments were performed on the MicroCal VP-ITC 
calorimeter (Northampton, MA, USA) at 25C. Protein concentrations were 
determined by the spectrophotometric assay as described in section 2.4.3. The 
RHA dsRBDs and the PsDCR1 NTD were dialyzed against the dialysis buffer 
containing 12.5 mM Tris (pH 7.4) and 100 mM NaCl. While both the 
full-length PsDCR1 and the PsDCR1-NTD proteins were dialyzed against 
12.5 mM Tris (pH 7.4) and 500 mM NaCl. Synthesized siRNA21 duplexes 
without biotin-labeling (a self-complimentary 21bp RNA with sequence 
shown in Table 2-2) was dissolved in the same buffer as its titrated protein. 
Both protein solution (20 M) and siRNA21 duplexes solution (200 M) were 
filtered and degassed before titration. Protein samples were loaded into the cell, 
and RNA samples were loaded into the syringe. Data were collected in the 
high feedback mode with a filter period of 2 seconds and a stirring speed of 
310 r.p.m. The calorimetric data were processed and fitted using Microcal 
Origin (version 5.0). The curves of RHA dsRBD1 and dsRBD2 as well as their 
mutants were fitted into the one-site-binding model, whereas that of RHA 
dsRBD1+2 was fitted into the two-site-binding model. Unlike the RHA 
dsRBDs, the PsDCR1fragments were fitted into the sequential binding model. 
2.8 Co-immunoprecipitation (Co-IP) assay 
293FT cells were maintained under standard culture conditions in 
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DMEM medium containing 10% FCS and 100 g/ml Penicillin/Streptomycin. 
The pcDNA5-FRT-6h Flag vector was used to make N-terminal 6h
Flag-tagged protein-encoding constructs, whereas pXJ40-c-Myc vector was 
used to make N-terminal c-Myc-tagged protein-encoding constructs. Plasmids 
were co-transfected into 293FT cells using a linear polyethylenimine 
(PEI)-mediated approach (Tom et al, 2008). Cells were harvested after 48 hrs 
and later lysed on ice using lysis buffer [50 mM Tris (pH 8.0), 100 mM NaCl, 
10% Glycerolˈ0.2% NP-40 and Protease inhibitor cocktail (Cat #P8304)]. 
After centrifugation, the supernatants were incubated with pre-equilibrated 15 
l Anti-Flag Affinity Gel (Sigma, Cat #A2220) for 3 hrs. The beads were 
washed 5 times with washing buffer [50 mM Tris (pH 8.0), 100 mM NaCl, 10% 
Glycerolˈ0.1% NP-40]. Then, the proteins were eluted using 60 l 250 g/ml 
3×FLAG peptides (Sigma, Cat #F4799). Both the input and anti-flag 
immunoprecipitants were resolved by 15% SDS-PAGE and visualized by 
western blot which will be described below. For RNase treatment assay, 4 l 
of RNase was added into 100 l of beads slurry during washing steps. The 
mixture was incubated in 37 ć water bath for 30 minutes. 
2.9 Western blot 
Western blot was performed following standard protocol except for the 
following modifications. The primary antibodies were monoclonal 
Anti-c-MYC antibody (Sigma, Cat #M4439) and monoclonal Anti-FLAG 
antibody (Sigma, Cat #F1804). Both of these antibodies were derived in 
mouse. The secondary antibody was horseradish peroxidase-conjugated (HRP) 
anti-mouse IgG (GE Healthcare, Cat #LNXA931). The working solutions of 
the primary antibodies were 1:5000 diluted by TBST solution while that of the 
secondary antibody was 1:5000 diluted by TBST solution supplemented with 
0.5% milk. Millipore's Immobilon Western Chemiluminescent HRP Substrate 
(WBKLS0500) was used for detection. The signal was imaged by ImageQuant 
62 

LAS 4000 (GE Healthcare). 
2.10 Circular dichorism (CD) 
All experiments were carried out on a Jasco J-810 spectropolarimeter 
(Jasco Corporation, Tokyo, Japan) at 25 C. The proteins were dialyzed against 
a dialysis buffer containing 10 mM K2HPO4 (pH 7.4) overnight. The far-UV 
(190-260nm) CD spectra were collected at a protein concentration of 20 μM, 
using 1 mm path length cuvette with a 0.1 nm spectral resolution. Data of 
three independent scans were averaged and analyzed. 
2.11 In vitro pull down assay 
GST-tagged dsRBD1, dsRBD2, dsRBD1+2 were expressed in E. coli 
(strain BL21/DE3/RILP) and purified as described in section 2.3. Proteins 
were dialyzed overnight against dialysis buffer [25mM Tris (pH 7.4), 100mM 
NaCl]. 50 g of each protein were incubated with 10 g 5’-Bio-siRNA duplex 
overnight at 4ć . The protein-RNA mixture was then incubated with 
pre-equilibrated 30 l Streptavidin Sepharose (GE Healthcare, Cat 
#17-5113-01) for 1 hr. The beads were washed 5 times with washing buffer 
[50 mM Tris (pH 8.0), 100 mM NaCl, 10% Glycerol, and 0.1% NP-40]. 40 l 
2×SDS Loading Dye was added to the beads and the mixture was boiled for 
20 mins. Both the input and anti-streptavidin pull outs were loaded onto 15% 
SDS-PAGE gels and visualized by western blot using anti-GST antibody.  
2.12 In vitro transcription of RNA substrates 
The primers for amplifying the DNA templates are all listed in Table 2-3. 
The forward primers contained the T7 promoter sequence, which guaranteed 
that the generated PCR products can be directly used for in vitro transcription. 
The pre-let-7a-1 DNA templates were PCR amplified from a plasmid 
containing pri-let-7a-1 gene by using the pre-let-7a-1 forward and reverse 
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primers. Similarly, the RNA161 templates were PCR amplified from pIS2 
plasmid (Addgene, plasmid #12177) by using the RNA161 primers. The PCR 
products were agarose-gel purified and quantified by NanoDrop. The 
unlabeled RNA molecules were synthesized by using the RiboMAX™ Large 
Scale RNA Production System-T7 (Promega, Cat #P1300) according to the 
manufacturer’s instruction. The biotin-labeled RNAs were synthesized by 
replacing rNTP in the Promega package with 2 l of the Biotin RNA Labeling 
Mix, 10 × conc. (Roche, Cat #11685597910). After 3 hrs’ incubation at 37 ć, 
2 l DNase was added into the reaction. The reaction was incubated at 37 ć 
for another 15 mins and stopped by adding 2 l of 0.2 M EDTA (pH 8.0). 
Then the RNA products were fractionated by 10%-12% Urea-PAGE. After the 
electrophoresis, the Urea-PAGE gel was stained by the SYBR® Safe DNA Gel 
Stain (Invitrogen, Cat #S33102) and imaged under the Safe ImagerTM2.0 
Blue-Light Transilluminator (Invitrogen, Cat #G6600). The visible bands of 
correct size were cut and preceded to RNA purification.  
Table 2-3 Primers’ sequence used for RNA templates amplification for in vitro 
transcription 









For RNA purification, 350 RNA elution buffer [0.3 M sodium acetate 
(pH 5.5), 1 mM EDTA and 1% SDS] was added into the 1.5 ml tube 
containing the gel slices. The tube was incubated on a 42 ć heat block 
overnight. The RNA products were extracted by ethanol precipitation 
following Narry Kim’s protocol (Han et al, 2004). The final purified RNAs 
were dissolved in appropriate amount of RNase-free H2O. Finally, the RNA 
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concentration was measured by NanoDrop. 
The dsRNA161 substrates were prepared by annealing the synthesized 
RNA sense strand and the anti-sense strand in a molar ratio of 1:1 in the 
annealing buffer [100 mM NaCl, 10 mM Tris (pH 8.0)]. The annealing was 
performed by heating the mixture to 90 ć for 1 min, and then slowly cooling 
the system down to 4 ć over the course of 4-5 hrs.  
2.13 RNA cleavage assay 
Protein samples were prepared as described above in Figure 2-1 and 
dialyzed against buffer containing 500 mM NaCl, 25 mM Tris (pH 7.4) and 4 
mM DTT. All proteins were diluted to 0.75 mg/ml. 20 l reactions contained 2 
l RNA transcripts (100 ng in total for dsRNA161 whereas 30 pM for 
biotin-labeled pre-let-7a-1), 8 l protein or protein buffer, 2 l MgCl2+ATP 
(100 mM each) and 8l H2O. The final concentration of NaCl in the reactions 
was 200 mM. The mixtures were incubated at 37 ć for 30 mins. After the 
addition of 5 l 5×RNA Loading Dye, the mixtures were boiled at 100 ć for 
10 mins and centrifuged at 12000 rpm for 5 mins. The supernatants were 
loaded onto Urea-PAGE gel for analysis. After electrophoresis, the cleavage 
products of dsRNA161 were illuminated by SYBR safe staining while those of 
bio-pre-let-7a-1 were detected by chemiluminescence.  
2.14 Urea-PAGE for RNA analysis 
Urea-PAGE was performed for RNA fractionation after in vitro 
transcription and RNA cleavage assays. The 10-15% Urea-PAGE gel was 
prepared following standard protocol. After being solidified for 30 mins to 1 hr, 
the gel was pre-run at 350 V for at least 1 hr in 0.5×TBE buffer [45 mM Tris, 
45 mM Boric Acid, 1 mM EDTA (pH 8.3)]. The wells were flushed before 
sample loading. The RNA samples were mixed with the 10hRNA Loading 
Dye (95% deionized formamide, 0.025% bromophenol blue, 0.025% xylene 
cyanol, 5 mM EDTA and 0.025% SDS) and boiled at 95 ć for 5 mins before 
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being loaded into the wells. The gel was run at 150-250 V until bromophenol 
blue reached the bottom of the gel. After gel electrophoresis, the gel was 
subjected to either staining or membrane transfer.  
2.15 Electronic mobility shift assay (EMSA) 
The sequences of small RNAs used for EMSA are listed in Table 2-2. 
Duplex RNA23 were prepared by annealing the ssRNA23 
oligoribonucleotides following the protocol of annealing dsRBA161. EMSA 
experiment was performed by using the LightShift® Chemiluminescent 
EMSA Kit (Pierce, Cat #20148) according to the manufacturer’s instruction 
with several modifications. Specifically, for the preparation of binding 
reactions, increasing amount (0.5 g, 1.0 g, 2.0 g) of PsDCR1 fragments 
and 1 l of 10 pM 5’-biotinlayted-dsRNA23 were incubated in a 20 l reaction 
system which contained 2 l 10×Binding buffer, 1 l 50% Glycerol, 1l 100 
mM MgCl2, 1 l 1% NP40 and GF buffer (topped up to 20 l). The GF buffer 
contained 25 mM Tris (pH 7.4), 500 mM NaCl, 0.5 mM EDTA and 4 mM 
DTT. Moreover, the final salt concentration in each reaction was adjusted to 
500 mM to avoid dsRNA cleavage by proteins. The binding reactions were 
incubated at room temperature for 30 mins before 5 l 5 × Loading Dye was 
added. After centrifugation, the reactions were then loaded onto a 5% 
Native-PAGE gel. After electrophoresis, membrane transfer, crosslinking and 
preparing the membrane for detection, the signal was detected by ImageQuant 
LAS 4000 (GE Healthcare). 
2.16 Glutaraldehyde (GA)-crosslinking 
Different protein fragments of PsDCR1 were prepared. Glutaraldehyde 
solution (25% in H2O, Sigma, Cat #G5882) was used as the crosslinking 
reagent for detecting protein polymerization status. The reagent was diluted to 
0.2% in H2O as stock solution. For each protein, 0, 0.5, 1, 2 l of 0.2% stock 
solution were added into four tubes, each containing 10 l of 0.4 mg/ml 
protein. All reactions were incubated at room temperature for 10 mins and 
quenched by boiling at 100 ć for 5 mins after addition of 5hSDS-PAGE 
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Loading Dye. Reactions were fractionated by 15% SDS-PAGE and analyzed 
by Coomassie Brilliant Blue staining. 
2.17 Analytical ultracentrifuge (AUC) 
The AUC velocity experiment was performed to determine the molecular 
mass of proteins in solution. Sedimentation velocity (SV) experiments were 
conducted at 20 °C on a Beckman XL-A analytical ultracentrifuge, equipped 
with absorbance optics and a An60-Ti rotor. The NTD of PsDCR1 were 
diluted to OD280=0.8333 in buffer containing 100 mM NaCl , 25 mM Tris 
(pH 7.4) while other truncated fragments were in buffer containing 500 mM 
NaCl , 25 mM Tris (pH 7.4). The rotor speed was set at 60,000 rpm for the 
highest resolution. The sedimentation coefficient and f/f0 were obtained with 





























CHAPTER 3: Structural insights into RISC assembly 
facilitated by dsRNA-binding domains of human RNA helicase 
A (DHX9) 
Intensive interest has focused on the structural studies of key components 
involved in the small RNA-processing machinery and the RISC, two key 
cellular machines in RNAi pathways. However, structural mechanism 
regarding RISC assembly, the primary step linking small RNA processing and 
RNA-mediated gene silencing, is largely unknown. Human RNA helicase A 
(RHA or DHX9) was reported to function as an RISC-loading factor and such 
function is mediated mainly by its dsRBDs. Here, we utilized the X-ray 
crystallography to study the structure of RHA dsRBDs/dsRNA. Moreover, 
several other methods of studying protein-RNA and protein-protein 
interactions were also utilized to investigate the roles of RHA dsRBDs in 
RISC assembly. 
3.1 Bioinformatics analysis of human RHA dsRBDs 
Sequence alignment analysis revealed that the tandem RHA dsRBDs 
share relatively high sequence similarities with other canonical dsRBDs, such 
as the dsRBD1 and dsRBD2 of human TRBP2 and PKR (Figure 3-1B lower 
panel). Moreover, secondary structure prediction of RHA dsRBDs showed that 
they contain two  helices and three  strands, similar to the canonical 
dsRBDs (Figure 3-1B upper panel). Given the fact that the canonical dsRBDs 
have dsRNA-binding abilities and that RHA associates with RISC wherein the 
siRNA is an essential component, we thus hypothesized that RHA dsRBDs 








Figure 3-1  Domain composition of RHA and sequence alignment of dsRBDs.
(A) Schematic diagram of human RNA Helicase A (DHX9).  
(B) Sequence alignment of RHA dsRBDs with various dsRBDs proteins from 
different organisms which are as follows: Hs stands for H.sapiens, Dm stands for 
D. melanogaster, Xl stands for X. laevis, At stands for A. thaliana, Sc stands for S. 
cereviase and Aa stands for A. aeolicus. Identical or similar residues are shaded 
in green, yellow or cyan. Asterisks indicate the critical residues involved in 
protein-RNA interactions in our determined complexes. The secondary structure 
elements are shown above the sequence. 
 
 
3.2 Both RHA dsRBD1 and dsRBD2 have siRNA duplex-binding affinity 
To test the hypothesis that RHA dsRBDs may directly bind to siRNA 
duplex, we performed in vitro protein-RNA pull down assay for RHA dsRBDs 
and a biotin-labeled self-complimentary 21-bp siRNA duplex (siRNA21: 
5’-P-AGACAGCAUUAUGCUGUCUUU-3’, shown in Table 2-2). As showed 
in Figure 3-2, both individual RHA dsRBDs [RHA dsRBD1 (residues: 1-91) 
and dsRBD2 (residues: 165-264)] and tandem dsRBDs [dsRBD1+2 (residues: 
1-264)] were pulled out by siRNA21 duplex. This observation suggests that 




Figure 3-2 RHA dsRBDs associate with RNA duplex both in vitro. 
In vitro pull down of dsRBDs by 5’-biotinylated siRNA21 duplexes. The upper panel 
shows the input of GST-tagged dsRBDs and the lower panel shows the pull outs of 
streptavidin beads. GST only was used as a negative control. 
3.3 Crystallization and crystal optimization by limited proteolysis 
To investigate the structural principles of RNA duplex recognition by 
human RHA dsRBDs, we systematically screened hundreds of crystallization 
conditions for various RHA fragments together with RNA duplexes of 
different lengths and sequences. The initial tested dsRBD1-containing 
fragments were 1-72aa, 1-80aa and 1-130aa, and the initial tested 
dsRBD2-containing fragments were 131-318aa and 131-264aa of dsRBD2 
(Table S-1). After the initial screening failed, we then turned to the limited 
proteolysis approach (Dong et al, 2007; Wernimont & Edwards, 2009). The 
proteases which generated protease-resistant bands were identified: Elastase 
for dsRBD1 (Figure 3-3A) and Trypsin for dsRBD2 (data not shown). And the 
residues of the protease-resistant bands were characterized by MS: 1-91 a.a. 
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for RHA dsRBD1 and 165-264 a.a. for dsRBD2. The gene fragments 
corresponding to the proteinase-resistant peptides were cloned, and the 
recombinant proteins were expressed and purified (Figure 3-3B&C). 
 

Figure 3-3 Limited proteolysis, protein purification and crystallization of RHA 
dsRBDs. 
(A) Limited proteolysis of RHA dsRBD1 (1-130aa) by using serial dilution (0.0625, 
0.125, 0.25, 0.5, 1.0, 2.0 M) of Elastase protease. The reactions were incubated 
at 37 ć for 10 mins and 30 mins, respectively.  
(B) 1 l of purified RHA dsRBD1 containing residues 1-91 resolved with 15% 
SDS-PAGE. 
(C) 1 l of purified RHA dsRBD2 containing residues 165-264 resolved with 15% 
SDS-PAGE. 
(D) Crystals of RHA dsRBD1/GC10 complexes. 
(E) Crystals of RHA dsRBD2/GC10 complexes. 
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Crystals of RHA dsRBD1 (residues 1-91) in complex with GC10 duplex 
(a self-complementary 10-bp RNA with sequence shown in Table 2-2) were 
grown in crystallization conditions containing 13-17% PEG 8,000, 0.2-0.3 M 
CaAc2, 0.1 M Sodium Cacodylate (pH 6.5) (Figure 3-3D), whereas the 
crystals of RHA dsRBD2 (residues 165-264) in complex with GC10 duplex 
were grown in crystallization conditions containing 15-17% PEG 4,000, 
0.6-0.8 M KNO3, 0.1 M Tris (pH 7.0) (Figure 3-3E). These crystals grew to a 
maximum size of 0.3 mm0.1 mm0.1 mm over the course of 7 days. 
3.4 Overall structures of RHA dsRBDs in complex with dsRNA 
After collecting the diffraction data, we determined the crystal structures 
of both RHA dsRBD1 (residues: 1-91) and RHA dsRBD2 (residues: 165-264) 
in complex with GC10 duplexes. The structure of RHA dsRBD1 was 
determined by molecular replacement using the NMR structure of the 
N-terminal dsRBD of hypothetical protein BAB28848 (PDB: 1WHQ) as the 
search model. The structure of RHA dsRBD2 was determined using the NMR 
structure of the second dsRBD of hypothetical protein BAB28848 (PDB: 
1UIL) as the search model.  
The RHA dsRBD1 in complex with GC10 duplex was crystallized in 
space group C2 and refined to 2.9Å, whereas the RHA dsRBD2 in complex 
with GC10 duplex was crystallized in space group P43212 and refined to 2.3Å. 
There are two RHA dsRBD1 domains, two GC10 duplexes and one 
single-stranded GC10 per asymmetric unit in the RHA dsRBD1/dsRNA 
structure. There are one RHA dsRBD2 and one GC10 duplex per asymmetric 
unit in the RHA dsRBD2/dsRNA structure. Notably, in the RHA 
dsRBD1/dsRNA structure, the two protein-bound GC10 duplexes stack 
end-to-end, and the single-stranded GC10 pairs with its symmetric-related 
single-stranded GC10 to form a GC10 duplex that stacks end-to-end to the two 
GC10 duplexes to form a continuous A-form-like helix. Similarly, in the RHA 
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dsRBD2/dsRNA structure, the bound GC10 duplex stacks end-to-end to its 
symmetry-related GC10 duplex to form a continuous elongated A-form-like 
helix. The detailed crystallographic statistics are summarized in Table 3-1. 
 
Figure 3-4 Overall structures of RHA dsRBDs in complex with GC10 duplex. 
(A) Overall structure of RHA dsRBD1 in complex with GC10 duplex in cartoon 
view. RHA dsRBD1 is colored in magenta and GC10 duplex is colored in 
orange. The critical residues belonging to region 1, 2, and 3 required for 
dsRNA recognition are shown in stick mode and colored in red, wheat and 
yellow, respectively. 
(B) Electrostatic surface view of the complex structure with the same view as that 
in the left panel. Blue, red and white colors represent positive, negative and 
nonpolar patches on the protein, respectively. 
(C) Structure of RHA dsRBD2 in complex with GC10 duplex in cartoon view. 
RHA dsRBD2 is colored in cyan and GC10 duplex is in orange. The critical 
residues belonging to region 1, 2, and 3 required for dsRNA recognition are 
shown in stick mode and colored in red, wheat and yellow, respectively. 
(D) Electrostatic surface view of the complex structure with the same color code as 
that in (C). 
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Similar to other dsRBDs, RHA dsRBDs contain the core structure with 
approximately 70 amino acids in length sharing a common ---- fold, 
where the two  helices lie on one surface of the three-stranded anti-parallel  
sheets (Doyle & Jantsch, 2002). However, RHA dsRBD1 has an additional 13 
a.a. random coil structure at its C-terminus, whereas RHA dsRBD2 has an 
additional 12 a.a. random coil at its N-terminus and a 10 a.a. random coil at its 
C-terminus (Figure 3-1B).   
Table 3-1 Data collection, phasing and refinement statistics 
 
Data collection 
 RHA dsRBD1 RHA dsRBD2 
Synchrotron beamline X29A, NSLS U17, SSRF 
Space group           C2 P43212 
Cell dimensions   
a, b, c (Å) 52.25, 78.53, 112.24 63.20, 63.20, 107.62 
 () 98.81 90 
Wavelength (Å) 1.007 0.9792 
Resolution (Å) a 50~2.9 (2.95~2.9) 50~2.3 (2.34~2.3) 
Rsym (%) 8.6 (25.4) 9.5 (29.9) 
I/(I) 27.7 (5.8) 32.2 (9.2) 
Completeness (%) a 99.5 (94.7) 100.0 (100.0) 
Redundancy 3.2 (3.7) 13.8 (12.5) 
Refinement  
Resolution Range (Å)    50~2.9 (3.0~2.9) 50~2.3 (2.35~2.3) 
No. reflections 9,511 9,800 
Rwork (Rfree) (%) 21.9/26.2 (27.2/36.8) 19.3 /26.3 (21.8/36.2) 
No. atoms   
Protein 1,356 765 
RNA 1060 432 
Water - 82 
B-factors (Å2)   
Protein 48.5 30.6 
RNA 44.1 29.0 
Water - 36.1 
R.m.s. deviations   
Bond lengths (Å) 0.011 0.015 
Bond angles (º) 1.65 1.72 
% favored (disallowed)  
in Ramachandran plot 
87.9 (0) 94.0 (0) 
a Values for the highest-resolution shell are in parentheses. 
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3.5 Identification of critical residues for RHA dsRBDs-dsRNAs interaction 
Structural analysis of RHA dsRBDs in complex with dsRNAs showed 
that the three conserved regions (Tian et al, 2004) in the ---- core 
structure are crucial for dsRNA binding (Figure 3-4A&C). In the RHA 
dsRBD1 structure, residues K5, N6 and Y9 at 1 interact with the minor 
groove, and residue N30 at the loop connecting 1-2 interacts with the 
successive minor groove, whereas residues N53 at the loop connecting 3-2, 
and K54, K55 at 2 interact with the intervening major groove of the bound 
dsRNA duplex directly (Figure 3-1B, and Figure 3-8A&B, left panel). 
Similarly, in the RHA RBD2 structure, residues N186 and Q187 interact with 
the minor groove, and residue H207 interacts with the successive minor 
groove, whereas residues N234, K235 and K236 interact with the intervening 
major groove of the bound dsRNA duplex directly (Figure 3-1B and Figure 
3-8A&B, right panel). Notably, these residues are surface-exposed and highly 
conserved in dsRBDs (Figure 3-1B). Consistent with our structural 
observation, the conserved lysine residues in RHA (K54, K55 in dsRBD1 and 
K236 in dsRBD2) were reported to be involved in selective recognition and 
translation of mRNA substrates (Ranji et al, 2011).  
To further validate whether these conserved residues in both RHA 
dsRBDs are critical to siRNA duplex binding in vitro, we introduced alanine 
mutations into these residues and performed ITC assays to measure the 
binding affinities of individual RHA dsRBDs and their mutants to the 
self-complimentary 21-bp siRNA duplex. As expected, individual RHA 
dsRBDs showed significant binding to siRNA duplex (Figure 3-5A, 3-6A, and 
Table 3-2A & 3-3A). Not surprisingly, introduction of an Y9A single mutation 
or N53A/K54A/K55A triple mutations into RHA dsRBD1 or introduction of 
N234A/K235A/K236A triple mutations into RHA dsRBD2 completely 
abolished siRNA duplex binding (Figure 3-5C&E, 3-6E and Table 3-2C&E, 
3-3E). Similarly, introduction of K5A/N6A double mutations into RHA 
dsRBD1 or introduction of a K182A single mutation, N186A/Q187A double 
mutations or an H207A single mutation into RHA dsRBD2 significantly 
reduced siRNA duplex binding (Figure 3-5B, 3-6B&C&D and Table 3-2B, 
3-3B&C&D). By contrast, introduction of an N30A single mutation into RHA 
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dsRBD1 showed comparable siRNA duplex-binding affinity to that of 
wild-type RHA dsRBD1 (Figure 3-5D and Table 3-2D). Circular dichroism 
analysis of conformational differences between wild-type and these mutant 
proteins showed that the mutations did not perturb the overall structure of 





Figure 3-5 Biochemical characterizations of key residues on RHA dsRBD1 
involved in dsRNA binding. 
 (A-E) represent the ITC data of titrating siRNA duplex into RHA dsRBD1 and four 
RHA dsRBD1 mutants: RHA dsRBD1 K5A/N6A, Y9A, N30A, 
N53A/K54A/K55A. Raw data is shown in the upper panel, whereas fitted 
curves and binding parameters after integration are shown in the lower panel of 
each profile. Equilibrium constants K and stoichiometry factor N are shown 













Figure 3-6 Biochemical characterizations of key residues on RHA dsRBD2 
involved in dsRNA binding. 
(A-E) represent the ITC data of titrating siRNA duplex into RHA dsRBD2 and four 
RHA dsRBD2 mutants: RHA dsRBD2 K182A, N186A/Q187A, H207A, 
N234A/K235A/K236A, respectively. Raw data is shown in the upper panel, 
whereas fitted curves and binding parameters after integration are shown in the 
lower panel of each profile. Equilibrium constants K and stoichiometry factor 











Table 3-2 Binding of RHA dsRBD1 and their mutants with siRNA21 by ITC 
 
siRNA21 titrated into RHA dsRBD1 WT and 4 mutants 
 A         B C D E 
 WT K5A/N6A Y9A N30A N53A/K54
A/K55A 
N 0.5 EWB NB 0.5 NB 
Kd (M) (5.93±0.36)×10-6 EWB NB (1.45±0.08)×10-5 NB 
H (cal/mol) (-2.81±0.057)×104 EWB NB (-4.23±0.11)×104 NB 
S (cal/mol/deg) -70.36 EWB NB -119.60 NB 
Notes˖ 
(A) WT: wild type; NB: No detectable binding; EWB: Extremely weak binding; Kd: 
dissociation constants, which were manually calculated from K (the binding 
constants shown in the fitting curve panels) based on equation Kd=1/K. The 
estimated errors for K, H were the sum of the squares of the deviations of the 





Table 3-3 Binding of RHA dsRBD2 and their mutants with siRNA21 by ITC 
 
siRNA21 titrated into RHA dsRBD2 WT and 4 mutants 
 A         B C D E 




N 0.5 0.5 EWB 0.5 NB 
Kd (M) (1.36±0.06)×10-5 (3.34±0.018)×10-4 EWB (2.91±0.24)×10-4 NB 
H (cal/mol) (-1.78±0.035)×104 (-2.33±0.11)×105 EWB (-1.57±0.12)×105 NB 
S (cal/mol/deg) -37.47 -765.20 EWB -511.50 NB 
Notes˖ 
(A) WT: wild type; NB: No detectable binding; EWB: Extremely weak binding; Kd: 
dissociation constants, which were manually calculated from K (the binding 
constants shown in the fitting curve panels) based on equation Kd=1/K. The 
estimated errors for K, H were the sum of the squares of the deviations of the 








Figure 3-7 CD analyses of conformational differences between wild-type and 
mutants. 
(A)  CD analyses of conformational differences between wild-type dsRBD1 and its 
mutants. 
(B)  CD analyses of conformational differences between wild-type dsRBD2 and its 
mutants. 
3.6 Structural comparison of RHA dsRBD1/dsRNA with dsRBD2/dsRNA 
Comparison of crystal structures of RHA dsRBD1/dsRNA with 
dsRBD2/dsRNA showed that these two dsRBD structures are very similar 
with an r.m.s.d. value of 2.1 Å (Z score 10.9, 81 C atoms), although these 
two dsRBDs only share 21% sequence similarity. In addition to the different 
orientations of N-and C- terminal random coils, the only other significant 
difference between these two dsRBD structures is at the loop region 
connecting 2-3 (Figure 3-1B). Compared to the RHA dsRBD1 structure, the 
RHA dsRBD2 structure has a longer loop with a 4 a.a. insertion; however, this 
loop is located at the other side of the surface and is not involved in dsRNA 
binding (Figure 3-8A). 
In contrast, comparison of the RHA dsRBDs/dsRNA complex structures 
demonstrated ~5Å movement and ~15 rotation between the two bound 
pseudo-continuous dsRNA helices (Figure 3-8A). The pseudo-continuous 
dsRNA helices bound to the RHA dsRBD1 adopt a standard A-form dsRNA 
helix, whereas the pseudo-continuous dsRNA helices bound to the RHA 
dsRBD2 adopt a relatively elongated structure with broader minor and major 
grooves (Figure 3-8A). Notably, the dsRNAs used for crystallization of both 
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RHA dsRBD1 and dsRBD2 are from the same batch with identical sequence. 
The significant structural deviation of the bound dsRNA suggests that the 
‘induced-fit’ mechanism (Gan et al, 2006) may be applicable to dsRNA 
binding by dsRBDs in general. Consistent with this notion, within the RHA 
dsRBD 1 structure, the N-terminal half of helix 1 moves ~5 Å towards the 
bound dsRNA to secure tight binding between RHA dsRBD1 and dsRNA 
(Figure 3-8A). 

Figure 3-8 Structural comparison of RHA dsRBDs in complex with dsRNAs. 
(A) Stereoview of structural superimposition of RHA dsRBD1/GC10 duplex 
(magenta) with RHA dsRBD2/GC10 duplex (cyan). The three protein-RNA 
interaction regions are highlighted in the circles colored in red, yellow and 
wheat, respectively. The key residues (N30 in dsRBD1 and H207 in dsRBD2) 
involved in dsRNA binding in region 2 are shown in stick mode.  
(B) Close-view of the molecular details of dsRNA recognition by RHA dsRBDs. 
(Left panel) Structural details of dsRNA recognition by RHA dsRBD1. 
Residues involved in dsRNA recognition in region 1 and 3 are colored in red 
and yellow, respectively. (Right panel) Structural details of dsRNA recognition 
by RHA dsRBD2. Residues involved in dsRNA recognition in region 1 and 3 
are colored in red and yellow, respectively. 
Strikingly, the 21% sequence similarity between the RHA dsRBD1 and 
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dsRBD2 mainly reside on the –helices (Figure 3-1B). In contrast, there is 
poor sequence homology among the -sheets (Figure 3-1B). Hence, even 
though the overall structures of RHA dsRBD1 and dsRBD2 are almost 
identical at the ---- core motif, significant differences are observed in 
the electrostatic surface charges on both sides of the protein surfaces (Figure 
3-4B&D). Notably, the side chain of the corresponding residue of K55 on 
RHA dsRBD1, which is protruding from the surface and is involved in dsRNA 
recognition by RHA dsRBD1, is rotated ~70º away from the bound dsRNA in 
the RHA dsRBD2 structure (Figure 3-8B). Consistently, ITC data showed that 
the dissociation constant between RHA dsRBD1 and siRNA duplex was 
5.93×10-6M, whereas that of dsRBD2 with siRNA was 1.36×10-5M (Table 
3-2A, 3-3A and Figure 3-5A, 3-6A), demonstrating that the binding affinity of 
RHA dsRBD1 to siRNA duplex is 2.3 fold higher than that of RHA dsRBD2 
to siRNA. Interestingly, the higher binding affinity displayed by RHA 
dsRBD1 is mainly facilitated by basic residues from 1 and 2, while the 
residue N30 residing at the loop connecting 1-2 has an insignificant 
contribution to binding affinity as revealed by ITC data (Figure 3-5D and 
Table 3-2D). In contrast, all the basic residues residing at regions 1, 2 and 3 in 
RHA dsRBD2 play a role in siRNA duplex binding. Consistent with the ITC 
data, the structure of RHA dsRBD1 in complex with dsRNA showed that basic 
residues K5, N6, Y9 form a cluster to enable tight dsRNA binding (Figure 
3-8B, left panel), whereas the structure of RHA dsRBD2 in complex with 
dsRNA showed that basic residues K182, N186, Q187 are spread out in helix 
1 (Figure 3-8B right panel). This structural difference could be the reason for 
weaker binding affinity to siRNA duplex displayed by RHA dsRBD2 
compared to RHA dsRBD1. The lack of significant overall sequence 
conservation in RHA dsRBDs suggests that the unique conformation and 
electrostatic distribution of each RHA dsRBD may determine selection of 
unique RNA or protein for interactions. 
3.7 Structural model of siRNA duplex recognition by RHA dsRBD1+2  
A protein possesses multiple dsRBDs, which is a common feature of 
many RNA binding proteins (Tian et al, 2004). Consistent with this common 
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feature, RHA contains two tandem dsRBDs at its N-terminus (Figure 3-1A). A 
structural and functional analyses of human TRBP2 protein showed that both 
TRBP2 dsRBD1 and dsRBD2 exhibited dsRNA-binding affinity, however the 
full-length TRBP2 and its fragment containing dsRBD1 and dsRBD2 
exhibited much stronger dsRNA binding affinity than individual domain alone 
(Yamashita et al, 2011). Similarly, both dsRBDs of human PKR protein are 
required for high binding affinity to TAR RNA (Kim et al, 2006). Strikingly, 
both dsRBDs of Arabidopsis HYL1 protein are required for tight binding to 
microRNA precursors, although HYL1 dsRBD2 only showed very weak 
dsRNA binding affinity (Yang et al, 2010). Nevertheless, structural and 
biochemical evidence demonstrated that the tandem dsRBDs of these proteins 
simultaneously bind to siRNA duplex to achieve high affinity, whereas the 
flexible linker between these two dsRBDs might wrap around the siRNA 
duplex to enhance the binding affinity (Nanduri et al, 1998).  
Interestingly, structural analysis of RHA dsRBD1 in complex with 
dsRNA showed that both faces of the bound dsRNA helix are recognized by 
the RHA dsRBD1, which suggests that the two RHA dsRBDs may adopt a 
similar binding mode in order to recognize the bound siRNA duplex and 
achieve higher binding affinity, as was observed in the crystal structure of A. 
aeolicus RNaseIII-dsRBD complexed with dsRNA (Gan et al, 2006) (Figure 
3-9A&B). This proposal that dsRBD1 and dsRBD2 may bind to the opposing 
faces of dsRNA was further validated by the co-IP experiment (Figure 3-10). 
Very weak signals were detected when using dsRBD1 fragments as baits to 
pull down dsRBD2 fragments. This observation could be explained by the 
relatively weak binding affinities of dsRBDs to siRNA duplex as revealed by 
ITC assays. Moreover, in this binding mode, the long flexible linker (~110 a.a.) 
of RHA might wrap around the bound siRNA duplex. Remarkably, structural 
superimposition of these two structures showed striking structural similarities 
and positioning for both the bound dsRNA duplex and the dsRBDs (Figure 
3-9C). Consistent with this structural observation, RHA dsRBD1+2 is reported 
to exhibit strong binding affinity to a poly (rI.rC)-agarose column by adopting 




Figure 3-9 Structural models of siRNA duplex recognition by RHA dsRBD1+2. 
(A) (Left panel) Cartoon view of crystal structure of RHA dsRBD1 in complex with 
dsRNA. In this structure, the dsRNA is recognized by a pair of RHA dsRBD1 
from both sides. The dsRNA is shown in stick mode and colored in orange, 
whereas two RHA dsRBD1 domains are shown in cartoon view. One copy of 
RHA dsRBD1 is colored in magenta and the second copy is colored in cyan. 
(Right panel) Cartoon view of the crystal structure of A. aeolicus 
RNaseIII-dsRBD in complex with dsRNA. In this structure, the dsRNA is 
recognized by a pair of dsRBDs from both sides. The dsRNA is shown in stick 
mode, whereas two dsRBDs are shown in cartoon view.  
(B) Electrostatic surface view of (A). 
(C) Structural alignment of RHA dsRBD1s/dsRNA complex with A. aeolicus 
dsRBDs/dsRNA complex. (Left panel) Superimposition of the structures by 
alignment of one dsRBD. Two RHA dsRBD1 domains and the bound dsRNA are 
colored in magenta, whereas two A. aeolicus dsRBDs and the bound dsRNA are 




Figure 3-10 RHA dsRBD1 and dsRBD2 bind to the two faces of RNA duplex in
vivo. 
Co-IP of RHA dsRBD1 (residues: 1-91 and 1-130) by RHA dsRBD2 (residues: 
165-264 and 131-264, respectively). RHA dsRBD1 displays a weak association with 
dsRBD2. The upper panel shows the expression of Myc-tagged dsRBD1 and the 
middle panel shows the loading control of Flag-tagged RHA dsRBD2. The lower 
panel shows the RHA dsRBD1 co-immunoprecipitated by dsRBD2 and detected by 
anti-myc antibody. Myc only and Myc-GFP protein were used as negative controls. 
 
3.8 The integrated two tandem dsRBDs enhanced siRNA-binding affinity  
In an effort to validate the structural observation that RHA dsRBD1+2 
recognizes the bound siRNA duplex in a cooperative manner, we performed 
the ITC assay again to measure the binding affinity between siRNA duplex 
and dsRBD1+2, and compared it with that of individual dsRBDs with siRNA 
duplex. As expected, RHA dsRBD1+2 exhibited much stronger binding 
affinity to siRNA duplex compared to RHA dsRBD1 alone or RHA dsRBD2 
alone (Figure 3-11, Table 3-4 & Figure 3-5A, 3-6A,Table 3-2A, 3-3A). Our 
ITC experiments indicated that RHA dsRBD1+2 binds to siRNA duplex in a 
two-site-binding mode. The fitted dissociation constants between RHA 
84 

dsRBD1+2 and siRNA duplex demonstrated a tight binding site for dsRBD1 
(Kd=1.06×10-7 M) and a relatively weaker binding site for dsRBD2 
(Kd=4.40×10-6 M) (Table 3-4). Remarkably, the binding affinities between the 
siRNA duplex and each RHA dsRBDs are dramatically elevated when the two 
dsRBDs are fused together. Compared with the corresponding individual 
dsRBDs, the binding affinity of dsRBD1 as part of RHA dsRBD1+2 to siRNA 
duplex increased 56-fold from 5.93×10-6 to 1.06×10-7 M (Table 3-2A and 
Table 3-4). Similarly, the binding affinity of dsRBD2 as part of RHA 
dsRBD1+2 to siRNA duplex increased 3-fold from 1.36×10-5 to 4.40×10-6 M 
(Table 3-3A and Table 3-4). Therefore, we concluded that RHA dsRBD1 
functions as the dominant binder to siRNA duplex, and that RHA dsRBD1 and 
dsRBD2 work cooperatively to simultaneously bind both faces of the siRNA 
duplex to enhance binding affinity. 

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Figure 3-11 ITC data of titrating siRNA duplex into dsRBD1+2. 
Raw data is shown in the upper panel, whereas fitted curves and binding parameters 
after integration are shown in the lower panel. Equilibrium constant K and 









Table 3-4 Binding of RHA dsRBD1+2 with siRNA21 by ITC

siRNA21 titrated into RHA dsRBD1+2  
1st binding site    2nd binding site 
N1 0.5 N2 0.5 
Kd1 (M) (1.06±0.19)×10-7 Kd2 (M) (4.40±0.51)×10-6 
H1 (cal/mol) (-1.49±0.016)×104 H2 (cal/mol) (-8.14±0.30)×103 
S1 (cal/mol/deg) -18.11 S2 (cal/mol/deg) -2.80 
 
3.9 Molecular insights into RISC assembly mediated by RHA dsRBDs 
3.9.1 RHA dsRBD1+2 directly interacts with RISC components 
RHA was reported as an RISC loading factor interacting with RISC in 
human cells. Importantly, N-terminal tandem dsRBDs (dsRBD1+2) are critical 
for this function since the RHA dsRBD deletion mutant, lacking the 
N-terminal 272 a.a., is not capable of co-immunoprecipitating human RISC 
components (Robb & Rana, 2007).  
To investigate whether RHA dsRBD1+2 directly interacts with RISC 
components and what the exact functional roles of the tandem dsRBDs are in 
RISC assembly, we performed co-IP experiments to assay for interactions 
between RHA dsRBD1+2 and human RISC components. As expected, 
Myc-tagged RHA dsRBD1+2 (residues: 1-264) successfully 
co-immunoprecipitated the Flag-tagged full-length Ago2 and TRBP2 when 
they were co-transfected into human 293FT cells (Figure 3-12). Further co-IP 
assays showed that Myc-tagged RHA dsRBD1+2 displays strong associations 
with the Ago2 MID domain and the first and second dsRBDs of TRBP2. A 
weaker association was observed with the Ago2 PAZ domain, and no 
interaction was observed with the N-terminal and PIWI domains of Ago2 or 
the third dsRBD of TRBP2 (Figure 3-12A). Interestingly, although the MID 
domain is present in the full-length Ago2, the interaction between RHA 
dsRBD1+2 and the full-length Ago2 is much weaker than that of RHA 
dsRBD1+2 and MID. 
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Figure 3-12Co-IP of RHA dsRBD 1+2 by components of RISC loading complex, 
Ago2 and TRBP2. 
(A) Co-IP of RHA dsRBD1+2 (residues: 1-264) by Ago2 and its domains. RHA 
dsRBD1+2 displays weak interactions with full-length Ago2 and the Ago2 PAZ 
domain and a strong association with the Ago2 MID domain. The upper panel 
shows the expression of Flag-tagged Ago2 and its domains and the middle 
panel shows the loading control of Myc-tagged RHA dsRBD1+2. The lower 
panel shows RHA dsRBD1+2 co-immunoprecipitated by Ago2 or its domains 
and detected by anti-myc antibody. Flag- only and Flag-GFP protein were used 
as negative controls. 
(B) Co-IP of RHA dsRBD1+2 (residues: 1-264) by TRBP2 and its domains. RHA 
dsRBD1+2 displays weak interaction with full-length TRBP2 and strong 
associations with TRBP2 dsRBD1 and dsRBD2. The upper panel shows the 
expression of Flag-tagged TRBP2 and its domains and the middle panel shows 
the loading control of Myc-tagged RHA dsRBD1+2. The lower panel shows 
RHA dsRBD1+2 co-immunoprecipitated by TRBP2 or its domains and 
detected by anti-myc antibody. Flag only and Flag-GFP protein were used as 
negative controls. 

3.9.2 Both RHA dsRBD1 and dsRBD2 are needed for RISC interactions  
Next, we tested whether both RHA dsRBD1 and dsRBD2 domains are 
needed for strong interactions with RISC components. We dissected RHA 
dsRBD1+2 into dsRBD1 and dsRBD2, and tested the interactions of these 
dsRBDs with the Ago2 MID domain, respectively. To our surprise, individual 
dsRBD did not show detectable interactions with the Ago2 MID domain 
(Figure 3-13A), suggesting that either the specific loop region connecting 
RHA dsRBDs or the higher dsRNA binding affinity displayed by RHA 
dsRBD1+2 is important for Ago2 interaction.  
To determine whether the flexible region is important for tight interaction 
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between RHA dsRBD1+2 and Ago2, we made two loop deletion mutants, 
RHA dsRBD1+2 (91-164) and dsRBD1+2 (131-164), and repeated the 
co-IP experiments. Co-IP results showed that the RHA dsRBD1+2 loop 
deletion mutants display strong association with the Ago2 MID domain, which 
was comparable to that between wild type RHA dsRBD1+2 and the Ago2 
MID domain (Figure 3-13B). This observation suggests that these specific 
parts of the loop region do not favor Ago2 binding and underscores the fact 
that the higher dsRNA-binding affinity displayed by RHA dsRBD1+2 is 
important for Ago2 interaction. 
Figure 3-13 Co-IP of Ago2-MID domain by RHA dsRBDs truncations. 
(A) Co-IP of RHA dsRBD1+2 (residues: 1-264) and individual dsRBDs by the 
Ago2 MID domain. The upper panel shows the expression of Myc-tagged RHA 
dsRBD1+2 and individual dsRBDs, and the middle panel shows the loading 
control of Flag-tagged Ago2 MID domain. The lower panel shows RHA 
dsRBD1+2 and individual dsRBDs co-immunoprecipitated by the Ago2 MID 
domain and detected by anti-myc antibody. Myc only was used as a negative 
control. 
(B) Co-IP of RHA dsRBD1+2 (residues: 1-264) and its mutants with loop deletion 
by the Ago2 MID domain. The upper panel shows the expression of 
Myc-tagged RHA dsRBD1+2 and its loop deletion mutants, and the middle 
panel shows the loading control of the Flag-tagged Ago2 MID domain. The 
lower panel shows RHA dsRBD1+2 and its loop deletion mutants 
co-immunoprecipitated by the Ago2 MID domain and detected by anti-myc 




3.9.3 Interactions between dsRBDs of RHA and RISC components are 
siRNA-dependent 
Interestingly, the interaction pattern between dsRBD1+2 and Ago as well 
as TRBP2 reminded us the fact that the Ago2 MTD and PAZ domains, the 
TRBP2 dsRBD1 and dsRBD2 domains are the domains responsible for siRNA 
binding. Moreover, the finding that only tandem RHA dsRBDs, but neither 
dsRBD1 nor dsRBD2 alone, is capable of co-immunoprecipitating the Ago2 
again reminded us the previous results that tandem dsRBDs have higher 
dsRNA-binding affinity. These two findings prompted us to test whether the 
association of RHA dsRBDs with Ago2 and TRBP2 are siRNA-dependent. 
To this end, we performed RNase treatment assay during the washing 
steps in co-IP experiments. As expected, RNase treatment completely 
abolished the interactions between RHA dsRBD1+2 and Ago2 or TRBP2 
(Figure 3-14A). This result demonstrates that the interactions between RHA 
dsRBD1+2 and RISC components depend on the dsRNA-binding activity of 
RHA dsRBD1+2. 
To further validate that the interactions between RHA dsRBD1+2 and 
RISC components are dsRNA-dependent, we mutated those critical residues 
for dsRNA binding shown in Table 3-2 & Table 3-3 and repeated co-IP assay. 
Remarkably, there are high correlations between the ITC data (Table 3-2, 3-3 
and 3-4) and the co-IP results (Figure 3-14B&C). Most of the alanine mutants 
showing no or extremely weak binding to siRNA duplex also demonstrated no 
or severely reduced association with the Ago2 MID domain, such as 
K5A/N6A, Y9A, K182A, N186A/Q187A, H207A and N234A/K235A/K236A 
mutants (Figure 3-14B&C). In contrast, the alanine mutant N30A that showed 
strong binding affinity to siRNA duplex demonstrated tight association with 
the Ago2 MID domain (Figure 3-14B). Interestingly, N53A/K54A/K55A 
mutants showing no binding affinity with siRNA duplex demonstrated only 




Figure 3-14Interactions between RHA dsRBDs and RISC-loading 
complexes are RNA-dependent. 
(A) Co-IP of RHA dsRBD1+2 (residues: 1-264) by Ago2, Ago2-PAZ, Ago2-MID, 
TRBP2, TRBP2-dsRBD1, and TRBP2-dsRBD2 after RNase treatment. “+” 
stands for RNase treatment that was introduced into the washing steps during 
co-IP, whereas “-” stands for no RNase treatment. The upper panel shows the 
expression of Flag-tagged Ago2, Ago2-PAZ, Ago2-MID, TRBP2, 
TRBP2-dsRBD1 and TRBP2-dsRBD2 in both experimental and control 
samples, and the middle panel shows the loading control of Myc-tagged RHA 
dsRBD1+2. The lower panel shows RHA dsRBD1+2 co-immunoprecipitated 
by Flag-tagged proteins and detected by anti-myc antibody. 
(B) Co-IP of RHA dsRBD1+2 (residues: 1-264) and its mutants by the Ago2 MID 
domain. The upper panel shows the expression of Myc-tagged RHA dsRBD1+2 
and its mutants as indicated, and the middle panel shows the loading control of 
the Flag-tagged Ago2 MID domain. The lower panel shows RHA dsRBD1+2 
and its mutants co-immunoprecipitated by the Ago2 MID domain and detected 
by anti-myc antibody. Myc only was used as a negative control. 
(C) Co-IP of RHA dsRBD1+2 (residues: 1-264) and additional mutants by the 
Ago2 MID domain as an extension of (F). The upper panel shows the 
expression of Myc-tagged RHA dsRBD1+2 and its mutants, and the middle 
panel shows the loading control of the Flag-tagged Ago2 MID domain. The 
lower panel shows RHA dsRBD1+2 and its mutants co-immunoprecipitated by 
the Ago2 MID domain and detected by anti-myc antibody. Myc only was used 
as a negative control. 
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Nevertheless, these results demonstrate that RHA N-terminal tandem 
dsRBDs are the primary functional domains for RISC interaction, which is 
mediated by siRNA duplex. The cooperative siRNA duplex binding mode by 
RHA may facilitate siRNA duplex transfer from another RISC component, 
such as TRBP2, to Ago2 for incorporation. 
3.10 Discussion  
In humans, the core components of RISC are Dicer, Ago2 and TRBP2 
proteins, which can be assembled in vitro to fulfill the dicing, Ago2-loading, 
guide-strand selection and slicing activities observed in endogenous RISC 
(MacRae et al, 2008; Maniataki & Mourelatos, 2005). Within the RISC, Dicer 
is the catalytic engine for microRNA processing, whereas Ago2 bound with a 
microRNA forms the minimal functional RISC, which tends to release from 
the holo-RISC once it is formed (Rivas et al, 2005).  
Although Dicer itself is sufficient to cleave, reposition, pre-select and 
handover small RNAs to Ago2 in vitro, other RISC components, such as 
TRBP2, PACT and RHA, are required for stabilization of Dicer, recruitment of 
Ago2, repositioning of RNA duplexes, facilitation of small RNA production 
and loading small RNAs onto Ago2 (Bernstein et al, 2001; Kok et al, 2007; 
Macrae et al, 2006a; Noland et al, 2011; Robb & Rana, 2007). 
RHA comprises several recognizable domains/motifs: N-terminal tandem 
dsRBDs, an ATPase-dependent helicase core (DEIH and helicase domains) 
and a C-terminal RGG motif (Zhang & Grosse, 1997). Notably, all these three 
domains/motifs are observed widely among RNA-interactive proteins. Many 
dsRBD-containing proteins, including Dicer and its partners TRBP2 and 
PACT (Kok et al, 2007), Drosha and its partner DCGR8 (Han et al, 2004; 
Sohn et al, 2007), participate in the RNA silencing pathway. Among them, 
both TRBP2 and PKR show cooperation between their N-terminal tandem 
dsRBDs to achieve higher binding affinity to RNA duplex (Yamashita et al, 
2011) (Nanduri et al, 1998).  
The N-terminal dsRBDs of RHA play important roles in enabling RHA to 
interact with the essential components of different cellular processes, 
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including transcriptional regulation (Nakajima et al, 1997), RNA processing 
(Hartman et al, 2006) and RNA export (Tang et al, 1999). Moreover, RHA 
enhances HIV-transcription in vivo by TAR binding via its N-terminal dsRBDs 
and K236 was shown to be essential for TAR binding (Fujii et al, 2001); RHA 
promotes DNA processing activity of WRN by directly interacting with 
Werner Syndrome Helicase WRN via its N-terminal dsRBD2 and C-terminal 
RGG box (Friedemann et al, 2005). In addition, RHA dsRBDs are necessary 
for selective recognition and translation of complex mRNAs and that 
conserved lysine residues (K54, K55 and K236) are necessary to engage 
structure features of its substrates (Ranji et al, 2011). Taken together, 
N-terminal dsRBDs of RHA are multiple functional domains, which enable 
RHA to target both protein substrates and RNA substrates.  
Our structural and functional efforts have demonstrated that the 
N-terminal tandem dsRBDs play important roles in siRNA duplex recognition 
and association with Ago2 for siRNA duplex loading. However, the biological 
functions of the ATP-dependent helicase core domains and RGG motif of 
RHA in RISC assembly are still unknown. Interestingly, the RHA helicase 
domain was also suggested to be involved in human RISC assembly since a 
K417R mutation on the RHA helicase domain which disrupts ATP-binding 
and abolishes RNA helicase activity, led to negative impacts on RHA 
interactions with RISC (Robb & Rana, 2007). 
Although the crystal structure of D1 (DEIH domain) of RHA helicase core 
provides the structural basis for unselective nucleotide base binding (Schutz et 
al, 2010), the structural principles of siRNA duplex binding by RHA helicase 
core domains are still unknown. Notably, a recent crystal structure of yeast 
Mss116p helicase provides remarkable structural details on short dsRNA 
recognition and unwinding by RNA helicase in general. This structure reveals 
that D2 (helicase domain) of Mss116p helicase core recognizes short RNA 
duplex, whereas D1 (DEAD domain) of Mss116p helicase core promotes the 
unwinding of bound substrate where only a few RNA base pairs are separated 






Figure 3-15Structural models of siRNA duplex recognition by RHA. 
(A) Structural model of RHA full protein without C-terminal RGG motif in 
complex with siRNA duplex. In this model, the siRNA duplex is sandwiched 
between two dsRBDs in the front and D1 and D2 of RHA helicase core in the 
back without stereo clashes. The dsRBDs are colored in magenta and cyan 
respectively, whereas D1 and D2 are colored in yellow and wheat, respectively. 
The siRNA duplex is colored in orange. This model might represent a working 
model for siRNA duplex recognition and partial unwinding by the full-length 
RHA protein.  
(B) Crystal structure of A. aeolicus RNaseIII-dsRBD in complex with dsRNA (PDB: 
2EZ6). 
 
Comparison of the Mss116p D2/dsRNA structure with our RHA 
dsRBD1/dsRNA structure through structural superimposition suggests that 
both the RHA helicase core domains and the RHA dsRBD1+2 domains are 
able to bind to the same short RNA duplex by bracketing from two opposite 
faces (Figure 3-15A). Interestingly, such a binding mode was observed in the 
crystal structure of A. aeolicus RNaseIII-dsRBD in complex with short RNA 
duplex (Gan et al, 2006). In this complex structure, the bound short RNA 
duplex is sandwiched between two dsRBDs on one side and two RNaseIII 
domains on the other side (Figure 3-15B). Therefore, we speculate that such a 
binding mode may be applicable to siRNA duplex recognition by full-length 
RHA as shown in Figure 3-15A. Collectively, as an essential human RISC 
component, RHA might play significant roles in transferring the siRNA 
duplexes processed from the Dicer-TRBP2 complex and facilitating siRNA 
loading onto Ago2 via interactions with siRNA duplex, TRBP2 and Ago2. 
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During this process, RHA N-terminal tandem dsRBD1+2 might first bind to 
siRNA duplex simultaneously, trigger the conformational change of RHA, 
assist siRNA duplex binding via the helicase domain and finally facilitate local 
unwinding of the bound duplex for Ago2 loading. Consistent with this 
hypothesis, RHA N-terminal tandem dsRBD1+2 is shown to engage in 
binding with RNA first and then stimulate the ATP-dependent helicase activity 
necessary for mRNA translation (Zhang & Grosse, 1997). Moreover, the 
binding of PKR N-terminal tandem dsRBD1+2 with dsRNA has been shown 
to act as a modulator of its C-terminal kinase domain activation for association 
with other factors involved in RNA transporting (Waechter et al, 1997). 
Taken together, our structural and functional studies of dsRNA 
recognition and RISC interaction by RHA dsRBDs have provided important 



























CHAPTER 4: Structural and functional studies of a budding 
yeast Dicer-like protein from P. Stipitis 
The RNase III family protein is a collection of Mg2+-dependent 
endoribonucleases that show specific cleavage activity for dsRNA. Recently, 
RNAi has been shown to be present in several budding yeast species. 
Meanwhile, an RNase III protein containing an NTD, an RNase III domain 
and two C-terminal dsRBDs serves as the budding yeast Dicer. These findings 
stimulated our interest in studying the structure and functions of a budding 
yeast Dicer-like protein in another budding yeast species which lacks 
canonical Argonaute. Here, we utilized X-ray crystallography to study the 
structure of one such protein, the DCR1 from P. stipitis (PsDCR1). Moreover, 
other methods, such as AUC, GA-crosslinking, EMSA, ITC and RNA 
cleavage assays were also used for the functional studies of PsDCR1. 
4.1 Bioinformatics analysis of the RNase III proteins in budding yeast 
Bioinformatics analysis revealed that the DCR1 protein is the second 
RNase III containing protein in addition to the homologue of S. cerevisiae 
Rnt1 in several budding yeast species, such as S. castellii and K. polysporus 
(Figure 4-1A) (Drinnenberg et al, 2009). While in several other budding yeast 
species, such as C. albicans and C. tropicalis, the DCR1 protein is the second 
RNase III containing protein in addition to the homologue of Candida 
Dicer-like protein Cdl1 (Figure 4-1A) (Bernstein et al, 2012). Generally, Rnt1 
is involved in rRNAs and spliceosomal RNAs maturation (Lamontagne et al, 
2001). However, the Cdl1 is most likely inactive, as the six conserved 
catalytically active residues are altered to catalytically inactive residues. 
Meanwhile, the function of Cdl1 also remains unknown (Bernstein et al, 
2012).  
Domain composition analyses of these three budding yeast RNase III 
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proteins by InterPro Scan showed that the Rnt1 contains an NTD, an RNase III 
domain and a dsRBD, whereas both the budding yeast Dicer DCR1 and the 
Cdl1 harbor an additional C-terminal dsRBD (Figure 4-1B).  
 

Figure 4-1Bioinformatics analysis of RNase III proteins in several budding yeast 
species. 
(A) The presence of RNAi and genes encoding Argonaute, DCR1, Rnt1 and Cdl1 in 
the following budding yeast species: Scer stands for Saccharomyces cerevisiae, 
Sca stands for Saccharomyces castellii, Kp stands for Kluyveromyces polysporus, 
Ca stands for Candida albicans, Ct stands for Candida tropicalis, Dh stands for 
Debaryomyces hansenii, Cl stand for Clavispora lusitaniae and Ps stands for 
Pichia stipitis. The presence of the corresponding gene is indicated as (+). The 
presence of DCR1-like protein encoding gene is indicated as (*). (NR) indicates 
that the corresponding gene has not been reported in this species. 
(B) A schematic representation of the domain structure of RNase III proteins in 









Figure 4-2  Sequence alignments of the PsDCR1 NTD, RNase III and dsRBD 
domains with its counterparts, respectively. 
(A) Sequence alignment of the PsDCR1 NTD with various NTDs of DCR1 and Rnt1 
homologues from different budding yeast species. The upper panels of A, B, C 
show the secondary structure elements of KpDCR1 NTD, RNase III domain and 
dsRBDs, respectively. The lower panel shows the secondary structure elements 
of PsDCR1 NTD. The full names of Ps, Kp, Scas, Ca, Ct, Scer are the same as 
those in Figure 4-1. 
(B) Sequence alignment of the PsDCR1 RNase III domain with various RNase III 
domains from all classes of RNase III proteins. Gi stands for Giardia intestinalis. 
The full names of Aa, Ec, Hs are the same as those in Figure 3-1. Red asterisks 
indicate the catalytically active residues conserved in all classes of RNase III 
proteins while yellow asterisks indicate the catalytically active residues 
conserved only in eukaryotic RNase III proteins. The residues in the red box 
represent the RNase III signature motif. 
(C) Sequence alignment of the PsDCR1 dsRBDs with dsRBDs from various budding 
yeast RNase III proteins.  
 
Phylogenetic relationship analysis of budding yeast species revealed that 
P. stipitis, D. hansenii and C. lusitaniae share very close genetic relationship 
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(Jeffries et al, 2007). Consistently, all three genomes contain the budding yeast 
Dicer-like protein-encoding gene and lack the RNT1 ortholog. Moreover, this 
budding yeast Dicer-like protein is the only catalytic active RNase III protein 
in these species (Figure 4-1A). Analysis of the PsDCR1 sequence revealed 
four distinct domains: an NTD spanning residues ~70-170, an RNase III 
domain spanning residues ~206-352, a dsRBD spanning residues ~363-429 
and a C-terminal dsRBD-like domain spanning residues ~486-566 (Figure 
4-1B). 
4.2 Crystallization and crystal optimization 
In order to gain the structural insights into the functions of PsDCR1, the 
full-length PsDCR1 and its truncated proteins, as listed in Table S-2, were 
constructed based on a multi-construct approach (Graslund et al, 2008). The 
recombinant proteins were expressed, purified and subjected to crystallization 
trials. In the end, we were able to crystallize one protein fragment containing 
the NTD as well as another protein fragment containing the RNase III and 
dsRBD1 domains. 
4.2.1 Crystallization of the NTD of PsDCR1  
A PsDCR1 NTD fragment spanning residues 70-170 was crystallized in 
various conditions, and well-diffracting crystals were obtained in conditions 
containing 14-19% PEG 4,000, 8.5% 2-propanol, 15% Glycerol and 0.085 M 
Hepes (pH 7.2-8.1) (Figure 4-3A, C). Then, SeMet-labeled proteins were 
prepared after introducing the double mutations L95M/I96M into the protein 
sequence (Figure 4-3B). Well-diffracting crystals of the SeMet-labeled 
proteins were obtained in conditions containing 12% PEG 3,350, 0.05 M 
Cadmium Chloride, 0.05 M Nickel Chloride, 0.05 M Cobalt Chloride, 0.05 M 




Figure 4-3 Protein purification and crystallization of the PsDCR1 NTD. 
(A) 1 l of purified native PsDCR1 NTD spanning residues 70-170 resolved with 15% 
SDS-PAGE. 
(B) 1 l of purified SeMet-labeled PsDCR1 NTD spanning residues 70-170 with 
L95M/I96M double mutations resolved with 15% SDS-PAGE. 
(C) Crystals of (A) in condition containing 16% PEG 4,000, 8.5% 2-propanol, 15% 
Glycerol and 0.085 M Hepes (pH 7.2). 
(D) Crystals of (B) in condition containing 12% PEG 3,350, 0.05 M Cadmium 
Chloride, 0.05 M Nickel Chloride, 0.05 M Cobalt Chloride, 0.05 M Magnesium 
Chloride and 0.1 M Hepes (pH 7.5). 
4.2.2 Crystallization and crystal optimization of PsDCR1 fragments 
containing the RNase III and dsRBD domains 
Another PsDCR1 fragment which contains the RNaseIII and dsRBD1 
domains and spans residues 200-431 was also successfully crystallized in a 
condition containing 1.0 M Li2SO4, 0.5 M (NH4)2SO4 and 0.1 M Sodium 
Citrate tribasic dihydrate (pH 5.6). However, the crystals obtained from this 
condition diffracted to very low resolutions. 
After several rounds of optimization (described in details in section 2.5.3), 
better diffracting-crystals from truncated fragments including 183-431aa, 
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187-431aa, 190-431aa, 192-431aa, 196-431aa and 192-431aa 
(K300A/E303A/E304A/K307A) were observed in conditions containing 
3.0-3.6 M NaCl and 0.1 M NaAC (pH 5.4-5.6). Some of the crystals observed 
during this optimization process are shown in Figure 4-4. The diffraction 
resolution has been improved from ~8 Å to ~4.5 Å in synchrotron radiation. 
Although tremendous effort has been invested into the optimization, no 
diffraction-quality crystal has yet been obtained. Thus, the structure of the 
PsDCR1 fragment containing the RNase III and dsRBD1 domains remains 
unresolved. 
However, sequence alignment analyses showed that the RNase III 
domain of PsDCR1 shares high sequence similarities with its counterparts 
from all three classes of RNase III proteins (Figure 4-2B). Specifically, the 
RNase III domains of PsDCR1 and KpDCR1 share 41.6% sequence identify 
and 59% similarity. In addition, the four catalytically active residues strictly 
conserved in all kingdoms of RNase III domains and the two catalytically 
active residues conserved only in the eukaryotic RNase III domains are all 
present in the RNase III domain of PsDCR1 (residue E244, D248, D316, E319 
and N281, K312, respectively) (Figure 4-2B). Moreover, structural alignments 
of the RNase III domains showed that their three-dimensional arrangements 
closely resemble each other. For example, the RNase III domains of A. 
aeolicus RNase III homodimer, G. intestinalis Dicer and KpDCR1 homodimer 
are well superimposed with each other (Figure 1-2F and Figure 1-7C). Further 
analysis of dsRBDs extended this relationship to the dsRBDs of PsDCR1 and 
KpDCR1 (Figure 4-2C). Alignment of the dsRBD sequences from various 
dsRBD-containing RNase III proteins indicated that the residues lying on the 
secondary structure elements are highly conserved (Figure 4-2C). Furthermore, 
the solved KpDCR1 dsRBD1 structure also adopts the canonical ---- 
fold (Weinberg et al, 2011). This information together suggests that the 
structures of the RNase III and dsRBD domains of PsDCR1 may most closely 






Figure 4-4 Optimization of the PsDCR1 RNase III-dsRBD1 crystals. 
(A) 1 l of purified indicated protein fragments resolved with 15% SDS-PAGE. 
(B) Crystals of a PsDCR1 fragment spanning residues 200-431 in condition 
containing 1.0 M Li2SO4, 0.5 M (NH4)2SO4 and 0.1 M Sodium Citrate tribasic 
dehydrate (pH 5.6).  
(C) Crystals observed after the optimization of crystals in (A) by fine-tuning the 
crystallization condition.  
(D) Crystals of a PsDCR1 fragment spanning residues 192-431 in condition 
containing 3.0 M NaCl and 0.1 M NaAc (pH 5.4). 
(E) Crystals of a PsDCR1 fragment spanning residues 192-431 with 
K300A/E303A/E304A/K307A mutations in condition containing 3.0 M NaCl 







Figure 4-5  Data collection and overall structure of the PsDCR1 NTD. 
(A) Diffraction pattern of a native crystal of PsDCR1 NTD spanning residues 
70-170. 
(B) Diffraction pattern of a SeMet-crystal of PsDCR1 NTD spanning residues 
70-170 with L95M/I96M double mutations. 
(C) Cartoon view of the crystal structure of the PsDCR1 NTD monomer. 
(D) Cartoon view of the crystal structure of the PsDCR1 NTD dimer. 
(E) Electrostatic surface view of (D) with the same color code as that in Figure 3-4B.  







Table 4-1 Data collection, phasing and refinement statistics 
 
Data collection 
 SeMetPsDCR1(70-170) Mut PsDCR1 (70-170) WT 
Synchrotron beamline U17, SSRF U17, SSRF 
Space group           P212121 C2221 
Cell dimensions   
a, b, c (Å) 36.60, 70.59, 80.58 36.25, 71.30, 69.85 
Wavelength (Å) 0.9794 0.9793 
Resolution (Å)a 50~2.5 (2.54~2.5) 50~1.5 (1.53~1.5) 
Rsym (%) 9.8 (45.8) 7.6 (55.1) 
I/(I) 30.7 (5.3) 33.6 (3.6) 
Completeness (%) a 100.0 (99.9) 98.4 (96.6) 
Redundancy 7.7 (7.5) 13.6 (11.0) 
FOM (50~2.5 Å) 0.452  
Refinement  
Resolution Range (Å)    50~2.5 (2.56~2.5) 50~1.5 (1.54~1.5) 
No. reflections 7,306 13,894 
Rwork (Rfree) (%) 23.6/32.6 (24.4/39.4) 19.7/23.4 (24.3/34.1) 
No. atoms   
Protein 1,447 727 
Water 17 80 
B-factors (Å2)   
Protein 28.4 26.4 
Water 29.5 36.3 
R.m.s. deviations   
Bond lengths (Å) 0.014 0.011 
Bond angles (º) 1.51 1.27 
% favored (disallowed)  
in Ramachandran plot 
90.8 (0) 94.1 (0) 
a Values for the highest-resolution shell are in parentheses. 
 
4.3 Data collection and structure determination of the PsDCR1 NTD 
    Diffraction data sets for a native crystal of PsDCR1 NTD (residues: 
70-170, wild type) and a SeMet-labeled crystal of NTD (residues: 70-170 with 
double mutations L95M/I96M) were collected at 1.5 Å and 2.5 Å, respectively 
(Figure 4-5A, B). The structure of the SeMet-labeled NTD was determined by 
the single-wavelength anomalous diffraction (SAD) method. This structure 
was then served as a search model for determining the wild-type NTD 
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structure by the molecular replacement method. The crystallographic statistics 
of both wild-type and SeMet-labeled NTD are listed in Table 4-1. The native 
NTD was crystallized in space group C2221, whereas the SeMet-labeled NTD 
was crystallized in space group P212121. There is one NTD molecule per 
asymmetric unit in the wild-type NTD structure, while there are two NTD 
molecules per asymmetric unit in the SeMet-labeled NTD structure. Both 
solved structures revealed that two NTD molecules form a homodimer. The 
calculated buried surface area between two dimerized NTD molecules is 737 
Å2, which takes up 31% of the total area of each NTD molecule. The overall 
structure of the dimerized PsDCR1 NTD resembles the shape of a butterfly, 
and each monomer consists of six  helices (Figure 4-5C, D). Electrostatic 
surface view of the NTD dimer displays a distinct positive charge area at the 
bottom of the butterfly (Figure 4-5E, F), which implies that this dimer may 
interact with the negatively charged RNA molecules. 
4.4 Structural comparison of the PsDCR1 NTD with the KpDCR1 NTD 
The overall structure of the dimerized KpDCR1 NTD resembles the 
shape of a saddle with each monomer consisting of five  helices (Figure 4-6A, 
B). The DaliLite pairwise alignment tool   (http://www.ebi.ac.uk/Tools/ 
structure/dalilite/ at EMBL-EBI) was used to compare the structure of 
PsDCR1 NTD with that of KpDCR1 NTD. With structural alignment of the 
KpDCR1 NTD chain A with the PsDCR1 NTD chain A, we obtained a Z-score 
of 4.8, a r.m.s.d value of 3.4 Å for 93 C- atoms and a number of equivalent 
residues of 69. Moreover, superimposition of these two structures showed that 
they share similar three-dimensional arrangements (Figure 4-6E, F). Among 
the five  helices of the KpDCR1 NTD, 1’, 2’, 3’ and 4’ are roughly 
aligned with the 1, 3, 4, 5 of the PsDCR1 NTD, respectively (Figure 
4-2A). These data are in good agreement with the sequence alignment analysis 
where the PsDCR NTD shares a portion of sequence similarity with the 
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KpDCR1 NTD (Figure 4-2A). Taken together, these results suggest that the 
PsDCR NTD and the KpDCR1 NTD are homologous to each other. These 
results further imply that they may have similar functions and evolutionary 
origin. 

Figure 4-6 Alignments of the PsDCR1 NTD structure with that of KpDCR1 
NTD. 
(A) Cartoon view of the crystal structure of the KpDCR1 NTD monomer. The 
KpDCR1 NTD structure is part of the KpDCR1C structure (PDB: 3RV0) 
(B) Cartoon view of the crystal structure of the KpDCR1 NTD dimer. 
(C) Electrostatic surface view of (B) with the same color code as that in Figure 3-4B..  
(D) Rotate (C) 90° along y axis. 
(E) Superimposition of the PsDCR1 NTD monomer (green) with the KpDCR1 NTD 
monomer (pale green).  
(F) Superimposition of the PsDCR1 NTD dimer (one monomer in green and the 
other one in magentas) with the KpDCR1 NTD dimer (one monomer in pale 




However, several differences between these two structures were also 
observed. Firstly, the 2 of the PsDCR1 NTD is replaced by a loop region of 
the KpDCR1 NTD, while 6 of the PsDCR1 NTD is distant from 5’ of the 
KpDCR1 NTD (Figure 4-2A and Figure 4-6E, F). Secondly, no distinct 
positive charged area was observed in the KpDCR1 NTD structure (Figure 
4-6C, D).  
4.5 PsDCR1 and its truncated fragments form dimers in solution 
Two RNase III domains are dimerized to form a 
single-dsRNA-processing center, which appears to be an obligate rule for the 
RNase III proteins. For example, the bacterial RNase III proteins, yeast Rnt1 
and budding yeast Dicer DCR1 contain a single RNase III domain and act as 
homodimers (Lamontagne et al, 2000; MacRae & Doudna, 2007; Weinberg et 
al, 2011). In contrast, the Drosha and canonical Dicer contain two RNase III 
domains and act as intramolecular heterodimers (MacRae & Doudna, 2007). 
Moreover, our structural analysis has shown that two PsDCR1 NTD molecules 
form a homodimer. Therefore, we speculate that both PsDCR1 and the 
PsDCR1 NTD behave as homodimers in solution.  
To verify this speculation, we performed GA-crosslinking assays to test 
the polymerization status of the full-length PsDCR1 and a fragment containing 
the NTD only (PsDCR1-NTD, residues: 70-170). As shown in Figure 4-7D&E, 
the dimerized forms of both proteins were detected. Consistently, an AUC 
analysis showed that the measured molecular weight of the PsDCR1-NTD 
(70-170 aa) was 25 KD (Figure 4-7C). These results suggest that both the 
full-length PsDCR1 and the NTD were able to form dimers in solution. 
To further investigate the impact on the PsDCR1 dimerization by deleting 
its NTD and dsRBD-L domain, we performed AUC analyses for two mutants: 
a NTD deletion mutant (PsDCR1-NTD, residues: 187-566) as well as a NTD 




Figure 4-7 AUC and GA-crosslinking analyses of PsDCR1 and its truncated 
fragments. 
(A) AUC result of a PsDCR1-NTD fragment spanning residues 187-566. 
(B) AUC result of a PsDCR1-N+C fragment spanning residues 187-431. 
(C) AUC result of a PsDCR1-NTD fragment spanning residues 70-170. 
(D) GA-crosslinking analysis of the full-length PsDCR1 spanning residues 1-566.  
(E) GA-crosslinking analysis of the PsDCR1 NTD spanning residues 70-170. For (D) 
and (E), indicated concentrations of glutaraldehyde were added into the protein 
solution. Reactions were fractionated by 15% SDS-PAGE and analyzed by 
Coomassie Brilliant Blue staining. 
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The theoretical molecular weights of PsDCR1-NTD (187-566aa) and 
PsDCR1-N+C (187-431aa) are 40 KD and 27 KD, respectively, while their 
measured molecular weights were 71 KD and 52.7 KD, respectively (Figure 
4-7A&B). These results indicate that the NTD and dsRBD-L domains are not 
absolutely required for PsDCR1 dimerization.  
4.6 The dsRNA-binding capabilities of PsDCR1 and its truncated 
fragments 
The distinct positive charge area at the bottom of the butterfly-like 
structure of the PsDCR1 NTD (Figure 4-5F) prompted us to examine its 
dsRNA-binding capability. An EMSA assay was first performed to 
qualitatively test the binding between the PsDCR1 NTD and a duplex RNA 
named RNA23. The sequence of dsRNA23 (shown in Table 2-2) is a short 
segment of P. stipitis genome, and it was obtained after mapping the 
sequenced small RNAs of K. polysporus to the genome of P. stipitis. As shown 
in Figure 4-8A, the PsDCR1 NTD did not show any detectable binding to the 
dsRNA23. Consistently, titrating a self-complementary siRNA21 duplex 
(shown in Table 2-2) into the PsDCR1 NTD solution did not detect any 
measurable binding (Figure 4-9A). In contrast, both the full-length PsDCR1 
and the PsDCR1-NTD showed relatively strong binding to the dsRNA23 
(Figure 4-8, lane 1-7). These results suggest that the PsDCR1 NTD may not 
directly interact with dsRNAs when PsDCR1 binds to substrate dsRNA. 
Next, we examined the effects on the binding between dsRNA and 
PsDCR1 after deleting its NTD. The binding affinities of the full-length 
PsDCR1 and the PsDCR1-NTD to the siRNA21 duplexes were measured by 
ITC assays. The ITC results showed that the PsDCR1-NTD displays slightly 
reduced binding affinity compared to the full-length PsDCR1 (Figure 4-9B&C 
and Table 4-2). These results suggest that the NTD of PsDCR1 plays an 
auxiliary role in the dsRNA binding. Furthermore, both ITC data sets were 
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fitted into a sequential-binding mode with two binding sites on proteins. The 
binding affinity of the second binding site on the full-length PsDCR1 is 93 
times higher than that of the first binding site (Table 4-2). Similarly, the 
binding affinity of the second binding site on the PsDCR1-NTD is 63 times 
higher than that of the first binding site (Table 4-2). These results imply that 
two dsRNA-binding sites on protein work together to enhance the binding of 
PsDCR1-dsRNA. However, the constituents of these two dsRNA-binding sites 
are unknown. As two PsDCR1 molecules form a dimer in solution, it is 
possible that they are made up of the two dsRBD1 of each dimer. 

Figure 4-8 EMSA analyses of different PsDCR1 fragments binding to dsRNA23. 
(A-C) Increasing amounts (0.5 g, 1.0 g, 2.0 g) of the indicated proteins were 






Figure 4-9 Quantitative measurements of the binding affinities of the PsDCR1 
NTD (A), full- length PsDCR1 (B) and the PsDCR1-NTD mutant (C) to a 21-bp 
dsRNA by ITC. 
Raw data are shown in the upper panel, whereas fitted curves and binding parameters 
after integration are shown in the lower panel. Equilibrium constant K, enthalpy (H) 
and entropy (S) are shown within each profile. The data sets of (B) and (C) were 
fitted into the sequential-binding model. 
 
Table 4-2 Quantitative measurements of the binding affinities of the full- length 
PsDCR1 and the PsDCR1-NTD 
 
dsRNA titrated into the full-length PsDCR1 
1st binding site 2nd binding site 
Kd1 (M) (2.70±0.59) ×10-5 Kd2 (M) (2.52±0.42) ×10-7 
H1 (cal/mol) (-2.34±0.35) ×105 H2 (cal/mol) (2.24±0.35) ×105 
S1 (cal/mol/deg) -766.6 S2 (cal/mol/deg) 780.9 
dsRNA titrated into the PsDCR1-NTD 
1st binding site 2nd binding site 
Kd1 (M) (1.31±0.12) ×10-5 Kd2 (M) (8.31±0.64) ×10-6 
H1 (cal/mol) (-1.69±0.68) ×104 H2 (cal/mol) (7.30±0.70) ×104 
S1 (cal/mol/deg) -34.45 S2 (cal/mol/deg) 47.74 
Note: Kd: dissociation constants, which were manually calculated from K (the binding 
constants shown in the fitting curve panels) based on equation Kd=1/K. The estimated 
errors for K, H were the sum of the squares of the deviations of the fitting curve from 
the experimental data. 
 
Moreover, we tested the dsRNA-binding capabilities of other truncated 
fragments of PsDCR1, including a fragment containing the RNase III and 
dsRBD1 domains (PsDCR1-N+C), a fragment with the C-terminal 
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dsRBD-like domain deletion (PsDCR1-C) and a fragment with both dsRBDs 
deletion (PsDCR1-2d). As shown in Figure 4-8C, the PsDCR1-C still 
showed relatively strong binding to the dsRNA23. In contrast, the 
PsDCR1-2d showed very weak binding to the dsRNA23 (Figure 4-8C, lane 
5-7). These results indicate that the dsRBD1 of PsDCR1 is essential for the 
dsRNA binding. Surprisingly, the PsDCR1-N+C showed only very weak 
binding to the dsRNA23 (Figure 4-8B, lane 8-10). Together with the ITC 
results, this result implies that the NTD and C-terminal dsRBD-like domain 
are required for the assembly of optimum PsDCR1-dsRNA ribonucleoprotein 
complex.  
Notably, the full-length PsDCR1 which contains both NTD and 
C-terminal dsRBD-L domain formed heterogeneous complexes when it was 
bound by the dsRNA23 (Figure 4-8 B, lane 2-4). The heterogeneous complex 
may be attributed to the binding of several proteins to a single RNA molecule 
or multiple protein-protein interaction. Nevertheless, the dsRNA23 molecules 
are only 23 bps in length, which is not long enough for two PsDCR1 dimers to 
bind. Therefore, these heterogeneous complexes are most likely caused by the 
protein-protein interaction. This observation suggests that the PsDCR1 may 
possess another intermolecular interaction signal in addition to its NTD. These 
interactions together may provide the full-length PsDCR1 a dynamic switch 
between different complexes during dsRNA binding. Consistent with this 
notion, only homogenous complexes were observed for both the 
PsDCR1-NTD and the PsDCR1-C (Figure 4-8B, lane 5-7 and 4-8C, lane 
2-4).  
Meanwhile, it was also reported that the NTD and dsRBD of yeast Rnt1 
interact with each other (Lamontagne et al, 2000). Based on these observations, 
we hypnotized that the NTD of PsDCR1 may be associated with the 
C-terminal dsRBD-L domain. The associations of NTD-NTD and 
NTD-dsRBD-L are both required for the assembly of optimum PsDCR1-RNA 
complex for efficient RNA binding and cleavage. 
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4.7 The NTD and the dsRBD-L domain of PsDCR1 are associated with 
each other 
To test our hypothesis that the NTD and the dsRBD-L domain interact 
with each other, we subcloned the gene fragment that encodes the 
PsDCR1-NTD (residues: 70-170) into a human cell expression vector 
pXJ40-myc, while the gene fragments that encodes the PsDCR1 dsRBD-L 
domain (residues: 475-566 and residues: 490-566) were subcloned into 
another human cell expression vector pXJ40-Flag. The pXJ40-myc-NTD and 
the pXJ40-Flag-dsRBD-L were cotransfected into human 293FT cells, and a 
co-IP experiment was performed. As shown in Figure 4-10, both the 
Flag-tagged dsRBD-L-containing fragments successfully 
co-immunoprecipitated the c-MYC-tagged NTD-containing fragment. This 
observation demonstrated that the NTD and the C-terminal dsRBD-L domain 
are associated with each other. 
 
Figure 4-10 Co-IP of the NTD of PsDCR1 by the dsRBD-like domain. 
The upper panel shows the expression of fragments covering Flag-tagged 
PsDCR1-dsRBD-like domain (residues: 475-566 or 490-566), and the middle panel 
shows the loading control of the c-Myc-tagged NTD (residues: 70-170). The lower 
panel shows the c-Myc-tagged NTD co-immunoprecipitated by the Flag-tagged 
PsDCR1-dsRBD-like domain and detected by anti-c-Myc antibody. Flag only was 
used as a negative control. 
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4.8 The dsRNA processing activities of PsDCR1 and its truncated 
fragments 
Both the canonical Dicer in fission yeast and other higher eukaryotes and 
the noncanonical Dicer in budding yeast are capable of precisely processing 
pre-dsRNAs into small RNAs of specific length. The mechanisms of 
pre-dsRNA processing by the canonical and noncanonical Dicer are described 
in section 1.1.2.3 and section 1.1.8. 
To investigate the dsRNA processing activities of PsDCR1 as well as its 
truncated fragments in vitro, we performed dsRNA cleavage assays for 
different PsDCR1 fragments. First, the protein fragments were expressed and 
purified following the procedures illustrated in Figure 2-1(Figure 4-11A). 
Then, the RNA substrates were prepared by in vitro transcription. The 
pre-let7a-1 is a stem-loop structure RNA while the dsRNA161 is a duplex 
RNA of 161 bps in length (Figure 4-11B&C, upper panel). Specifically, the 
dsRNA161 was also used as the RNA substrates of KpDCR1 in the in vitro 
RNA cleavage assays (Weinberg et al, 2011). 
As shown in lane 2 of Figure 4-11B&C, the full-length PsDCR1 cleaved 
both pre-let7a-1 and dsRNA161. Remarkably, the dsRNA processing activities 
of these PsDCR1 fragments are highly correlated to their dsRNA binding 
capabilities (Figure 4-8B&C and Figure 4-11B&C). The fragments which 
showed relatively stronger binding to the dsRNA23 demonstrated relatively 
higher catalytic activity, such as the full-length PsDCR1, the PsDCR1-NTD, 
and the PsDCR1-C (Figure 4-11B&C, lane 2, 4, 6). In contrast, the 
fragments that showed relatively weaker binding to the dsRNA23 displayed 
relatively lower catalytic activity, such as the PsDCR1-N+C and the 
PsDCR1-2d (Figure 4-11B&C, lane 5, 7). The observation that the 
PsDCR1-N+C displayed very weak cleavage activity confirmed the previous 
speculation that both NTD and dsRBD-L domain are required for the assembly 
of optimum PsDCR1-dsRNA ribonucleoprotein complex. 
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Mutating catalytically active residues at the active sites within the 
PsDCR1 RNase III domain, such as the D248N/E319Q and N281A/K312A 
double mutations, completely abolished the catalytic activity of the full-length 
PsDCR1 (Figure 4-11B&C, lane 9, 10). These results indicate that these four 
conserved catalytically active residues are also crucial for mental-ions 
coordination during dsRNA cleavage. Moreover, the addition of EDTA into 
the reaction completely abolished the catalytic activity of the full-length 
PsDCR1 (Figure 4-11B&C, lane 3). This observation suggests that the 
Mg2+-dependent catalytic mechanism is also applicable to the PsDCR1.  

Figure 4-11 RNA processing by PsDCR1 and its truncated fragments. 
(A) The purified full-length PsDCR1 and its truncated fragments. 
(B) The biotin-labeled pre-let7a-1 was cleaved by the full-length PsDCR1 and its 
truncated fragments. Sumo-KpDCR1-C (lane 8) and the addition of buffer only 
(lane 1) were used as positive and negative controls. The final products were 
detected by chemiluminescence. 
(C) The unlabeled dsRNA161 was cleaved by the full-length PsDCR1 and its 
truncated fragments. The final products were detected by SYBR safe staining. 
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4.9 Discussion  
It is noteworthy that NTD distinguishes the yeast RNase III proteins from 
the bacterial RNase III proteins. The NTD of yeast Rnt1 has dual functions. 
One of them is to interact with its C-terminal dsRBD, and the other one is to 
self-interact via the dimerization signal. Both interactions contribute to the 
assembly of optimum Rnt1-RNA ribonucleoprotein complex, which ensures 
efficient dsRNA cleavage (Lamontagne et al, 2000). Although extensive 
biochemical studies have been performed for KpDCR1, the specific role of its 
NTD has not yet been well defined. Moreover, a DALI search for structural 
similarity failed to identify any significant homologue.  
In this study, we solved the crystal structure of the NTD of a budding 
yeast Dicer-like protein, the PsDCRl from P. stipitis. The overall shape of the 
PsDCR1 NTD dimer resembles the shape of a butterfly with each monomer 
consisting of six  helices. Structural comparison between the PsDCR1 NTD 
and the KpDCR1 NTD revealed that they are homologous to each other, which 
implies that they may share similar functions and evolutionary origin. This 
result is consistent with the sequence alignment analysis. 
We have also examined the contribution of the NTD of PsDCR1 to 
protein dimerization, dsRNA binding and cleavage. AUC and GA-crosslinking 
assays showed that the NTD contributes an additional dimerization interface to 
the PsDCR1 homodimer. However, it is not essential for the dimerization of 
the full-length protein. Indeed, the homodimeric nature of the PsDCR1 NTD is 
consistent with the finding that the NTD of yeast Rnt1 domain contains a 
dimerization signal (Lamontagne et al, 2000). Moreover, this observation is in 
good agreement with a previous finding that the NTD of KpDCR1 contributes 
an additional dimerization interface to the KpDCR1 homodimer while it is not 
absolutely required for the dimerization or siRNA generation (Weinberg et al, 
2011).  
It has been reported that the dsRBD and the RNase III domain of E.coli 
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RNase III can be structurally and functionally separated. The dsRBD is 
sufficient for dsRNA binding while the RNase III domain is sufficient for 
dsRNA cleavage (Kharrat et al, 1995). Our dsRNA binding and cleavage 
results of various truncated fragments of PsDCR1 validated the essential role 
of dsRBD1 in the dsRNA binding. Moreover, the dsRNA cleavage assay 
combined with mutagenesis verified the importance of the catalytically active 
residues of the RNase III domain in dsRNA cleavage. Consistent with this 
notion, sequence alignment analyses showed that the RNase III domain and 
the dsRBD of PsDCR1 share high sequence similarity with their counterparts. 
Unlike the E.coli RNase III, PsDCR1 contains additional domains, the NTD 
and the C-terminal dsRBD-like domain. Although the NTD did not bind to the 
dsRNA directly, a NTD deletion mutant showed reduced binding affinities to 
the dsRNA, compared to the full-length protein. Nevertheless, these results 
suggest that the NTD of PsDCR1 is a functional domain required for optimum 
PsDCR1-dsRNA binding. Moreover, a truncated fragment that lacks the NTD 
and the dsRBD-L demonstrated very weak dsRNA binding and cleavage 
activity. Similar to the yeast Rnt1, our co-IP experiment also demonstrated that 
the NTD and the C-terminal dsRBD-like domain are associated with each 
other. As implied by the EMSA results of the full-length PsDCR1 and dsRNA, 
this association may provide an additional interface for protein-protein 
interaction. Collectively, our results suggest that the NTD mediates 
intermolecular associations by interacting with itself and the dsRBD-L domain. 
These associations are required for the assembly of optimum PsDCR1-dsRNA 
complex to ensure efficient dsRNA binding and cleavage.  
Meanwhile, the structural and functional studies of PsDCR1 revealed that 
PsDCR1 shares some structural similarities with KpDCR1 and some similar 
function manners with S. cerevisiae Rnt1. Given that PsDCR1 is the only 
catalytic active RNase III protein in P. stipitis, we speculate that the PsDCR1 
may process dual functions. That is, the PsDCR1 may not only act as yeast 
Rnt1 that functions in ribosomal and spliceosomal RNA maturation, but also 
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serves as a noncanonical Dicer that generates the siRNAs in the RNAi 
pathway of P. stipitis. Consistent with this notion, the sole functional RNase 
III enzyme in C. albicans, CaDCR1, is not only capable of generating siRNAs, 
but also required for the processing of ribosomal and spliceosomal RNAs 
(Bernstein et al, 2012). However, it is also possible that RNAi is absent in P. 
stipitis, similar to the case of another budding yeast species named S. bayanus. 
S. bayanus, which harbors a budding yeast Dicer-like protein but lacks 
Argonaute, appeared to lack RNAi. This is revealed by the fact that it lacks 
enriched small RNAs of 21-27 nts (Drinnenberg et al, 2009). However, due to 
evolution reason, PsDCR1 may still keep the siRNA-generating capability. 
Therefore, other studies, such as in vivo functional studies and small RNA 
sequencing, should be performed to investigate the functions of PsDCR1 and 
the existence of RNAi in P. stipitis. 
Nevertheless, our structural and functional studies of PsDCR1 contribute 
to a better understanding of the specific roles and the relationships of domains 
within PsDCR1. This information may be applicable to the budding yeast 
















CHAPTER 5: Conclusion and Future work 
RNAi attracts significant attentions in biological field, due to its 
fundamental roles in directing development of eukaryotes, its practical 
applications in high throughput analysis of gene function as well as its exciting 
therapeutic promise. As the three-dimensional structures of macromolecules 
can provide insightful information to elucidate their functions and interaction 
details with their binding partners, X-ray crystallography thus has become a 
popular tool to analyze the functions of key components involved in RNAi.  
The existing structures of the RNase III family proteins and the 
Argonautes from both prokaryotes and eukaryotes have provided important 
insights into the mechanisms of small RNA biogenesis and small 
RNA-mediated gene silencing (Jinek & Doudna, 2009; Kuhn & Joshua-Tor, 
2013; MacRae & Doudna, 2007). However, limited structural data are 
available regarding the RISC assembly, the essential step connecting the small 
RNA biogenesis and the small RNA-mediated gene silencing. The RISC 
assembly refers to the process of mature RISC formation. Although virtually 
mature RISCs are assembled following RNA duplexes loading, guide strands 
selection and passenger strands removal (Matranga et al, 2005), the detailed 
structural mechanism of duplex RNA loading remains largely unknown. Many 
proteins in humans have been shown to associate with RISC (Hock et al, 2007; 
Landthaler et al, 2008). Among these proteins, Ago2, Dicer and TRBP2 have 
been reported to participate in RNA duplexes loading (Gregory et al, 2005; 
MacRae et al, 2008; Sakurai et al, 2011; Wang et al, 2009a). Moreover, RHA 
has also been characterized to be an RISC-loading factor in human cells (Robb 
& Rana, 2007). Specifically, the two N-terminal dsRBDs of RHA play a 
dispensable role in duplexes loading (Robb & Rana, 2007). However, the 
structural mechanism of RHA dsRBDs in RISC loading is unknown.  
On the other hand, the recent discovery that RNAi is present in several 
budding yeast species has pushed the boundary of RNAi. Moreover, the 
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subsequent structural and functional studies on the DCR1 from K. polysporus 
have provided the structural basis for the mechanism of long dsRNA 
processing by budding yeast Dicer (Drinnenberg et al, 2009; Weinberg et al, 
2011). Surprisingly, the budding yeast Dicer-like proteins also exist in several 
budding yeast species lacking Argonaute. This stimulates our interest in 
studying one such protein from these budding yeast species.  
In this thesis, we aimed to utilize the X-ray crystallography and other 
molecular and cellular techniques to study the structure and functions of these 
two proteins, RHA from Homo sapiens and a budding yeast Dicer-like protein 
PsDCR1 from P. stipitis. 
In chapter 3, we verified that the two N-terminal dsRBDs of RHA 
specialize in dsRNA binding by the in vitro protein-dsRNA affinity pull down 
assay. Based on this feature, we then determined the complex structures of 
RHA dsRBD1/GC10 duplex and RHA dsRBD2/GC10 duplex. Both dsRBDs 
adopt the canonical ---- fold, while the GC10 duplexes stack end-to-end 
to form continuous elongated A-form-like helices. Moreover, three regions on 
dsRBDs were identified to be involved in dsRNA binding, and the key 
residues which are crucial for dsRNA binding in these regions were pinpointed 
by the ITC assays combined with mutagenesis. Structural comparison between 
RHA dsRBD1/GC10 duplex and RHA dsRBD2/GC10 duplex revealed that 
there are conformational deviations in both dsRBDs and GC10 duplexes, 
suggesting that the “induced-fit” mechanism may be applicable to the dsRNAs 
binding by dsRBDs in general. Furthermore, the arrangements of the critical 
residues for dsRNA interaction imply that dsRBD1 may have higher 
dsRNA-binding affinity. This was further validated by the ITC assays.  
In addition to these structural observations, a crystallographic dsRBD1 
pair binding to both faces of GC10 duplex was observed in RHA 
dsRBD1/GC10 duplex structure. This observation is of physiological 
significance, since it suggests that the two RHA dsRBDs may adopt a similar 
binding mode in recognizing siRNA in vivo. The proposal that RHA dsRBD1 
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and dsRBD2 recognize both faces of siRNAs were further supported by a 
co-IP experiment. A plausible significance of this binding mode is to enhance 
the binding, which was also supported by an ITC experiment.  
The deletion of the RHA dsRBD1+2 abolishes the interactions of RHA 
with Ago2, Dicer and TRBP2 (Robb & Rana, 2007). By co-IP assays, we 
mapped the interaction details of RHA dsRBD1+2 with Ago2 and TRBP2. The 
co-IP assays combined with RNase treatment assays showed that these 
interactions are all mediated by siRNAs. Moreover, the co-IP assays combined 
with mutagenesis demonstrated that the integrated tandem dsRBDs with 
higher siRNA-binding affinity are required for these interactions. Finally, 
based on available structural and functional data, we built a structure model 
for RHA (without C-terminal RGG motif) complexed with a small RNA 
duplex. From this model, we speculated a working model of the siRNA duplex 
recognition and partial unwinding by the RHA in vivo.  
In chapter 4, we solved the crystal structure of the NTD of DCR1 from P. 
stipitis. Comparison of our structure with that of the NTD of KpDCR1 
indicated that they share homology to each other. We also obtained the crystals 
of protein fragments containing the RNase III and dsRBD1 domains of 
PsDCR1. However, these structures were unsolved due to the relatively low 
resolution data. Nevertheless, based on sequence alignment analyses of the 
NTDs, RNase III domains and dsRBDs from various RNase III proteins, we 
speculated that the structures of the RNase III and dsRBD domains may be 
conserved with their counterparts’ structures. Structural analysis revealed that 
the PsDCR1 NTD form homodimers in solution. AUC and GA-crosslinking 
assays not only confirmed this observation, but also verified the homodimeric 
nature of the full-length PsDCR1 as well as several other truncated fragments. 
These data, together with previous findings that the RNase III proteins from 
various species function as dimers, suggest that it may be a universal 
phenomenon that the RNase III proteins act as dimers. The dimerized NTDs of 
PsDCR1 contributes an additional dimerization interface to the PsDCR1 
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homodimer. However, it is dispensable for this dimerization, as the deletion of 
the NTD did not affect the dimerization of the PsDCR1-NTD mutant.  
The RNA binding and processing capabilities of the full-length PsDCR1 
and various truncated fragments were examined by EMSA, ITC and RNA 
cleavage assays, respectively. These results not only verified the canonical 
roles of the RNase III domains in dsRNA cleavage and the dsRBDs in dsRNA 
binding, but also demonstrated the requirements of the NTD and C-terminal 
dsRBD-like domains in both activities. Although the PsDCR1 NTD did not 
bind to dsRNA directly, it increased the binding affinities of PsDCR1 to 
dsRNA. Remarkably, by a co-IP assay, we demonstrated that the NTD and the 
C-terminal dsRBD-like domain associate with each other. This association 
may facilitate the assembly of optimum PsDCR1-RNA complex for efficient 
RNA cleavage, as the deletion of either domain slightly reduced the dsRNA 
binding and the deletion of both domains led to weak dsRNA binding and 
cleavage activities.  
Taken together, our structural studies on dsRNA recognition by RHA 
dsRBDs and functional characterization of RHA dsRBDs in RISC assembly 
provide structural insights into the RISC assembly facilitated by the dsRBDs 
of RHA. Our determined structure of PsDCR1 NTD and functional studies on 
PsDCR1 provide new perspective of the roles and relationship of domains of 
PsDCR1. This information may be extrapolated to the DCR1 homologues and 
the Rnt1 homologues. 
However, one limitation of this study is that the mechanism underlying 
the cooperative binding is still unclear due to the lack of dsRBD1+2/dsRNA 
complex structure. Our attempts have been unfruitful, despite the fact that we 
have screened more than ~1,500 conditions for various RHA 
dsRBD1+2-containing fragments together with siRNA duplexes of different 
lengths and sequences. We observed that these protein fragments are very 
unstable, as revealed by the following facts. Firstly, the RHA dsRBD1+2 
fragments were easily degraded into smaller single dsRBD-containing 
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fragments by the addition of trace amount of proteases. Secondly, the purified 
dsRBD1+2 fragments were digested even in the crystallization solution after 
several days. This instability is most likely due to the existence of the long 
unstructured loop region between the two dsRBDs. We tried to avoid protease 
contamination during the purification procedures by adding PMSF (a protease 
inhibitor) into purification buffers. In this case, the proteins obtained were 
relatively more stable. However, we have not yet obtained any crystal. Further 
research should attempt to develop new methods for the crystallization of this 
type of proteins. 
The second limitation of this study is that the functions of the other 
domains of the full-length RHA in the RISC assembly, such as the helicase 
core and the C-terminal RGG motif, were not explored. To address this 
problem, the structure of the full-length RHA either in free form or in complex 
with other components of the RISC-loading complex may be required.  
The third limitation of this study is that the detailed function of PsDCR1 
is still unknown. Although we have revealed that it is capable of both dsRNA 
binding and dsRNA processing in vitro, its cleaved products were not 
observed in our RNA cleavage experiments. Furthermore, similar case also 
happened in the positive control (the KpDCR1-C) which should have 
generated final products of 23 nts in length. Thus, a more sensitive detection 
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Table S-3 Crystallization kits used for initial screening 

Hampton Research Qiagen Crystalgen 
GridScreenAS JCSG+Suite CryoMax
GridScreenPEG6000 PACTSuite NaMax
GridScreenNaCl ClassicsSuite MPDMax
CrystalScreen1 ClassicsIISuite PhosMax
CrystalScreen2 ComPASSuite AsMax
CrystalScreenlite AnionsSuite MemMax
Index CationsSuite 
ScreenCryo PHClearSuite 
Natrix PHClearIISuite 
 ProteinComplexSuite 
 NucleixSuite 
 MbClassSuite 
 MbClassIISuite 


